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Cerebral small vessel disease (SVD) is associated with various pathological and 
neurological processes that affect perforating arterioles, capillaries and 
venules. The characteristic features of cerebral SVD include small lacunar 
subcortical infarcts, white matter hyperintensities, microbleeds and cortical 
microinfarcts. The underlying pathology of cerebral SVD is not fully known, 
owing to the difficulty of studying the disease in humans. Small lacunar 
infarcts are rarely fatal and often asymptomatic. In cases where death occurs, 
autopsy tissue is often difficult to interpret since multiple pathological changes 
have occurred at this late-stage in disease pathology.  
 
Spontaneously hypertensive stroke prone rats (SHRSPs) are an accepted and 
validated model of cerebral SVD, demonstrating many of the features observed 
in the human condition. Arteriosclerosis, thickening of the vessel wall, 
narrowing of the arterial lumen, endothelial dysfunction and a loss of vessel 
reactivity have all been reported in SHRSPs. Given these pathologic 
cerebrovascular changes, the hemodynamic response in these animals may be 
sensitive to such changes and therefore provide a marker of cerebrovascular 
health and an indicator of therapeutic effect. Blunted BOLD responses have 
been observed in patients with SVD but no study has assessed whether SHRSPs 
demonstrate a similar reduction in the stimulus-evoked BOLD response. 
Therefore, the main aim of this thesis was to evaluate whether differences in 
the hemodynamic response could be detected in between SHRSPs compared to 
age-matched WKYs. 
 
Prior to performing the study described above, we deemed it necessary to 
evaluate the ability to non-invasively monitor PaCO2, by measuring end-tidal 
CO2 using side-stream capnography. Baseline and stimulus-evoked cerebral 
blood flow (CBF) and blood oxygenation level dependent (BOLD) responses are 
sensitive to changes in the partial pressure of arterial carbon dioxide (PaCO2). 
Therefore, it is important that PaCO2 is monitored and kept within normal 
physiological values to avoid introducing confounds into the data. Blood gas 
analysis remains the gold standard for assessing PaCO2 and other blood gases, 
however these measurements are invasive and discrete, only providing a 
measure of PaCO2 for a short time following withdrawal and analysis of the 
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blood sample. The ability to continuously and non-invasively assess PaCO2 using 
side-stream capnography would be beneficial for preclinical fMRI studies, 
particularly longitudinal studies, as it could minimise/eliminate any invasive 
surgery/procedure required to periodically take blood samples for blood gas 
analysis and provide a continuous measurement. However, the combination of 
the rat’s small tidal volume, long sample lines, and large sample volumes 
required by most capnographs complicate the accurate assessment of PaCO2 
using ETCO2 in these small animals. Therefore, an aim of this thesis was to 
assess the ability of micro-sampling side stream capnography to non-invasively 
assess PaCO2 by comparing ETCO2 measurements with PaCO2 measurements 
obtained by blood gas analysis. Despite the smaller sample volumes require by 
micro sampling capnographs, our findings indicate that a large variability still 
exists between ETCO2 and PaCO2 values when long sampling lines are used, as 
would be required for use in an fMRI experiment. Therefore, side-stream 
capnography was not implemented in any of the other studies described in this 
thesis. However, the use of shorter lines for bench top experiments may hold 
promise with some opimisation. 
 
It was also deemed necessary to explore the effects of varying forelimb 
stimulation parameters on stimulus-evoked BOLD, CBF and neural responses 
under combined medetomidine-isoflurane anaesthesia. Anaesthesia is known to 
have various effects on CBF and neural activity, depending on the anaesthetic 
being used, which can subsequently affect stimulus-evoked hemodynamic and 
neural responses. Therefore, there is a general consensus that stimulus 
parameters should be optimised to the anaesthetic being utilised, especially in 
cases where a novel anaesthetic is being used or if no stimulus optimisation is 
currently provided in the literature. Since no study has previously 
characterised the effects of varying stimulus parameters on the hemodynamic 
and neural responses under this anaesthetic protocol, the effect of varying the 
stimulus intensity, stimulus frequency and pulse duration on the stimulus-
evoked BOLD, CBF and neural responses was subsequently investigated using 
fMRI, laser speckle contrast imaging and electrophysiology, respectively. The 
aim of these experiments was to identify the optimal stimulus parameters that 
evoked the largest response. Tested parameters were selected based on 
commonly used values in the literature. We observed that frequency had the 
largest impact on the resultant hemodynamic or neural measurements, with 
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higher frequencies generally evoking larger peak responses. However, analysis 
of the SEPs revealed that at higher frequencies there was a periodic loss of the 
SEP response and the overall amplitude of the SEPs declined over the course of 
stimulation. Stimulus intensity had a modest effect on the hemodynamic 
response with larger responses generally being observed >4 mA. Ultimately, 
the optimal parameters were selected as 6 mA, 0.3 ms and 3 Hz. These 
parameters were subsequently used for the fMRI study in SHRSPs. 
 
 
The findings in this thesis represent one of the few preclinical studies assessing 
the hemodynamic response in SHRSPs. Several studies have assessed the 
hemodynamic response in patients with cerebral SVD and observed blunted 
BOLD responses to stimulation. However, to our knowledge, this has not been 
assessed in the SHRSP. Given the role of the endothelium in mediating the 
hemodynamic response, and that dysfunction of the endothelium has been 
reported in the SHRSP and patients with cerebral SVD, assessing the 
hemodynamic response may provide a biomarker of cerebrovascular health and 
therapeutic effect. Several clinical trials have already assessed cerebrovascular 
reactivity by evaluating changes in the BOLD response to a hypercapnic 
challenge as a primary endpoint, suggesting this assessment is clinically 
relevant. Characterising the hemodynamic response in SHRSPs could further 
support their use as a model of cerebral SVD and allow consistent assessments 
to be performed in preclinical and clinical stages, which could aid in drug 
identification and development. Therefore, the main aim of this study was to 
characterise any differences between the stimulus-evoked BOLD and CBF 
responses to forelimb stimulation in the SHRSP, including any differences 
between young and old animals and aged-matched WKYs. The hemodynamic 
response was found to differ between older SHRSPs and young and older WKYs, 
with the stimulus-evoked BOLD and CBF responses being larger in the old 
SHRSPs. This observation opposes the findings of other studies that assess the 
hemodynamic response in patients with SVD, but aligns with fMRI findings in 
the SHR parent strain. It will be important for future studies to characterise 
this difference of responses between preclinical and clinical populations to 
confirm whether it is underpinned by a biological and pathologic mechanism or 
whether it has been artificially created by some of the requirements for 





1.1 Cerebral circulation 
The brain is one of the most perfused organs within the human body, being 
supplied by a dense network of blood vessels. Blood is delivered to the brain 
via the internal carotid and vertebral arteries that provide anterior and 
posterior circulation, respectively. The right and left vertebral arteries join at 
the level of the pons to form the basilar artery. The basilar artery subsequently 
joins an arterial ring, known as the circle of Willis, that connects the basilar, 
internal carotid and posterior cerebral arteries via anterior and posterior 
communication arteries. Branches of the posterior cerebral, basilar and 
vertebral arteries supply the posterior cortex, midbrain, and brainstem, while 
branches from the internal carotid arteries supply the forebrain. Major 
branches of the internal carotid include the anterior and middle cerebral 
arteries, the latter of which gives rise to the lenticulostriate arteries that 
penetrate the basal surface of the brain to supply deep structures such as the 
basal ganglia. Branches of the anterior, middle and posterior cerebral arteries 
also run across the surface of the brain, within the pia-arachnoid. These pial 
arteries give rise to penetrating arterioles that enter the brain tissue and 






1.1.2 Blood vessel structure 
Cerebral arteries consist of three concentric layers. The innermost layer, the 
tunica intima, consists of a single layer of endothelial cells that are arranged 
in continuous tubular formations, being ensheathed on the abluminal side by a 
layer of connective tissue known as the internal elastic lamina. The next layer, 
the tunica media, consists largely of vascular smooth muscle cells (VSMCs) with 
some elastin and collagen fibres. The number of VSMCs as well as the shape, 
size and orientation of individual cells varies depending on species, vessel size 
and position along the vessel (Todd et al. 1983; Ushiwata and Ushiki 1990). 
VSMCs express contractile proteins, such as actin and myosin, and play a 
crucial role in regulating vessel diameter (Hill et al. 2015). The outer most 
layer, the tunica adventitia/tunica externa, consists mostly of collagen fibres. 
 
While the previously described structure generally relates to larger arteries, 
there are subsequent changes in vessel structure when progressing through the 
vascular tree from large arteries to capillaries, particularly in the tunica 
media. While large arteries may have as many as 20 VSMC layers within the 
tunica media, pial vessels may only have 2-3 layers of VSMCs and penetrating 
arteries that enter the brain parenchyma consist of an endothelial layer, a 
single layer of VSMC cells and the outer, tunica adventitia. In smaller 
arterioles and capillaries, VSMCs are replaced with a different type of mural 
cells known as pericytes. The role of pericytes in regulating vessel diameter 
has been questioned over the past decade. Pericytes were previously thought 
to play a critical role in regulating cerebral blood flow (CBF) in the 
microcirculation by driving changes in vessel diameter. However, it was later 
reported that pericytes lacked the contractile protein α-smooth muscle actin, 
thereby suggesting that they did not participate in capillary vasomodulation 
(Hill et al. 2015). However, recently it has been shown that pericytes do 
indeed contain the contractile protein α-smooth muscle actin (Alarcon-
Martinez et al. 2018), with the authors attributing the inability to previously 
detect this protein due to the previously utilised tissue preservation technique 
and degradation of tissue samples. Pericytes have also been shown to play a 
role in maintaining the blood brain barrier (BBB; Armulik et al. 2010). 
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1.1.3 Blood brain barrier 
The existence of the BBB was first postulated in the early 1900’s following the 
observation that intravenously injected aniline dyes stained all organs in small 
animals, with the exception of the brain (Goldmann 1909). Later, when tryptan 
blue dye was injected into the cerebrospinal fluid (CSF) of rabbits and dogs, 
the brain became readily stained but other organs did not (Goldmann 1913). 
Thus, early theories considered the BBB as an impermeable barrier, however 
years of subsequent research have shown that it is not impermeable and plays 
a more regulatory role. 
The microvasculature of the central nervous system (CNS) is the foundation of 
the BBB and demonstrates unique properties to tightly regulate the entry and 
exit of substances from the brain. The two main components of the BBB are 
the brain capillary, formed from a single layer of endothelial cells, and the 
basement membrane that envelopes the capillary. Endothelial cells that 
comprise the BBB differ from those in the peripheral vasculature, having 
increased mitochondria, a lack of fenestrations and exhibiting minimal 
pinocytic activity (Oldendorf et al. 1977; Fenstermacher et al. 1988; Sedlakova 
et al. 1999). The basement membrane comprises collagen type IV and 
extracellular matrix proteins, such as proteoglycans and laminin (Thomsen et 
al. 2017). Additionally, pericytes reside within the basement membrane and, 
as previously mentioned, play a role in regulating vessel diameter. Astrocytic 
end-feet processes also contact the basement membrane and encapsulate the 
entire structure.  
 
In the BBB, endothelial cells are arranged in a continuous tubular formation 
and joined by tight junctions. Tight junctions are intermembranous strands 
that form a barrier between adjacent endothelial cells and are comprised of 
various proteins that include occludin, claudin and zona occludens (Anderson 
and Van Itallie 2009). As such, the brain endothelium forms a continuous 
barrier that restricts the paracellular exchange of molecules and cells. This 
limitation of movement between the periphery and central nervous system 
maintains an optimal chemical environment for neural activity and shields the 
brain from fluctuations in blood plasma composition and from circulating toxins 
or pathogens that could otherwise disturb the homeostatic chemical 
environment and injure the brain. 
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Despite the restrictions imposed by the presence of the BBB, the brain requires 
various molecules and substrates to sustain metabolic activity and requires the 
removal of metabolic waste products that could otherwise negatively alter the 
chemical environment and lead to cytotoxic damage. There are several 
mechanisms by which various molecules can cross the BBB. Firstly, passive 
diffusion in which a molecule follows a concentration gradient from high to 
low. Generally, only lipid soluble molecules with low molecular weight are able 
to cross the BBB by passive diffusion. These include gases such as oxygen and 
carbon dioxide. The majority of substances that cannot cross the BBB by 
diffusion are transported via carrier mediated and receptor mediated 
transport. The glucose transporter type 1 (GLUT1) enables the transport of 
glucose across the BBB and subsequently into the brain (Pardridge et al. 1990). 
Additionally, the large neutral amino-acid transport type 1 (LAT1) enables the 
transport of phenylalanine and other large neutral amino acids (Pardridge and 
Oldendorf 1975). Not all transport mechanisms result in an influx of molecules 
and substances into the brain and some also play a role in regulating 
homeostasis of the brain environment by removing substances from the brain. 
Receptor-mediated transport generally aid the transport of endogenous 
substances. One such example is the transport of insulin which is transported 
by binding to the endogenous insulin receptor (Pardridge et al. 1985). Efflux 
pumps such as P-glycoprotein and breast-cancer resistant protein are part of 
the adenosine triphosphate (ATP)-binding cassette family and actively remove 
exogenous compounds and drugs from the brain, which presents a challenge for 
drugs that target the central nervous system (Kooij et al. 2012).  
 
1.1.4 The neurovascular unit 
While the neuron is generally considered the fundamental unit of the brain and 
plays a critical role in signal transmission/processing throughout the nervous 
system, it is integrated with various other cell types such as astrocytes, 
microglia, pericytes and blood vessels to form the neurovascular unit. The 
concept of the neurovascular unit first emerged from the Stroke Progress 
Review meeting of the National Institute of Neurological Disorders and Stroke 
in 2001 to emphasise the relationship between brain cells and the 
cerebrovasculature (NINDS 2001). Prior to this time, there were some within 
the scientific community who assumed that there was generally little 
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interaction between neurons and the cerebrovasculature and similarly, that 
neurodegenerative diseases e.g. Alzheimer’s disease and cerebrovascular 
diseases e.g. stroke were mutually exclusive and mechanistically unrelated 
(Iadecola 2017). Following the Stroke Progress Review group meeting, there 
was increasing interest in studying the neurovascular unit, as evidence by the 
annual increase in the number of publications citing “neurovascular unit” in 
the years following the meeting (Iadecola 2017). Such research supported the 
concept that the components of the neurovascular unit were reciprocally 
connected with each other, both structurally and functionally, to enable cross-
talk between the various cell types. This interdependence between the 
components of the neurovascular unit aid in its functions in brain development, 
the formation and maintenance of the BBB, signal transduction via the 
cerebrovascular matrix, clearance and immune surveillance through the 










1.1.5 Neurovascular coupling 
While the brain only constitutes approximately 2% of the total body mass, it 
uses 20% of the total energy consumed by the body at rest. Of the total energy 
available to the brain, it is estimated that 50% is used to reverse glutamate-
evoked ion fluxes (sodium and calcium), 21% on reversing ion gradients from 
induced action potentials, 20% on maintaining resting membrane potentials by 
actively pumping out sodium ions, 5% to reverse action potential-induced 
presynaptic calcium ion (Ca2+) influx and 4% on neurotransmitter recycling 
(Howarth et al. 2012). Since there are no significant energy reserves within the 
brain, it depends on a continuous and adaptable blood supply to transport 
metabolic substrates, such as oxygen and glucose, to meet the dynamic 
metabolic changes associated with neural activity. Furthermore, the vascular 
system also enables the clearing of metabolic by-products that would 
otherwise build up and lead to cytotoxic damage.  
 
Neurovascular coupling defines the close temporal and spatial relationship 
between neural activity and CBF; generally, an increase in neural activity is 
followed by a local increase in CBF. Such a relationship was first noted by the 
Italian physiologist Angelo Mosso, who observed increased blood pulsations over 
the right prefrontal cortex when a subject with a skull defect performed a 
mental arithmetic task (Mosso 1880). Later, Roy and Sherrington (1890) 
proposed that a metabolic feedback mechanism underpinned the coupling of 
cerebral blood flow to neural activity due to the observation that neural 
metabolic by-products, such as carbon dioxide (CO2), could dilate cerebral 
vasculature. This subsequently led to the hypothesis that the local increase in 
cerebral blood flow observed with increased neural activity was generated due 
to a reduction in metabolic substrates, such as glucose and oxygen, and an 
increase in metabolic by-products such as CO2, adenosine and lactate (Kety 
1950). Indeed such metabolic by-products are capable of inducing vasodilation 
of cerebral vessels (O’Regan 2005). However, local decreases in O2 
concentration at the site of neural activation are small and transient compared 
to the substantial increases in CBF that attend (Fox and Raichle 1986). 
Furthermore, these large CBF increases still occur under conditions of excess 
oxygen and glucose, and under hypoglycaemic conditions, suggesting that 
depletion of these substrates does not drive the observed increased CBF 
response (Powers et al. 1996; Wolf et al. 1997; Lindauer et al. 2010). 
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Therefore, such observations suggest that neurovascular coupling is unlikely 
driven by a metabolic ‘feedback’ mechanism.  
 
An alternative feed-forward mechanism has been suggested to underpin 
neurovascular coupling, with increased neuronal activity initiating various 
signalling cascades that ultimately lead to vasodilation. In this model, neurons 
and astrocytes are thought to play key roles in mediating changes in CBF. In 
neurons, glutamate binding causes the influx of Ca2+ into postsynaptic 
terminals through activated N-methyl-D-aspartate (NMDA) and amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, increasing 
intracellular Ca2+ and activating Ca2+-dependent enzymes such as neuronal 
nitric oxide synthase (nNOS) and cyclooxygenase (COX) 2 which synthesise 
potent vasodilators (Iadecola 2017). Astrocytic end feet processes contact 
synapses exposing them to glutamate released from activated neurons. Here, 
glutamate acts on astrocyte metabotropic glutamate receptors and leads to 
the activation of phospholipase A2 and the production of arachidonic acid from 
membrane phospholipids. Arachidonic acid is subsequently metabolised by COX 
and cytochrome p450 epoxygenase pathways to produce prostaglandins and 
epoxyeicosatrienoic acids (EETs), respectively, which can act on both smooth 
muscle cells and pericytes, leading to vasodilation of arteries and capillaries, 
respectively (Peng et al. 2002; Peng et al. 2004; Metea and Newman 2006; 
Gordon et al. 2008). The dominant prostaglandin in vasodilation is thought to 
be PGE2 which has been shown to induce vasodilation by binding to the EP2 and 
EP4 prostaglandin receptors (Lacroix et al. 2015). Astrocytes have also 
previously been thought to mediate vasodilation through the siphoning of 
potassium ions (K+), in which K+ released from activated neurons depolarises 
nearby astrocytes resulting in the efflux of K+ from astrocyte end feet 
contacting cerebral vessels (Paulson and Newman 1987). Indeed, modest 
increases in extracellular K+ concentration can hyperpolarise smooth muscle 
cells which subsequently reduce the influx of Ca2+ through voltage-gated 
channels resulting in smooth muscle cell relaxation and dilation of the vessel 
(Knot et al. 1996).  
 
The exact contributions of neurons and astrocytes in neurovascular coupling 
are not fully known. In a recent meta-analysis, blockade of nNOS was found to 
have the largest effect in reducing the magnitude of the neurovascular 
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response; an average reduction of 64% was observed across 11 in vivo studies 
(Hosford and Gourine 2019). Pharmacological inhibition and genetic deletion of 
nNOS result in a similar reduction of the hemodynamic response to stimulation 
(Ma et al. 1996; Yang et al. 2003), indicating that full inhibition of NO was 
likely achieved in these studies and therefore, the observed reduction of 64% 
was unlikely due to incomplete inhibition of nNOS. Interestingly, NO donors in 
nNOS-inhibited rats have been observed to restore the attenuated CBF 
response to non-nNOS-inhibited levels (Lindauer et al. 1999). Since NO donors 
provide a constant level of NO that does not vary with the level of neural 
activity, NO is likely to play a more permissive role in neurovascular coupling 
rather than mediate it. However, while nNOS signalling may account for the 
majority of the neurovascular response, a significant proportion of the 
response remains when this pathway is blocked, suggesting other signalling 
mechanisms are involved. Interestingly, blockade of COX or epoxygenase 
pathways results in an approximate 50% reduction in the hemodynamic 
response in animals and humans (Bruhn et al. 2001; Hosford and Gourine 2019). 
However, it should be noted that this observation may overestimate the 
contribution of these signalling pathways in neurovascular coupling since the 
non-specific COX inhibitor, indomethacin, was used. Indomethacin also inhibits 
cyclic AMP-dependent protein kinase activity, a critical component of 
vasomotor responses. Interestingly, blockade of NOS, COX and epoxygenase 
activity does not completely abolish the neurovascular response suggesting 
other mechanisms are involved (Leithner et al. 2010). 
While neuron- and astrocyte-mediated signalling likely underpin the main 
pathways to induce CBF increases in neurovascular coupling, these are 
generally localised to the activated area. For flow to increase sufficiently, 
these vasodilatory signals need to be conveyed to upstream arterioles (Segal 
2015). Indeed, several studies have shown that vasodilation is retrogradely 
propagated to upstream pial vessels (Dietrich et al. 1996; Iadecola et al. 1997; 
Silva and Koretsky 2002). The cellular origin of this retrograde vasodilation 
propagation has been attributed to the endothelium; lesion of the endothelium 
results in the failure of neural activation induced vasodilation to propagate 
beyond the local area of activity and alters the amplitude and temporal 




Cerebral autoregulation is the process whereby changes in cerebrovascular 
tone regulate blood flow and volume to ensure that a constant cerebral 
perfusion pressure (CPP) is maintained across a wide range of arterial blood 
pressures. The underlying mechanisms of cerebral autoregulation are not 
completely understood although myogenic, metabolic, neurogenic and 
endothelial mechanisms have been proposed (Armstead 2016). The myogenic 
component relates to the constriction or dilation of vessels through the actions 
of VSMCs that regulate vessel size and resistance, and has been suggested to 
play a dominant role in cerebral autoregulation (Hamner and Tan 2014). 
Additionally, metabolic by-products such as CO2, H+ and adenosine are 
vasoactive and thereby may provide a metabolic component to autoregulation 
(Meng and Gelb 2015). Perivascular adrenergic nerves densely innervate the 
brain cerebrovasculature and VSMCs express alpha- and beta-adrenergic 
receptors (Edvinsson 1982), suggesting a neurogenic component to 
autoregulation. However, animal studies have reported both the abolishment 
and preservation of autoregulation in sympathetic and parasympathetic 
denervated animals (Sagawa and Guyton 1961), while in humans, the 
sympathetic and parasympathetic system have been shown to modulate 
cerebral autoregulation (Hamner et al. 2010; Hamner et al. 2012). 
Additionally, nNO has been shown to influence cerebral autoregulation in 
animal models (Talman and Nitschke Dragon 2007) while its role in human 
cerebral autoregulation remains unclear (White et al. 2000; Zhang et al. 2004). 
Such observations may be due to differences between species (Sándor 1999), 
however a definitive consensus concerning the involvement of a neurogenic 
component in cerebral autoregulation has yet to be achieved. Endothelial 
factors such as endothelial nitric oxide, endothelial derived hyperpolarisation 
factor, eicosanoids and endothelins may also be involved in regulating cerebral 
autoregulation due to their vasoactive properties (Peterson et al. 2011). 
In a normal adult, CBF is maintained at approximately 50 mL per 100 g of brain 
tissue per min, providing mean arterial pressure remains within the lower and 
upper limits of autoregulation (60−160 mmHg) (Phillips and Whisnant 1992). 
While CBF and vessel diameter are generally well maintained within these 
limits, increases in blood pressure above the upper limit (autoregulation 
breakthrough) results in forced dilation of the vessel, resulting in increased 
CBF, disruption of the BBB and increases in vascular permeability, all of which 
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may also contribute to the development of hypertensive encephalopathy 
(Lassen and Agnoli 1972; Strandgaard et al. 1974; MacKenzie et al. 1976; 
Kawamura et al. 1993; Tamaki et al. 1995). Conversely, below the lower limit 
of autoregulation, a cascade of deleterious events ensue as CBF declines below 
critical thresholds to sustain various metabolic processes; protein synthesis is 
first reduced then subsequently inhibited, anaerobic glycolysis and disruption 
to energy metabolism follow and finally anoxic depolarisation and cerebral 





1.2 Cerebral small vessel disease 
Cerebral small vessels refer to the arteries branching from the anterior, middle 
and posterior cerebral arteries that penetrate the brain and provide blood flow 
to deeper cerebral structures (Pantoni 2010). Cerebral small vessel disease 
(SVD) generally refers to various pathological and neurological processes that 
are characterised by structural changes within these perforating arterioles, 
capillaries, and venules, as well as the resultant changes occurring in deep 
white and grey matter structures. Cerebral SVD underlie lacunar strokes, a 
subtype of ischemic stroke that accounts for 20% of all strokes (25% of ischemic 
strokes), although the prevalence of lacunar infarction may be higher in some 
populations, such as the Chinese population, where epidemiological studies 
have indicated that lacunar infarction accounts for 38-46% of ischemic strokes 
(Fang et al. 2012; Tsai et al. 2013).  
 
Lacunar strokes are characterised by small infarcts (2-20 mm in diameter) 
localised within deep brain structures that include cerebral white matter, 
basal ganglia and the pons (Bamford et al. 1988; Sudlow and Warlow 1997a; 
Wardlaw et al. 2013). While lacunar strokes can be symptomatically ‘silent’ 
and therefore go unnoticed, 25% of patients suffering a lacunar stroke are left 
with functional disabilities (Pantoni 2010). Symptoms of cerebral SVD include 
cognitive impairment, depression and gait problems. Additionally, a long term 
study in lacunar stroke patients reported that up to 25% of patients suffered a 
second stroke within 5 years of the first (Samuelsson et al. 1996).  
 
1.2.1 Pathogenesis 
The underlying mechanisms that lead to the development of cerebral SVD are 
not fully known. This is largely due to the difficulty of studying the disease in 
humans. Lacunar strokes are rarely fatal and can be ‘silent’ or ‘mild’ in regard 
to their clinical manifestation, and therefore often go unnoticed (Hainsworth 
and Markus 2008). In cases where death does occur from cerebral SVD, this 
may be long after lacunar stroke and other pathological changes have 
occurred. Therefore, there is limited autopsy tissue for analysis and identifying 
causative pathological mechanisms while assessing tissue from established or 
late-stage disease is difficult. However, it is generally thought that cerebral 
SVD arises from reduced CBF, impaired autoregulation and increased BBB 
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permeability. In recent years, evidence supporting a role of endothelial 
dysfunction in driving disease progression has also been observed (Quick et al. 
2021). 
 
1.2.2 Features of cerebral small vessel disease 
The main features of cerebral SVD are typically identified by magnetic 
resonance imaging (MRI) and include small lacunar ischemic stroke or 
hemorrhage (typically sub-cortical), fluid-filled cavities known as lacunes of 
vascular origin (Vermeer et al. 2007; Shi and Wardlaw 2016), white matter 
hyperintensities (WMHs) (Rost et al. 2010; Kynast et al. 2018), visible 
perivascular spaces (Doubal et al. 2010), microbleeds (Cordonnier et al. 2007), 
brain atrophy (Aribisala et al. 2013) and cortical microinfarcts (Smith et al. 
2012). 
 
1.2.2.1 Lacunar ischemic stroke 
Lacunar ischemic stroke is commonly observed in cerebral SVD and is defined 
as a stroke that causes small infarcts <15 mm (or sometimes <20 mm) in 
diameter in the white matter, basal ganglia, pons or brainstem (Wardlaw et al. 
2013). These infarcts generally arise due to abnormalities, such as 
atherosclerosis, lipohyalinosis and fibrinoid necrosis, in a single small deep 
perforating or lenticulostriate artery (Fisher 1965). Of these, the most 
commonly described defect that leads to lacunar ischemic stroke is 
lipohyalinosis, characterised by thickening of the vessel wall, focal dilation and 
eventually, disintegration of the wall and development of an infarct (Wardlaw 
2005). Unlike non-lacunar ischemic stroke, an embolism arising from the heart 
or large arteries does generally not cause lacunar stroke. However, that is not 
to say that lacunar strokes cannot be caused by embolism. Indeed, these have 
been observed to occur although the incidence of such is generally low, 
accounting for no more that 10-15% of all lacunar infarcts (Jackson et al. 
2010). Lacunar ischemic strokes can normally be identified as rounded, ovoid 
or tubular hyperintense areas on diffusion-weighted, T2-weighted and fluid-
attenuated inversion recovery (FLAIR) images, hypointense on apparent 
diffusion coefficient (ADC) maps and T1-weighted images, or hypoattenuated 
on computed tomography (CT; Shi and Wardlaw 2016) 
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1.2.2.2 Lacunes of presumed vascular origin 
Lacunes of presumed vascular origin are small round or ovoid cavities 3-15 mm 
in diameter that contain cerebrospinal fluid and are located in either the grey 
or white matter. Lacunes are usually recognised as a hypointense ‘hole’ 
surrounded by a hyperintense rim on FLAIR images, which aids in 
differentiating them from enlarged perivascular spaces (Shi and Wardlaw 
2016). It is generally accepted that lacunes represent old infarcts that were 
asymptomatic and appeared ‘silently’ in the brain (Vermeer et al. 2007). 
However, large numbers of lacunes are associated with dementia, cognitive 
impairment, gait disturbance and increased risk of stroke (Snowdon 1997; 
Vermeer et al. 2003; Vermeer et al. 2007) 
 
1.2.2.3 White matter hyperintensities 
White matter hyperintensities (WMHs) are areas of increased signal intensity on 
T2-weighted and FLAIR images that are typically distributed bilaterally and 
symmetrically in the white matter and deep grey matter. They are the 
hallmark of pathological change in cerebral SVD when assessed by MRI, and 
have been attributed to demyelination, axonal loss and gliosis (Frisoni et al. 
2007). The underlying cause for WMHs is not clear, although incomplete 
infarction, chronic hypoperfusion and venous collagenous have all been 
proposed. In recent years, it has been observed that WMHs are heterogeneous 
and therefore may indicate different stages of lesion development. Attempts 
have been made to classify WMHs by size, contrast/“whiteness” and position to 
inform on the clinical risks associated with each class (Jung et al. 2021). The 
development of WMHs are preceded by a decline in the microstructural 
integrity of normal-appearing white matter, as evidenced by reduced 
fractional anisotropy (FA) and increased mean diffusivity (MD) being observed 
in the NAWM prior to the development of a WMH (Sam et al. 2016a; Van 
Leijsen et al. 2018). In a meta-analysis, WMHs were associated with an 
increased risk of stroke, dementia and death (Debette and  Markus 2010). 
 
1.2.2.4 Perivascular spaces 
Perivascular spaces are fluid-filled spaces that surround perforating arterioles 
as they penetrate through deep grey and white matter structures. The visibility 
of some perivascular spaces is generally considered normal (Groeschel et al. 
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2006), however increased numbers of enlarged, visible perivascular spaces are 
associated with WMHs, hypertension, lacunar stroke and reduced cognitive 
function, suggesting that these may provide a marker of some underlying 
pathological processes (MacLullich et al. 2004; Hurford et al. 2014). Enlarged 
perivascular spaces appear as hyperintense punctuate areas of <3 mm in 
diameter on T2-weighted images, if viewed perpendicular to the vessel, or 
linear if viewed parallel to the vessel (Potter et al. 2015). It has been 
suggested that the number of visible perivascular spaces indicates active 
inflammation (Wuerfel et al. 2008), however the exact mechanisms underlying 
enlarged perivascular spaces are not well-known. Others have hypothesised 
that enlarged perivascular spaces may indicate impaired BBB or blockage in the 
draining of interstitial fluid due to the reduced pulsatility of hardened vessels 
to drive drainage (Shi and Wardlaw 2016). 
 
1.2.2.5 Microbleeds 
Cerebral microbleeds are generally observed as small (3-5 mm in diameter), 
homogenous hypointense foci on T2-weighted images (Cordonnier et al. 2007). 
In symptomatic patients with cerebral SVD, microbleeds in the frontal, parietal 
and basal ganglia were independently associated with visuospatial/executive 
impairment suggesting that microbleeds may affect cognitive impairment, 
although their number and localisation likely plays a key role in determining 
any impact on cognition (Abdullah et al. 2020). However most cerebral 
microbleeds are asymptomatic and can be found in healthy adults, yet are 
often considered a marker of vascular risk factors (e.g. hypertension, diabetes) 
or amyloid deposition (Cordonnier et al. 2007). The underlying pathophysiology 
of cerebral microbleeds is not fully known but previous studies have shown 
that cerebral microbleeds are predominantly associated with perivascular 
hemosiderin-laden macrophages, although haematomas, intact erythrocytes, 
vascular pseudocalcification, microaneurysm and distended dissected vessels 
have also been observed (Shoamanesh et al. 2011). In a postmortem study, 
brains with the most extensive microbleeds had a higher Sclerosis Index, 




1.2.3 Functional MRI in patients with SVD 
While the structural characteristics of cerebral SVD have received much 
attention, there is a growing interest in using functional MRI (fMRI) to 
characterise cerebrovascular reactivity and brain connectivity in patients with 
cerebral SVD. Abnormal changes and remote connectivity in the sensorimotor, 
frontoparietal and default mode networks have been associated with gait 
disorders, instability and aggravating factors in patient with cerebral SVD when 
assessed by resting-state fMRI (Zhou et al. 2020). Compared with controls, 
reduced stimulus-evoked BOLD responses in the visual cortex have been 
observed in patients with cerebral amyloid angiopathy (CAA), a small vessel 
disease (Dumas et al. 2012; Peca et al. 2013). Furthermore, it was noted that 
the reduction in the BOLD response occurred in the absence of any changes in 
the neural response, as assessed by comparing the visual-evoked potentials 
with controls, suggesting that this observation was underpinned by changes in 
the reactivity of the cerebrovasculature and not the neural response (Peca et 
al. 2013). Adults with severe-to-moderate WMHs have also demonstrated 
reduced task-related BOLD responses in the fronto-temporal and parietal 
cortices when performing an attention test (Atwi et al. 2018). In pre-
symptomatic and symptomatic patients with a genetic form of CAA (hereditary 
cerebral haemorrhage with amyloidosis-Dutch type), the stimulus-evoked BOLD 
signal to visual stimulation was reduced (van Opstal et al. 2017). Several 
studies have used a hypercapnic challenge to assess cerebrovascular reactivity 
in patients with moderate-to-severe white matter disease and observed a 
reduced magnitude and speed of the hemodynamic response in normal-
appearing white matter that later progressed to WMH (Sam et al. 2016a; Sam 
et al. 2016b). Collectively, the studies discussed in this section suggest that 
cerebrovascular reactivity is impaired in patients with cerebral SVD; both in 
those with established disease and those who are pre-symptomatic. Thus, the 
assessment of cerebrovascular reactivity in this patient population may provide 
a useful biomarker for early detection of cerebral SVD and a biomarker of the 
therapeutic efficacy.  
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1.2.4 Sporadic and monogenic forms of cerebral SVD and associated risk 
factors 
Cerebral SVD can broadly be divided into two main categories, sporadic and 
monogenic. Most cases of cerebral SVD are sporadic and these can be further 
classified as non-amyloidal (most common sporadic form) or amyloidal. The 
sporadic non-amyloidal form of cerebral CVD generally describes disease with 
degenerative alterations in the cerebrovasculature (Charidimou et al. 2016), 
and is associated with traditional vascular risk factors that include 
hypertension, diabetes mellitus, hypercholesterolaemia and smoking. It is 
worth noting that such risk factors are equally as common in cortical 
atherothromboembolic stroke (Jackson et al. 2010) and some patients with 
cerebral SVD are not hypertensive or diabetic (Lammie et al. 1997). The brain-
gut axis has also been implicated as a factor in the development of sporadic 
cerebral SVD. Improved BBB integrity was recently observed in SHRSPs who had 
been placed with WKY foster dams compared with those placed with SHRSP 
foster dams (Nelson et al. 2021). Environmental bacteria of the foster dam and 
nesting surroundings shape gut microbiomes suggesting that gut microbiota 
may contribute to the loss of BBB integrity often observed in early cerebral 
SVD. The amyloidal form of sporadic SVD is known as cerebral amyloid 
angiopathy (CAA) and describes a chronic degenerative disease characterised 
by progressive deposition of amyloid-β in the vessel wall of small arteries and 
arterioles which subsequently leads to fibrinoid necrosis, loss of smooth muscle 
cells, wall thickening, and formation of microaneurysms (Attems et al. 2011). 
Several familial forms of CAA also exist and include hereditary cerebral 
haemorrhage with amyloidosis Icelandic type (HCHWA-I) and hereditary 
cerebral haemorrhage with amyloidosis Dutch type (HCHWA-D; Revesz et al. 
2002) 
 
Monogenic forms of cerebral SVD arise from single-gene disorders and include 
cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL), cerebral autosomal recessive arteriopathy 
with subcortical infarcts and leukoencephalopathy (CARASIL) cathepsin A-
related with strokes and leukoencephalopathy (CARASAL), hereditary diffuse 
leukoencephalopathy with spheroids (HDLS), COL4A1/2-related cerebral SVD, 
autosomal-dominant retinal vasculopathy with cerebral leukodystrophy, and 
Fabry disease (FD; Giau et al. 2019). CADASIL is the most common monogenic 
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form of cerebral SVD and arises from mutations in the Notch Receptor 3 gene 
(NOTCH3) which encodes a transmembrane receptor expressed on vascular 
smooth muscle cells and pericytes. Distinct vulnerabilities in both grey and 
white matter have been observed in patients with typical CADASIL (Kim et al. 
2019). Clinical symptoms of CADASIL may appear at younger ages or during 
adulthood and may include stroke, migraine, transient ischemic attack, 
cognitive impairment, dementia, mood disturbances or seizures (Giau et al. 
2019). CARASIL is an extremely rare autosomal recessive disorder that has been 
linked to mutations in the HTRA1 gene which encodes HtrA serine 
peptidase/protease 1 (Hara et al. 2009; Verdura et al. 2015). Similar to 
CADASIL, CARASIL is radiologically characterised by diffuse white matter 
lesions and small infarcts in the basal ganglia. CARASAL is a rare, autosomal 
dominant small vessel disease linked to point mutations in CTSA, a gene 
encoding cathepsin-A, a carboxypeptidase associated with lysosomal enzymes 
(Finsterer et al. 2019). Symptoms of CARASAL include migraine, stroke, facial 
pain, cognitive dysfunction, sleep disorder and depression. HDLS is an 
autosomal dominant form of cerebral SVD clinically characterised by 
behavioural changes, dementia, depression, parkinsonism, and seizures 
(Rademakers et al. 2012). It has been linked with mutations in CSF1R, a 
receptor that has been observed to play a key role in microglial proliferation 
and differentiation. COL4A1/A2 related diseases are linked to mutations in 
COL4A1 and COL4A2 genes which encoded collagen type IV alpha chains (Giau 
et al. 2019). Clinically, COL4A1/A2 related diseases present with symptoms 
consistent with typical cerebral SVD. FD is a X-linked cerebral SVD attributed 
to mutations in the GLA gene that encodes lysosomal α-galactosidase A (Giau 
et al. 2019). 
 
1.2.5 Animal models of cerebral small vessel disease 
The ability to study cerebral SVD in humans is difficult, for reasons previously 
described. In such cases, animal models provide a useful tool to inform on 
disease pathology and progression and identify potential therapeutic targets. 
However, the lack of understanding of the pathological events that lead to 
cerebral SVD makes modelling this disease in animals difficult. Various models 
have been established for preclinical research, each mimicking certain features 
of cerebral SVD that may help to better understand the mechanisms underlying 
pathological changes in cerebral SVD. 
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1.2.5.1 Hypertensive primate model 
Non-human primate models of disease are relatively rare in preclinical 
research, owing to cost and low public approval for their use. However, 
primates have large gyrencephalic brains similar to the human brain, exhibit 
complex behaviours resembling aspects of human cognition, and often mimic 
various disease features as seen in humans (Moss and Jonak 2007; Ndung’u et 
al. 2012; Camus et al. 2015). Chronically hypertensive macaque monkeys 
exhibit a progressive decline in cognitive functions such as memory, attention 
and executive functions similar to the human condition of cerebral SVD (Moss 
and Jonak 2007; Jiménez-Balado et al. 2019). Furthermore, microinfarcts of 
irregular shape and associated with local gliosis have been observed in the grey 
and white matter of these animals (Kemper et al. 1999; Kemper et al. 2001). 
However, these infarcts were smaller that those seen in human lacunar stroke, 
being less than 0.5 mm. Histological assessment also revealed a lack of white 
matter lesions or any changes occurring within the penetrating arteries in this 
model. 
 
1.2.5.2 Chronic carotid occlusion 
Cerebral hypoperfusion is thought to underlie cerebral SVD and therefore 
several different models have been developed to mirror this aspect of the 
disease. Bilateral occlusion of the common carotid arteries (two vessel 
occlusion, 2-VO) is the most commonly used hypoperfusion approach and 
results in chronic hypoperfusion in rats and results in cognitive impairment and 
the development of white matter lesions (Hainsworth et al. 2012).  In rats, the 
bilateral occlusion approach is characterised by white matter degeneration, 
loss of oligodendrocytes, neuroinflammation and a loss of BBB integrity (Choi 
et al. 2016; Arena et al. 2019). Variations in this model include the 3-vessel 
occlusion (3-VO), 4-vessel occlusion (4-VO) and 2-vessel gradual occlusion (2-
VGO) models. The 3-VO is achieved by performing both bilateral carotid artery 
occlusion and unilateral occlusion of a vertebral artery (de la Torre et al. 
1992), while the 4-VO is achieved by performing unilateral occlusion of a 
carotid and a vertebral artery, and then occluding the remaining two arteries 7 
days later (Pulsinelli and Buchan 1988). These severe chronic hypoperfusion 
models demonstrate spatial learning deficits, likely arising from neuronal loss 
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observed in CA1 pyramidal neurons in the hippocampus. The 2-VGO model is 
achieved by placing ameroid restrictor cuffs around each common carotid, 
which gradually swell and completely occlude the vessel after 3 days (Kitamura 
et al. 2012). This model develops spatial working memory impairment and 
white matter lesions but grey matter is relatively spared. 
 
1.2.5.3 Middle cerebral artery occlusion 
Changes in the structure of upstream large vessels, such as middle cerebral 
artery atheroma, have been shown to contribute to cerebral SVD pathology 
(Fisher 1979; Brisset et al. 2013; Xu 2014). Middle cerebral artery occlusion 
(MCAo) is a common method for the induction of ischemic stroke, of which the 
intraluminal filament model is the most widely used in preclinical rodent 
studies. The blockage of the MCA origin induces both cortical and subcortical 
ischemia, with lesions generally occurring in the cortex, hippocampus and 
striatum. However, tissue infarction is generally confined to subcortical 
structures in rat strains with good collateral blood supply to the cortex (Macrae 
2011). However, this technique often suffers from frequent cases of early 
reperfusion, partial occlusion or subarachnoid haemorrhages (Braeuninger and 
Kleinschnitz 2009). Selective occlusion of the hypothalamic artery by advancing 
an intraluminal filament near to, but not occluding the origin of the MCA has 
also been shown to induce small infarcts in deep grey and white matter 
structures (He et al. 1999). Temporary MCAo in macaque monkeys for 30 mins – 
4 hours has been observed to produce subcortical infarcts in grey matter 
structures (DeGirolami et al. 1984). However, these typically resembled 
striatocapsular infarcts, and there was relatively sparing of the white matter.  
 
1.2.5.4 SHRSP  
The spontaneously hypertensive rat family consists of both the spontaneously 
hypertensive rat (SHR) and the spontaneously hypertensive stroke prone rat 
(SHRSP). The SHR was developed first, being bred from Wistar rats 
demonstrating high blood pressure in a colony at Kyoto University (Okamoto 
and Aoki 1963). This model develops hypertension between 5-6 weeks of age 
which plateaus at approximately 8 weeks of age, with blood pressure reaching 
between 180-200 mmHg. However, this model does not generally develop 
stroke and is typically used as a model of hypertension. The SHRSP was 
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developed from 24th generation SHRs, being selectively bred from parental 
animals who demonstrated spontaneous stroke (Okamoto et al. 1974). The 
established strain demonstrated severe hypertension (220−240 mmHg) and a 
high incidence of stroke (SHRSP, 80% vs SHR, 10%).  
 
Cerebral pathology observed in the SHRSP includes cortical infarcts, enlarged 
perivascular spaces (Okamoto et al. 1974), microinfarcts, microaneurysms 
(Coyle 1987; Fredriksson et al. 1987), white matter lesions and BBB breakdown 
(Yamori et al. 1976; Takiguchi 1983; Minami et al. 1985; Chue et al. 1993), all 
of which are consistent with human cerebral SVD. Systematic reviews 
comparing several preclinical models of cerebral SVD with the human condition 
found that the SHRSP demonstrates many characteristics observed in human 
cerebral SVD and therefore represents a valid model of sporadic cerebral SVD 
(Hainsworth and Markus 2008; Bailey et al. 2009). The validity of the SHRSP as 
a model for cerebral SVD is further strengthened by observations that confirm 
similar underlying pathophysiological changes in the SHRSP and human patients 
with cerebral SVD. A higher number of proliferating endothelial cells (a sign of 
endothelial dysfunction) was observed in the brain tissue of 3-week SHRSPs and 
presymptomatic human patients with cerebral SVD when compared with 
controls (Rajani et al. 2018). Dysfunctional endothelial cells were subsequently 
noted to secrete factors, such as heat shock protein 90α, that blocked 
oligodendrocyte maturation and proliferation, processes important in 
maintaining white matter integrity. A mutation in the Atp11b gene was 
identified in the SHRSP as the underlying cause of the observed endothelial 
dysfunctions, and seven single-nucleotide polymorphisms were subsequently 
identified in ATP11B in human patients which were significantly associated 
with WMHs (Rajani et al. 2018). Thus, in assessing the pathology of the SHRSP, 
early endothelial dysfunction was identified as an underlying mechanism of 
white matter pathology in both a model of cerebral SVD and in the human 
condition, and a mutation in ATP11B was identified as a potential contributor 
to SVD vulnerability. 
 
SHRSPs <12 weeks old demonstrate vascular remodelling of large arteries due 
to increases in the number of VSMC layers (Fredriksson et al. 1988; Sironi et al. 
2004). Such remodelling leads to an increase in the external diameter of large 
vessels as well as a decrease in the vessel lumen (Mangiarua and Lee 1992; 
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Kitazono et al. 1995a). Furthermore, vascular remodelling increases vessel 
stiffness with the resistance of large arteries being at least double in 1-year 
old SHRSPs compared to age-matched WKYs (Nordborg et al. 1985). Similar 
changes are observed within smaller vessels, which have shown decreases in 
lumen size (Thompson et al. 1988; Furspan and Bohr 1990; Furspan and Webb 
1993). In 24-week old SHRSPs, internal and external diameters of third-order 
branches of the posterior cerebral artery were smaller to those in age-matched 
WKYs, in the absence of hypertrophy (Coyle 1987), suggesting that SHRSPs may 
have inherently smaller vessels compared to WKYs. 
 
1.2.5.5 Transgenic mouse models 
Transgenic mouse models have been developed for CADASIL and CAA. CADASIL 
is caused by mutations in NOTCH3, and ultimately results in accumulation and 
aggregation of the extracellular domain of Notch3 around vascular smooth 
muscle cells and pericytes of brain arteries and capillaries, in proximity to 
granular osmiophilic material (Chabriat et al. 2009). There are four mouse 
models that express common CADASIL mutations (R90C, R169C, C428S and 
R142C), all of which demonstrate accumulation of Notch3 and granular 
osmiophilic material, consistent with the human condition (Ayata 2010). Mouse 
models of CADASIL also display progressive white matter damage, reduced 
cerebral blood flow, decreased myogenic responses, impaired autoregulation 
during hypotension, and attenuated functional hyperaemia but an absence of 
pathological changes in cerebral artery structure and BBB breakdown (Joutel et 
al. 2010). There are also several models of CAA which are caused by mutations 
in amyloid precursor protein (APP). APPDutch mice overexpress human E693Q 
APP and subsequently demonstrate extensive amyloid angiopathy in the 
cerebrovascular, smooth muscle cell degeneration, hemorrhages and 
neuroinflammation (Herzig et al. 2004). Another model combines human 
Swedish, Dutch and Iowa APP mutations (Tg-SwDI) and demonstrate early onset 
deposition of amyloid-β in cerebral microvessels, decreased cerebral vascular 
densities, apoptotic cerebral vascular cell and cerebral vascular cell loss (Miao 
et al. 2005). Amyloid-β deposits are also associated with reactive astrocytes 
and activated microglia, and exaggerated by chronic hypoperfusion which can 
to increased amyloid angiopathy, microbleeds and haemorrhages (Salvadores et 






1.3 Principles of magnetic resonance imaging 
The atomic nucleus is at the centre of MRI. Although other nuclei are used for 
fMRI, hydrogen nuclei (protons) are the primary nuclei of interest in MRI. 
Atomic nuclei consist of protons and neutrons with a net positive charge and 
some atomic nuclei, such as hydrogen, possess ‘spin’. The ‘spinning’ proton 
can be thought of as a moving electrical charge and as such generates a small 
magnetic field known as a magnetic moment. Under normal conditions, protons 
are orientated randomly within a sample and therefore it possesses no overall 
net magnetisation. However, when placed in a strong, external magnetic field 
(B0), protons align either parallel with (low energy state) or antiparallel to 
(high energy state) the external field. The general preferred state of alignment 
is the one that requires the least energy, which results in an excess of protons 
aligning with the B0 direction (z-axis), creating an overall net magnetisation 
vector (M0) in that direction, referred to as longitudinal magnetisation. Given 
that each proton has angular momentum as a result of its ‘spin’, alignment 
with B0 is not completely parallel but rather the proton precesses around the 
B0 axis. The frequency with which a proton precesses within an external 
magnetic field is known as the Larmor frequency (ω), which can be calculated 
using the Larmor equation (Equation 1). The gyromagnetic ratio (𝛾𝛾) is a 
constant for a particular nuclear species and it’s value for protons is 42.6 
MHz/T. 
 
𝜔𝜔 = 𝛾𝛾𝐵𝐵0 
(1) 
The application of a radio frequency (RF) pulse results in the equalisation of 
the number of protons in the two energy levels (parallel and antiparallel to B0) 
as well as induces phase coherence so that all protons subsequently precess in 
the same direction at the same time. However, this can only be done when the 
RF pulse matches the Larmor frequency of the nucleus of interest, referred to 
as resonance. The resultant transverse magnetisation, which now has a 
magnetisation vector in the xy-plane, precesses at the Larmor frequency, 
generating a rotating magnetic field that is capable of inducing an alternating 
voltage if a conductive receiver is placed nearby. Once the RF pulse is stopped, 
phase coherence is no longer maintained and protons begin to ‘relax’ back to a 
lower energy state and lose phase coherence by T1 and T2 relaxation. 
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1.3.1 Free induction decay 
Once the RF pulse is stopped, both T1 and T2 relaxation occur. The protons 
continue to precess, but as they begin to re-align with the B0 axis, the net 
magnetisation vector shrinks in the xy-plane and increases along the z-axis. 
With a receiver coil placed in the vicinity, the spiralling magnetisation vector 
generates an electrical signal known as the free induction decay. 
 
1.3.2 T1 relaxation 
T1 relaxation is associated with the restoration of longitudinal magnetisation 
and occurs as high energy state protons exchange energy with their 
surroundings to return to a lower energy state. T1 is defined as the time taken 
for longitudinal magnetisation to return to 63% of its final value. The rate at 
which this occurs is dependent on the rate of motion of the molecules 
(tumbling rate) in which the proton resides. Energy exchange between protons 
and their surrounding molecules is more favourable when the tumbling rate 
matches the Larmor frequency of the proton. The tumbling rate is affected by 
the structure and size of a molecule and therefore different molecules have 
different tumbling rates, and therefore different T1 relaxation times. 
Unrestricted water has a fast tumbling rate due to its small molecular size and 
as a result, energy transfer between protons and the surrounding molecules is 
not efficient. Therefore, longitudinal magnetisation takes a relatively long 
time to return and the T1 of water is relatively long. Alternatively, fat 
molecules have a short T1 because they are larger molecules with a tumble 
rate closer to the proton Larmor frequency. Given these inherent properties of 
various molecules, cerebrospinal fluid (CSF) is usually dark and white matter is 
usually brighter than gray matter in T1weighted images of the brain.  
 
1.3.3 T2 and T2* 
T2 and T2* relaxation are underpinned by the gradual loss of transverse 
magnetisation as protons lose phase coherence in the xy-plane. Other nuclei 
within a tissue possess their own magnetic field, thereby generating local 
inhomogeneities that can influence the magnetic spin of nearby protons. This 
causes individual protons to precess at different frequencies thereby leading to 
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a loss of phase coherence. This is known as T2 relaxation or spin-spin relaxation 
since the ‘spin’ of neighbouring nuclei influences the ‘spin’ of nearby protons. 
T2 is defined as the time for T2 relaxation to decay to approximately 37% of its 
initial value.  
 
T2* relaxation is also derived from magnetic field inhomogeneities however 
these arise due to inhomogeneities within the B0 field. These may arise to due 
imperfections in the homogeneity of the magnet or due to susceptibility-
induced distortions from tissue or other objects within the magnetic field. 
Given that the Larmor frequency is proportional to the magnetic field strength, 
inhomogeneities cause protons to precess at different frequencies within 
different locations of the magnetic field thereby resulting in a loss of phase 
coherence.  
 
1.3.4 Gradient coils 
Gradient coils controllably change the magnetic field and generate a gradient 
along a chosen axis. This subsequently results in protons having different 
Larmor frequencies along the gradient and therefore, specific precession 
frequencies will correspond to a spatial location along the gradient. Each 
gradient coil corresponds to an orthogonal direction (x, y, z). The three 
orthogonal directions that are used are, in standard imaging, referred to as 
slice selection, phase-encoding and frequency-encoding gradients and can be 
at oblique angles. The slice selection gradients induce a gradient along the z-
axis. Then by applying a RF pulse across a range of frequencies, a slice the 
thickness of which can be varied by changing the upper and lower limits of the 
RF pulse frequency range or by altering the steepness of the gradient. Spatial 
localisation within the remaining x- and y-axis is similarly determined through 
the use of the frequency- and phase-encoding gradients. 
 
1.4 Functional MRI 
1.4.1 BOLD 
Like many other neuroimaging techniques, fMRI takes advantage of 
neurovascular coupling by measuring changes associated with the local 
increase in CBF (hemodynamic response) to inform on changes in neural 
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activity. Specifically, the hemodynamic response elicited by increased neural 
activity alters the ratio of oxygenated and de-oxygenated haemoglobin, which 
subsequently alters the magnetic susceptibility of the blood. 
Deoxyhaemoglobin is paramagnetic (Pauling and Coryell 1936) and causes local 
field inhomogeneities within the blood vessels, which subsequently shortens 
T2*. Thus the fMRI signal becomes dependent on the level of oxygenation of the 
blood and is therefore appropriately named the blood oxygenation level-
dependent (BOLD) signal. Therefore, the BOLD signal provides an indirect 
measure of neuronal activity by measuring changes in the magnetic 
susceptibility of the blood associated with the coupled hemodynamic response.  
 
The ability to use BOLD as an intrinsic contrast in MRI imaging was first 
identified by (Ogawa et al. 1990) who noted that changes in metabolic demand 
or blood flow induced by anaesthetics, hypoglycaemia or hypercapnia, resulted 
in changes to the BOLD contrast. Given that oxygen is extracted from the blood 
to support neural activity, it would be logical to assume that the T2 signal 
decreases in an active brain area. However, as previously described in Section 
1.1.5, the hemodynamic response that is coupled with increased neural activity 
is substantially surplus to the increased metabolic needs of the active brain 
area and therefore the concentration of deoxyhaemoglobin actually decreases, 
resulting in longer T2 values and therefore the T2 signal increases in active 
neural areas. The requirement for such a surplus increase in CBF in response to 
increased neural activity is not fully understood. Previous studies have 
suggested that this may be required to generate high gradients of oxygen to 
overcome the inefficient, passive diffusion of oxygen at high flow rates (Buxton 
and Frank 1997; Hyder et al. 1998). Others have suggested that the 
disproportionate increase in CBF is required to ensure tissue locations 
downstream of the activated area are still sufficiently oxygenated (Devor et al. 
2011). Additionally, the increased CBF response may be required to remove 
heat generated during neural activity (Yablonskiy, Ackerman, and Raichle 
2000). The relative delay in the hemodynamic response suggests that the 
additional substrates are not required for the initial needs of evoked neural 
activity.  
 
The temporal profile of the BOLD response to a brief stimulus is well 
documented and referred to as the hemodynamic response function (HRF). 
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Following the presentation of a stimulus, the BOLD signal demonstrates a small 
decrease known as the initial dip, in which the increased metabolic demands of 
the stimulus-induced neural activity cause a local increase in oxygen 
metabolism and therefore an increase in deoxyhaemoglobin (Pauling and 
Coryell 1936). Following this, there is a rapid increase in the BOLD signal which 
generally starts 2-4 seconds post-stimulus and then peaks at approximately 6-9 
seconds post-stimulus. The BOLD response then returns to baseline and in some 
instances a post-stimulus undershoot is observed. The underlying mechanism of 
the post-stimulus undershoot is not known, however delayed vascular 
compliance, sustained increases in CMRO2 and post-activation reduction in CBF 
have all been suggested (van Zijl et al. 2012). 
 
1.4.2 Physiological basis of the BOLD signal 
The BOLD signal is an indirect measure of neural activity due to the 
phenomena of neurovascular coupling, however identifying the underlying 
mechanisms that link BOLD and neural activity has been a popular area of 
research since the discovery of the BOLD signal and is still ongoing. A 
substantial advancement in our understanding of the relationship between 
neural activity and BOLD came when simultaneous electrophysiology and fMRI 
were performed in the monkey visual cortex (Logothetis et al. 2001). When 
comparing several different electrophysiological measures, that included local 
field potentials (LFPs) and single- and multi-unit recordings, it was observed 
that LFPs highly correlated with the BOLD response while single- and multi-unit 
activity had lower correlations. LFPs are thought to provide a measure of 
synaptic activity, while single and multi-unit activity is indicative of neural 
spiking activity. Therefore, these findings suggested that the BOLD signal 
represented neural input and local processing within a local brain area as 
opposed to the spiking activity of a neuron. 
 
1.4.3 Factors affecting the BOLD signal 
The BOLD signal is the result of the interaction between neural activity and the 
cerebrovasculature and therefore any factors affecting either one or both of 
these measures can affect the resultant BOLD signal observed in fMRI and 
potential complicate interpretation of the data.  
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1.4.3.1 Carbon dioxide 
CO2 is known to be a potent vasodilator. Inhalation of 5-7% CO2 has previously 
been shown to increase baseline CBF by 75% (Kety and Schmidt 1948). The 
underlying mechanism by which CO2 mediates vasodilation is not completely 
understood. However, in the blood CO2 and water diffuse into red blood cells 
where they are converted into carbonic acid (H2CO3) by carbonic anhydrase. 
Carbonic acid subsequently dissociates into hydrogen ions (H+) and bicarbonate 
(HCO3). H+ can activate voltage gated K+ channels, resulting in 
hyperpolarisation of the endothelial cells which reduces intracellular calcium 
and thereby induces vascular relaxation and increased CBF (Kety and Schmidt 
1948). The increase in CBF induced under hypercapnic conditions results in an 
increase of oxyhaemoglobin and decreased deoxyhaemoglobin which results in 
a longer T2* (Kitazono et al. 1995; Kontos, Raper, and Patterson 1977). This 
subsequently leads to an increase in the baseline BOLD signal, which has been 
observed in both human and animal studies, where hypercapnia was induced by 
either breath-holding or breathing exogenous CO2 concentrations (Kemna and 
Posse 2001).  
 
The increase in baseline CBF and BOLD arising from the vasodilatory effects of 
CO2 are associated with decreased stimulus-evoked CBF and BOLD responses 
(Sicard et al. 2005). Many studies assume that CO2 challenges do not affect the 
underlying neural activity and therefore such observations relate solely to 
changes in the ability of the vasculature to respond. Indeed, early studies using 
MRI to assess oxygen consumption reported that CMRO2 did not change under 
hypercapnic conditions (Posse et al. 1997), suggesting that neural activity was 
not affected by CO2. However, later studies reported conflicting observations 
with some noting decreases in CMRO2 (Kety and Schmidt 1948; Nilsson and 
Siesjö 1976) or neural activity (Kliefoth et al. 1979; Sicard and Duong 2005) in 
response to increased CO2 while others reported increases (Balestrino and 
Somjen 1988; Zappe et al. 2008). The discrepancy in these observations may 
be underpinned by differences in methodologies and the species used, however 
an underlying mechanism for these observations has yet to be confirmed. In 
cases where neural activity was observed to increase under hypercapnic 
conditions, it has been suggested that the increased formation of carbonic acid 
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in response to increased CO2 leads to a decrease in pH which reduces neural 
spiking and synaptic activity (Horvath et al. 1994; Jones et al. 2005). Indeed, 
mild acidosis has previously been reported to reduce neural activity in 
hippocampal cultures (Kliefoth et al. 1979; Balestrino and Somjen 1988). 
Collectively, these studies suggest CO2 may affect neural activity as well as the 
hemodynamic response, however, given the various methodologies and species 
utilised in these studies, it is possible that such differences may have affected 
the results and therefore further investigation is required.  
 
1.4.3.2 Anaesthesia  
It is generally known that most anaesthesia exhibits a depressive effect on 
neural activity and CBF, which may introduce potential confounds interpreting 
the BOLD signal. Indeed, CBF responses to a hypercapnic challenge are larger 
in conscious animals compared to anaesthetised animals (Tombaugh and 
Sapolsky 1990). Additionally, NO inhibitors block the stimulus-evoked CBF 
response in anaesthetised animals but not in awake animals suggesting that the 
underlying mechanisms linking neural and hemodynamic responses may be 
affected by anaesthesia (Nakao et al. 2001). While most anaesthetics depress 
neural activity by affecting various components underlying neural transmission, 
their effects on the CBF response vary depending on the anaesthetic used. 
Commonly used anaesthetics in preclinical studies include α-chloralose, 
urethane, medetomidine, and volatile anaesthetics such as isoflurane. 
Generally, volatile anaesthetics are vasodilatory; isoflurane has been observed 
to dose-dependently dilate large cerebral and pial vessels (Brevard et al. 2003; 
Sicard et al. 2003). Additionally, baseline CBF is substantially lower in rats 
under isoflurane anaesthesia compared to pentobarbital or fentanyl (Iida et al. 
1998). Such observations highlight the difficulty in comparing CBF and BOLD 
responses between studies utilising different anaesthetics as differences in 
response magnitude may be underpinned merely by differences in the 
anaesthetic used. Furthermore, the effect of various drugs on CBF may be 
confounded by the chosen anaesthetic. Cocaine administration was observed to 
cause a decrease in baseline CBF under isoflurane but an increase in baseline 
CBF under α-chloralose anaesthesia (Hendrich et al. 2001). Additionally, 
ethanol induced vasoconstriction in pial arteries under α-chloralose but 
vasodilation under halothane anaesthesia (Du et al. 2009). These observations 
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indicate various drugs can affect CBF differently, depending on the anaesthetic 
being used.  
 
1.4.3.3 Ageing 
Ageing is associated with various changes in the structure and functioning of 
the cerebral vasculature. Both human and animal studies have observed 
thickening of the vessel wall and basal membrane, narrowing of the arterial 
lumen (Nagasawa et al. 1979; Burns et al. 1981; Furuta et al. 1991; Alba et al. 
2004), necrosis of medial smooth muscle cells (Knox et al. 1980; Masawa et al. 
1994) and region-specific decreases in cerebral capillary density (Abernethy et 
al. 1993; Sonntag et al. 1997). Age-related alterations can also lead to the 
occlusion of venous structures (Moody et al. 1997). The development of blood 
vessel tortuosity has also been noted to occur with ageing, which can 
subsequently reduce or restrict blood flow to various areas of the brain, 
including deep white matter (Kawamura et al. 1993; Han 2012). Cerebral 
perfusion in frontal, temporal and parietal cortices is decreased in older, 
healthy individuals compared to younger individuals, an observation that was 
highly correlated with the development of leukoaraiosis around the anterior 
horns of the lateral ventricles (Kawamura et al. 1993). In addition to perfusion 
changes, mean blood flow velocity in anterior, middle and posterior cerebral 
vessels is also reduced in the older population (Krejza et al. 1999).  
 
Given that the BOLD response largely arises from vasodilatory changes in 
cerebral vessels that increase CBF, it is unsurprising that structural changes 
that reduce vessel reactivity can impact functional responses. Indeed, reduced 
BOLD responses to visual and motor stimulation have been reported in older 
individuals compared to younger individuals (Hesselmann et al. 2001; Ances et 
al. 2009). Several studies have also reported decreased vessel reactivity to CO2 
in older individuals (Yamamoto et al. 1980; Ito et al. 2002; Leoni et al. 2017). 
Similarly, cerebral vessels excised from aged rats demonstrate reduced 
vasodilation to adenosine, acetylcholine and bradykinine (Mayhan et al. 1990; 
Jiang et al. 1992).. 
  
Collectively, these studies show that age-related changes to the structure of 
the cerebrovasculature can affect functional responses and thereby introduce 
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potential confounds when using neuroimaging techniques that are dependent 
on the hemodynamic response as a measure of neural activity.  
1.4.3.4 Disease 
Alzheimer’s disease 
Alzheimer’s disease (AD) is a chronic neurodegenerative disorder and the most 
prevalent form of dementia (Vinters 2015). The hallmark of AD is the 
accumulation of amyloid-beta (Aβ) in extracellular plaques and 
hyperphosphorylated tau protein in intracellular neurofibrillary tangles in the 
brain (De Strooper and Karran 2016). Traditionally, AD is considered to arise 
from neuronal and glial dysfunction, however, there is also substantial 
evidence that a vascular component contributes to AD pathology (Govindpani 
et al. 2019). Aβ is known to be vasoactive (Thomas et al. 1996) and mice 
overexpressing amyloid precursor protein (APP), the precursor to Aβ, 
demonstrate reduced baseline CBF and enhanced responses to vasoconstrictors 
(Niwa et al. 2001; Niwa et al. 2002). Furthermore, cerebral vessels in mice 
overexpressing APP demonstrate reduced vasodilation to acetylcholine and 
increased susceptibility to ischemic infarcts, an observation attributed to 
reduced endothelium-dependent vascular reactivity in ischemic areas at risk of 
infarct (Zhang et al. 1997). Attenuated stimulus-evoked CBF responses to 
somatosensory stimulation have also been observed in mice overexpressing APP 
and Aβ, with the level of attenuation reported to correlate with the 
concentration of Aβ (Niwa et al. 2000). Despite attenuation of the stimulus-
evoked CBF response in this model, neuronal activity as assessed by glucose 
metabolism, was reported to remain similar to controls suggesting that the 
reduction in CBF response was due to vascular changes rather than neuronal 
(Niwa et al. 2000). Vascular changes in AD have also been shown to arise from 
the effect of Aβ on pericytes. Aβ has been observed to degrade pericytes and 
promote AD-like neurodegeneration (Sagare et al. 2013). Pericyte-deficient 
mice exhibit reduced microcirculation, baseline CBF and attenuated stimulus-
evoked CBF responses to whisker stimulation (Bell et al. 2010). Collectively, 
these studies indicate that Aβ can affect the functioning of the 
cerebrovasculature and subsequently affect baseline CBF and stimulus-evoked 
responses. These could ultimately lead to the inaccurate assessment of fMRI 
measures, such as BOLD, in patients with AD. Indeed, resting state fMRI in AD 
patients has shown that the functional connectivity of BOLD fluctuations is 
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decreased compared to controls (Greicius et al. 2004; Sorg et al. 2007; Lim et 
al. 2014). However, such findings have been challenged by the observation that 
reductions in functional connectivity correlate with hypoperfusion and were 
independent from changes in glucose metabolism (Göttler et al. 2019). 
 
Hypertension 
It is well established that hypertension induces vascular changes that alter 
blood vessel structure. This vascular remodelling is generally classified as 
inward or outward remodelling to reflect decreases or increases in the lumen 
diameter, respectively (Mulvany 1999). Furthermore, remodelling can be 
hypertrophic (increase in cross-sectional area of vessel wall), eutrophic (no 
change in cross-sectional area of vessel wall) or hypotrophic (decrease in cross-
sectional area of vessel wall). Generally, the effects of hypertension on the 
cerebral vasculature are similar to those observed with normal ageing, and 
observations are also similar between human and animal studies. Hypertrophy 
of smooth muscle cells and increases in collagen content lead to thickening of 
the arterial wall and narrowing of the vessel lumen in large cerebral arteries, 
resulting in an increase in vessel rigidity and vascular resistance (Baumbach 
and Heistad 1988; Pires et al. 2013). While this hypertension-induced vascular 
remodelling may be beneficial and reduce stress on the vessel wall and thereby 
protect downstream microvasculature (Heistad and Baumbach 1992), the loss 
of arterial elasticity can reduce the vasodilatory capability of the vessel. 
Indeed, blunted CBF responses to stimulation have been observed in 
hypertensive patients compared to normotensive controls (Jennings et al. 
2005). Additionally, vessel reactivity to carbon dioxide is also reduced in 
hypertensive animals compared to normotensive controls (Tamaki et al. 1995; 
Nakajima et al. 2008). Collectively, these observations indicate that 
hypertension-induced vascular remodelling increases vessel stiffness and 
reduces vessel compliance, which subsequently reduces the ability of these 
vessels to dilate in response to appropriate stimuli. 
1.5 Summary 
The SHRSP is a valid model of cerebral SVD and demonstrates many disease 
characteristics observed in the human condition. However, to our knowledge, 
no study has yet evaluated the hemodynamic response in this animal model. 
Several fMRI studies in patients with cerebral small vessel disease have 
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observed blunted stimulus-evoked BOLD responses to visual and somatosensory 
stimuli, as well as vasodilatory stimuli (Pineiro et al. 2002; Dumas et al. 2012; 
Peca et al. 2013; van Opstal et al. 2017). This impaired hemodynamic response 
is likely attributed to dysfunctional endothelium which has been observed in 
SHRSPs and patients with cerebral SVD (Rajani et al. 2018). Furthermore, 
dysfunctional endothelium is associated with white matter pathology, and 
drugs that stabilise the endothelium have been shown to reverse the 
pathological endothelial cells and oligodendrocytes highlighting the 
endothelium as a therapeutic target. Therefore, assessing the BOLD response 
in animal models and patients with cerebral SVD may provide a marker of 
therapeutic efficacy. Indeed, several clinical trials have already used 
cerebrovascular reactivity with BOLD MRI as a primary endpoint to assess such 
efficacy (Lavallée et al. 2009; NCT01821118; NCT03082014). However, no study 
has yet evaluated the hemodynamic response in the SHRSP, a finding that 
could further strengthen the validity of this model and aid in the development 
and assessment of drug development in preclinical studies. Therefore, the 
main aim of the studies described in this thesis was to assess the hemodynamic 
response through the assessment of the stimulus-evoked BOLD and CBF 
responses. Given that the current monitoring of CO2 in rodents relies on an 
invasive and discrete measure, we sought to establish a method of noninvasive 
and continuous monitoring through side-stream capnography to permit real-
time recording of CO2. Under a relatively, novel anaesthetic regime, we also 
sought to establish the optimal stimulation parameters for forelimb 
stimulation, given that such parameters should be optimised for different 
anaesthetic regimes, owing to their different effects on neural activity and the 
cerebrovasculature. Ultimately, these studies would then follow on to the 
assessment of the hemodynamic response in young and aged SHRSPs to 
evaluate whether the functional responses of this model align with those 








In accordance with the Animals (Scientific Procedures) Act 1986, all 
experiments and procedures were carried out under license from the UK Home 
Office, working under Project Licenses 60/4449, P5A377AD5 and P6C83EF0 and 
personal license number I640B6D28. Surgical procedures pertaining to 
electrophysiology were carried out under Project License number 70/8163. 
Male SHRSP and WKY rats were obtained from inbred colonies in the Institute 
of Cardiovascular and Medical Sciences at the University of Glasgow. Male 
Sprague-Dawley rats were obtained from Harlan Laboratories, UK. All animals 
were allowed a 1-week acclimatisation period upon arrival before any 
experimentation. Animals were housed in standard laboratory cages with 
sawdust, sizzle nest and cardboard tubing. Animals were caged in maximum 
groups of 4. Food and water was available ad libitum. All animals were 
maintained on a 12 hour light/dark cycle. Surgical procedures were carried out 
by Robert Morgan, unless otherwise stated in the relevant study chapter 
methods section. 
 
For all surgical procedures except those relating to electrophysiology (Section 
4), rats were transferred from the animal housing unit in the veterinary 
research facility (VRF) to the surgical suites within the Wellcome Surgical 
Institute or the Glasgow Experimental MRI Centre (GEMRIC). For surgical 
procedures relating to electrophysiology, animals were transferred from the 





2.2 Surgical preparation 
2.2.1 Aseptic technique 
Aseptic techniques were adhered to for all surgical procedures as defined in 
the project license. Prior to surgery, surgical instruments were autoclaved 
along with other thermostable surgical consumables (e.g. swabs, gauze pads) 
and the bench top and corkboard were disinfected with 70% ethanol. The 
corkboard and sterile instruments were then set out on a sterile drape placed 
over the bench top. When multiple surgeries were performed in a single day, 
the surgical tools were scrubbed with DeconR90, rinsed, dried and autoclaved 
again between surgeries. The corkboard and bench top were also disinfected 
and a new sterile drape was used. Clean gloves and a sterile gown were worn 
for all procedures. 
Following induction of anaesthesia, the animal’s hair at the intended surgical 
site(s) was shaved using electric clippers on a bench top distant to that 
intended for surgery. Prior to commencing any surgical procedure at the 
relevant surgical site, the skin was disinfected with a swab soaked in 0.5% w/v 
Chlorhexidine digluconate in 70% w/v ethanol solution (HydrexRClear, Ecolab) 
 
2.2.2 Anaesthesia 
Animals were initially placed in an anaesthetic chamber (Baxter Healthcare 
Ltd, UK) and anaesthesia was induced with 5% isoflurane in a mixture of oxygen 
and nitrous oxide at 30% and 70%, respectively. Sufficient depth of anaesthesia 
was assessed by lack of a withdrawal reflex when the footpad of the hindpaw 
was pinched. Following removal from the anaesthetic chamber, all animals 
underwent endotracheal intubation as described in Section 2.3.1. Ventilation 
parameters were generally set to 60-70 breaths/min with a stroke volume of 3-
4 ml. Anaesthesia was maintained at 2% isoflurane in medical air (1L/min) 
supplemented with oxygen at 21 %.  
The anaesthetic protocol followed in all surgical procedures was previously 
established in our lab (Hollyer 2016). Prior to the experiment, a stock solution 
of medetomidine (Domitor, Orion Pharma) was supplied at 1mg/ml and stored 
at room temperature.  The animal was weighed and an aliquot of the stock 
solution was diluted in saline to 100 µg/kg/ml. A syringe containing 10 ml of 
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the medetomidine solution was then mounted onto a syringe pump (Fresenius 
Kabi, Injectomat MC Agilia®). For all non-MRI experiments, one end of a 
cannula was then attached to the mounted syringe and the other end to a 
butterfly needle. For all MRI experiments, the butterfly needle was replaced 
with a 16-gauge catheter. 
Following all preparatory surgical procedures, the butterfly needle or catheter 
connected to the syringe pump was inserted into the subcutaneous space of 
the animal’s shaved flank. A 0.5 ml bolus of medetomidine was administered. 
When blood pressure began to decrease (approx. 1-2 mins after bolus), the 
isoflurane was reduced to 1%. 15 minutes after the administration of the bolus, 
the subcutaneous infusion of medetomidine was started at 1 ml/hr and 
continued for the duration of the experiment.  
 
2.2.3 Analgesia 
For recovery experiments, buprenorphine was administered subcutaneously 
prior to the animal gaining consciousness, in addition to 2 ml of saline for 
hydration. Naropin was administered subcutaneously at the prepared surgical 
site prior to incision. 
 
2.3. Surgical procedures 
2.3.1 Endotracheal intubation  
A loop of 2-0 suture thread was pinned to a corkboard and attached to the 
incisors of the anaesthetised rat. Once secured, the corkboard and the rat 
were lifted at a vertical angle so that the animal hung from its incisors with 
the mouth partially open. The tongue was pulled to one side using forceps and 
the oral cavity was dried using a cotton bud. A fibre optic light was positioned 
at the animal’s neck to illuminate the larynx and upper trachea. A 16-gauge 
catheter attached to a guide wire was carefully advanced into the trachea 
before the guide wire was removed. The catheter was then connected to a 
volume-driven ventilator (Ugobasile, Harvard Bioscience). Correct placement 
of the catheter within the trachea was confirmed by observing synchronisation 
of chest expansion with the ventilator. In all non-recovery experiments, the 
catheter was secured in place by a 4-0 suture in the lip. 
 
 55 
2.3.2 Arterial and venous cannulation 
Arterial cannulation was required for physiological monitoring of an animal’s 
blood pressure and heart rate using Biopac Acquisition software. It also 
enabled the sampling of arterial blood for analysis using a clinical blood gas 
analyser (RAPIDLabTM 248 System, Siemens). Venous cannulation was only 
required to administer a contrast agent in certain MRI experiments. 
Experiments involving venous cannulation have this noted in the relevant 
chapter methods section. 
 
The procedure for carrying out arterial and venous cannulation is very similar 
for both respective vessel types. Therefore, unless otherwise stated, the 
reference to ‘the vessel’ in the following procedure will refer to both the 
femoral artery and femoral vein. The upper part of the animal’s hindlimb was 
secured using stick tape and a small incision was made using blunt ended 
scissors in the inguinal area. After clearing connective tissue, the femoral 
artery, vein and nerve were carefully isolated from one another using forceps. 
Two 4-0 suture threads were loosely tied at the distal and proximal ends of the 
exposed vessel. The ligatures were pulled tight and secured to the corkboard 
using stick tape to restrict blood flow through the now raised area of the 
vessel. A small incision was made in the vessel using micro-scissors. A 
polythene catheter (0.93 mm internal diameter) connected to a 1 ml syringe 
containing heparinised saline was inserted into the vessel and advanced 
approximately 2 cm along the vessel. Both ligatures were then tightened and 
tied around the vessel and the catheter to secure it in place. Once secured, a 
small volume of blood was drawn back into the syringe to ensure that blood 
flow through the catheter was unobstructed. The catheter was then flushed 
with saline and connected to a transducer to enable real-time recording of 
blood pressure and heart rate. Excess thread from the suture was then 
removed and the incision closed using 4-0 suture thread to prevent the tissue 
drying out. 
 
2.3.3 Needle electrode placement 
Prior to placement of the electrodes, the animal’s right forepaw was cleaned 
using a gauss pad soaked in 70% ethanol. The needle electrodes were then 
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inserted into the paw at the 2nd and 4th digits (Figure 2.1), and tape was then 








Figure 2.1: Representation of a rat right forepaw. The red circles indicate the 




2.3.4 Laminectomy and craniotomy 
For electrophysiology experiments, a laminectomy and craniotomy were 
performed to expose the underlying spinal cord and brain for the placement of 
silver ball electrodes and subsequent recording of cord dorsal potentials (CDPs) 
and somatosensory evoked potentials (SEPs). The animal was placed on a 
corkboard and a rolled-up gauze pad was placed under the animal’s chest 
thereby putting the animal in a hunched position, which allowed easier access 
to the spinal cord. A midline incision was made from upper cervical to upper 
thoracic regions and the skin retracted. The muscles overlaying the vertebral 
column were retracted or partially removed, if necessary, to expose the 
vertebral column. The posterior arches of C4-C6 vertebrae were carefully 
removed using small bone rongeurs to expose the underlying spinal cord.  
 
Following the laminectomy, the animal was carefully transferred to a 
stereotaxic frame and secured using an incisor bar and ear bars. The rolled-up 
gauze pad was again placed under the animal’s chest to maintain access to the 
spinal cord. Liquid paraffin was applied to the site of the laminectomy to 
prevent the cord from drying out.  
 
A unilateral craniotomy of the left hemisphere was performed. A midline 
incision was made along the skull and using 4-0 suture thread, the skin was 
retracted and tension applied to raise the skin so that it would form a pool 
when liquid paraffin was later applied. The muscles overlying the skull were 
removed using a scalpel and forceps. A dental drill was used to thin a 5 x 5 mm 
area of skull until the surface vessels on the brain could be clearly seen. The 
area extended from -1 mm to 4 mm AP and 0 mm to 5 mm ML, relative to 
Bregma. Small bone rongeurs and watchmaker forceps were then used to 
remove the thinned area of skull, with care being taken to maintain the 
integrity of the dura. Liquid paraffin was applied to the surface of the brain.  
 
2.3.5 Skull thinning 
For laser speckling imaging, the skull was thinned prior to recording. The 
animal’s head was secured in a stereotaxic frame using ear and tooth bars.  A 
midline incision was made along the skull and the skin retracted and secured in 
place using 4-0 suture thread and sticky tape. The muscles overlying the skull 
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were removed using a scalpel and forceps. Using a dental drill, the frontal and 
parietal plates were thinned until the vessels on the surface of the brain were 
clearly visible and the skull flexed when light pressure was applied. Care was 
taken to ensure that the dura remained intact. During this process, saline was 
periodically applied to the exposed skull to clear away bone debris and to 
minimise any heating effect of drilling on the brain. Following skull thinning, a 
layer of paraffin oil (Johnson’s baby oil, UK) was applied to the surface of the 
thinned skull to prevent it from drying out and ensure stable signal acquisition 
during imaging.  
 
2.4 Magnetic resonance imaging 
MRI experiments were performed using either a Bruker Biospec 7T, 30 cm 
system with a BGA12S2-HP 700 mT/m gradient insert or a Pharmascan 7T. 
Volume transmit coil with 4-channel phased array receive coil was used with 
both scanners. The scanner used in each study as well as details of the 
scanning protocol can be found in the relevant study chapter methods section. 
 
Animals were anaesthetised, intubated and mechanically ventilated as 
described in Sections 2.2.2 and 2.3.1. The femoral artery was cannulated and 
if administration of a contrast agent was required, the femoral vein was also 
cannulated (Section 2.3.2). The animal was transferred to the MRI compatible 
Perspex cradle (Bruker Biospin) and placed prone, with the animal’s head being 
secured using a tooth bar and ear bars. The animal’s respiration rate was 
monitored using a pressure sensor (GrasebyTM) placed under the animal’s chest, 
on the base of the cradle. Body temperature was monitored using a rectal 
probe and maintained using a water jacket placed over the dorsal surface of 
the animal connected to a closed circuit heated water system (Cole-Palmer 
Polystat). A four-channel phased array surface coil was placed over the 
animal’s head and secured to the cradle. Respiration, heart rate and blood 
pressure were monitored using Biopac MP150 acquisition system and recorded 
using AcqKnowledge software. 
 
2.5 Laser Speckle Contrast Imaging 
Laser speckle contrast imaging (LSCI; PeriCam PSI HD system, Perimed, 
Stockholm, Sweden) was used to record real-time relative changes in cerebral 
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blood flow from the estimation of intravascular red blood cell movement. The 
penetration depth of the near infrared laser (785 nm) is approximately 500 µm 
below the thinned skull and therefore captures cerebral blood flow from 
cortical vessels located in the surface of the brain.  
With the animal anesthetised and secured in the stereotaxic frame, the laser 
speckle camera was positioned over the exposed and thinned skull at a 
distance of 10 cm. The camera’s position was adjusted to ensure that the 
entire thinned skull was within the field of view and then secured in place. The 
temporal resolution was set to give an effective frame rate of 1 image per 
second, capturing 10 frames per second with averaging every 10 frames. The 
spatial resolution was set at 20 µm. Body temperature was monitored using a 
rectal probe and maintained using a thermo-coupled electric pad placed under 
the animals. 
 
2.6 Recovery and post-operative care 
2.6.1 Recovery following MRI 
Only animals involved in the acute and chronic hypertensive studies were 
recovered (Chapter 5). As the following procedure applies to both the femoral 
artery and femoral vein, the term ‘the vessel’ will again be used to refer to 
both respective vessel types. Following surgery and scanning, the animal was 
removed from the MRI cradle and transferred back to the bench top. 
Anaesthesia was maintained on 2% isoflurane in medical air (1 L/min) 
supplemented with oxygen at 21%. The suture thread holding the inguinal 
incision closed was cut to re-expose the underlying femoral vessels. The suture 
thread knots at the proximal and distal end of the vessel were loosened. The 
ligatures were pulled tight and secured in place using sticky tape. Using 
forceps to hold the vessel, the polythene catheter was carefully removed from 
the vessel. If necessary, the tension on the ligatures was re-adjusted as the 
polythene tubing was being removed to ensure there was no blood flow 
between the two ligatures. The incision in the vessel was sealed using 
diathermy forceps (Eschmann). The tension on the ligatures was slowly 
released to enable reperfusion of the hindlimb. Upon confirmation of 
successful reperfusion and the absence of any bleeding from the vessel, the 
ligatures around the proximal and distal ends of the vessel were removed and 
the inguinal incision was sutured closed using 4-0 thread.  
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Upon completion of the surgical procedure, 1 ml of Antisedan (Dosage, Brand) 
was administered subcutaneously and the isoflurane turned off. The ventilator 
was kept on until the animal showed signs of breathing on its own. At this 
point, the ventilator was switched off, the intubation tube removed and the 
animal was placed on a facemask with 21% oxygen only. The animal was then 
given a 1 ml subcutaneous bolus of saline (0.9%) and upon displaying additional 
signs of recovery (swallowing, blinking, pinch reflex), the animal was 
transferred to a cage lined with AD pads. The cage was placed in a designated 
recovery room and the animal was provided with softened food pellets in a 
plastic weighing boat. The animal was checked and weighed daily for the 
remainder of the recovery period (1 week). Softened food pellets were again 
provided on the day following surgery and the animal continued to have access 
to food and water ad libitum. If an animal’s weight dropped by 25% of the pre-
operative body weight, the Named Animal Care and Welfare Officer (NACWO) 
or Named Veterinary Officer (NVO) were to be notified and the animal’s 
welfare and future assessed, as outlined in the Project license. 
 
2.6.2 Perfusion fixation 
At the end of the study, animals involved in the acute and chronic 
hypertension MRI studies were transcardially perfused with fixative for future 
histological analysis. Animals were transferred to a tray lined with absorbent 
pads, deeply anaesthetised with 5% isoflurane in a mixture of oxygen and 
nitrous oxide (30:70) and maintained on a facemask. The chest cavity was 
exposed by an initial incision at the sternum using blunt ended scissors. The 
diaphragm and ribcage were then cut and the ribcage retracted. The heart was 
loosely grasped with Halsted Mosquito forceps and a blunt 16 gauge needle 
attached to a perfusion-fixation set up was inserted into the apex of the heart 
and advanced into the aorta. During needle insertion, the perfusion-fixation 
set up was running heparinised saline (10 ml/l) at a pressure of 80-100 mmHg. 
Once satisfactory placement of the blunt needle tip in the aorta was achieved, 
the forceps were clamped to secure the needle in place and the right atrium 
cut to allow complete exsanguination. When saline draining from the cut 
atrium was clear of blood, paraformaldehyde (PAM; 4% in 50 mM phosphate 
buffer) was perfused at the same pressure and continued until spontaneous 
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movement ceases and tissue rigor were achieved (after approx. 200 - 300 ml). 
The animal was then decapitated and the head immersed in 4% PAM for a 
minimum of 24 hours. The brain was then removed and again immersed in 4% 
PAM until batch embedding.  
 
2.7 Tail cuff plethysmography 
To confirm the normotensive and hypertensive phenotypes in WKYs and 
SHRSPs, respectively, it was necessary to monitor systolic blood pressure in 
conscious animals. The tail cuff method use followed in the relevant study has 
previously been described (Tarr 2012). The tail cuff method to measure systolic 
blood pressure involves the placement of an inflatable cuff around the rat’s 
tail which is inflated until the pressure matches that of the tail artery and 
transient occlusion of the vessel is achieved. A signal transducer placed around 
the rat’s tail distal to the tail cuff, detects the absence of a pulse in the tail 
following occlusion and signals the central monitoring system connected to a 
laptop (Dell, UK). The pressure at which this occurs is recorded and displayed 
as the systolic blood pressure in mmHg. The cuff is then deflated. 
 
2.7.1 Acclimisation training 
Prior to the recording of systolic blood pressure via tail cuff plethysmography, 
animals were subjected to a 2-day acclimisation period to acclimatise them to 
the tail cuff procedure. On the first day, the animals were taken into the room 
where the tail cuff apparatus was kept and were removed from their cage and 
allowed to explore the table where tail cuff measurements would take place 
and where the apparatus was set up. After 5-10 mins, the animal was also 
wrapped in a towel and mildly restrained to mimic the tail cuff procedure. The 
animal was also placed in the heating box that would be used warm the animal 
to ensure maximal vasodilation of the tail artery. However, on this first 
instance, the animal was merely placed in the box and allowed to explore, 
without any heating. The animal was also handling throughout this session 
which generally lasted 20-25 minutes. On the second day, the same procedure 
was followed as described on the first day, however in this instance, the 
heating box was switched on and heated to approx. 34oC. The tail cuff and 
transducer were also positioned on the animals tail during mild restraint. 
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2.7.2 Systolic blood pressure measurements 
Systolic blood pressure was measured 1-3 days prior to animals undergoing MRI 
scanning. Prior to transferring the animals into the room with the tail cuff 
apparatus, the heating box was switched on and warmed to approx. 34oC and 
the tail cuff apparatus set-up and laptop switched on. The tail cuff consisted 
the medial portion of a 5 ml syringe that had been cut to a length of 2 cm, in 
which a 6 cm length (1.5 cm width) of latex tubing was inserted. A 10-gauge 
catheter cut to a length of 4 cm was inserted and secured in the tubing by 
tying 5-0 thread. The opposite end of the tubing was folded over the outer 
surface of the syringe and secured in place using a plastic O-ring. The catheter 
was then connected to the central monitoring system that was also connected 
to a cylinder of medial air (BOC Gases, UK) via a hose, a piezoceramic 
transducer and a laptop (Dell, UK). 
Prior to systolic blood pressure measurements, animals were placed in the pre-
warmed heat box for 10-15 mins. Animals were checked periodically during this 
time. The rats were considered ready for blood pressure measurements when 
there was little spontaneous activity and the ears appeared pink. Once this was 
achieved, the animal was removed from the heating box, wrapped in the towel 
with the tail exposed, and the tail cuff and transducer positioned on the tail. 
The laptop was then used to control the inflation and deflation of the tail cuff 
in cycles and record the systolic blood pressure. In cases where a blood 
pressure reading could not be obtained, the animal was placed back into the 
heating box for 3-5 minutes. The cycles of inflation and deflation were 
repeated until 10 consistent measurements were acquired. Measurements 
recorded while the animal was visibly stressed were excluded. After the 
successful acquisition of 10 consistent measurements, the animal was returned 












Establishing non-invasive monitoring of PaCO2 for 




The sensitivity of the BOLD signal to physiological variables, in particular CO2, 
requires that these variables be monitored and maintained within normal 
physiological limits during fMRI experiments. The lack of careful monitoring 
risks introducing variability into the data which can reduce statistical power 
and thereby complicate interpretation of the BOLD signal. Furthermore, non-
invasive monitoring of an animal’s vitals is preferable for recovery 
experiments. In this chapter we investigated the ability of micro-sampling side-
stream capnography to provide a non-invasive surrogate measure of the partial 
pressure of arterial CO2 (PaCO2) by analysing end-tidal CO2 (ETCO2) in the 
anaesthetised rat. We compare ETCO2 with PaCO2 to evaluate the side-stream 
capnography method and assess the effect of varying the PaCO2 on the 
stimulus-evoked BOLD signal. 
 
3.1.1 Carbon dioxide and the BOLD signal 
It is well known that CO2 is a potent vasodilator and that variation in the level 
of arterial CO2 affects the baseline and stimulus-driven fMRI time series (Kety 
and Schmidt 1948). Exogenous CO2 challenges and breath-holding challenges in 
animals and humans have clearly demonstrated that increases in PaCO2 evoke 
an increase in the baseline BOLD signal intensity, an observation that is largely 
underpinned by CO2-associated increases in CBF and CBV (Rostrup et al. 1994; 
Stillman et al. 1995; Kastrup et al. 1999; Li et al. 1999; Corfield et al. 2001; 
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Brevard et al. 2003; Sicard and Duong 2005). Alternatively, hyperventilation-
induced hypocapnia has been observed to decrease the baseline BOLD signal 
intensity (Posse et al. 1997; Posse et al. 2001). Small fluctuations in PaCO2 
have also been observed to cause statistically significant low frequency BOLD 
signal fluctuations (Wise et al. 2004). This observation is especially important 
to consider for resting state fMRI, which probes temporally coherent low-
frequency BOLD signal fluctuations to identify functional neural networks.  
 
The stimulus-evoked BOLD response is also affected by variations in CO2 with 
most studies observing an inverse relationship where increased PaCO2 results in 
smaller stimulus-evoked responses (Wong and Bandettini 1997; Cohen et al. 
2002; Stefanovic et al. 2006). However, it is unclear at what level of PaCO2 the 
stimulus-evoked BOLD response is affected with some studies in rodents 
reporting changes only at severe hypocapnic and hypercapnic conditions 
(Weckesser et al. 1999; Kemna and Posse 2001; Posse et al. 2001; Sicard and 
Duong 2005).  It is possible that differences in experiment methodologies, in 
particular the choice of anaesthetic, contribute to the lack of consensus in 
determining the level of PaCO2 at which the BOLD response is affected. A 
systematic review of adults found that individual anesthetic agents differed in 
their degree of reactivity to hypercapnic and hypocapnic stimuli, with 
reactivity being highest under isoflurane and lowest under propofol (Mariappan 
et al. 2015). Given that the BOLD response is dependent on changes in the 
cerebrovasculature, any compounded effects of CO2 and anaesthesia on vessel 
reactivity could affect the BOLD response. 
 
Some human fMRI studies have also observed no difference in the stimulus-
evoked BOLD response between normal and hypercapnic conditions (Corfield et 
al., 2001; Whittaker et al., 2016). However, such observations may arise due 
to the experiments being performed in conscious participants which can 
introduce potential confounds related to participant tolerance, sensitivity to 
hypercapnia and various involuntary changes to counteract CO2 increases. 
Collectively, these findings highlight the importance of monitoring and 
maintaining PaCO2 within normal physiological limits when performing fMRI. 
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3.1.2 Monitoring carbon dioxide 
The current gold standard for monitoring PaCO2 in animals is via blood gas 
analysis (Huttmann et al. 2014). This involves removing a small sample of 
arterial blood (50−100µL), which is then passed through a blood gas analyser to 
provide a measure of the current PaCO2, as well as informing on the partial 
pressure of arterial oxygen (PaO2), blood pH and several other parameters. 
However, these measurements are invasive and discrete, providing a blood gas 
profile only relevant for a short period of time after the sample is withdrawn. 
Therefore, over the course of a typical fMRI experiment, it may become 
necessary to take multiple blood samples for analysis to ensure that blood 
gases are within normal physiological limits and to avoid introducing confounds 
into the data. This is not ideal as there are limits to the amount of blood that 
can be withdrawn and withdrawing arterial blood is associated with increased 
risk of infection and thrombosis (Diehl et al. 2001).  
 
Capnography overcomes the limitations of arterial blood gas analysis and 
provides a non-invasive method to continuously probe arterial CO2 by analysing 
ETCO2 as a surrogate measure. End-tidal CO2 is the partial pressure of CO2 
expelled at the end of expiration and provides the closest representation of 
the expired gases coming from the alveoli and therefore the blood. Under 
normal conditions ETCO2 and PaCO2 are closely correlated, with ETCO2 
typically being 2 – 5 mmHg lower than PaCO2. This difference between the two 
measures, known as the PaCO2-ETCO2 gradient, arises because not all inspired 
air participates in gas exchange due to physiologic dead space (Intagliata and 
Rizzo 2018). Physiologic dead space is defined as the sum of anatomical dead 
space, referring to the conducting airways that do not participate in gas 
exchange, and alveolar dead space that refers to ventilated alveoli that are 
not well perfused. In healthy adults, the alveolar dead space is generally 
considered negligible and therefore physiologic dead space is equivalent to 
anatomic dead space (Intagliata and Rizzo 2018).  
 
3.1.3 Mainstream capnography and side-stream capnography 
The foundation of capnography is based on the observation that CO2 molecules 
strongly absorb infrared (IR) light at a wavelength of 4.3 µm. The amount of 
light absorbed is proportional to the CO2 concentration. Therefore, by allowing 
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a sample of gas to pass between an IR source and a photodetector, the IR 
intensity before and after passing through the gas can be compared, and the 
partial pressure of CO2 calculated.  
 
There are two main types of capnography that are categorised based on the 
position of the CO2 sensor in the ventilation pathway (Block and McDonald 
1992). Mainstream capnography places the sensor at the airway in line with the 
respiratory gas stream, typically attaching between the breathing circuit and 
intubation tube in anaesthetised patients (Figure 3.1A). The proximity of the 
sensor to the airway permits real-time measurements of ETCO2. The signal 
from the sensor is then passed to a unit where the ETCO2 value and CO2 
waveform (capnogram) are displayed. Sidestream capnography places the CO2 
sensor in a unit remote to the participant, with a sample of the individual’s 
respired gases being constantly diverted from the sampling site to the sensor 
through a sample tube (Figure 3.1B). Similar to mainstream capnography, the 
sample site is typically located between the breathing circuit and intubation 
tube in anaesthetised patients, with the sample line being connected using a 
T-piece adapter. In awake individuals, a nasal catheter can be used to sample 
expired gases. Due to the sensor being distant to the sample site in side-stream 
capnography, ETCO2 measurements do not occur in real-time but rather suffer 
a time delay. This delay is dependent on several factors such as sample tube 
length and sample rate and may result in the displayed ETCO2 value and 
capnogram being out of phase with respiration.  
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Figure 3.1: Overview of the two main types of capnography. In (A) 
mainstream capnography, the CO2 sensor is placed in-line with the respiratory 
gas stream, between the intubation tube and breathing circuit. (B) Sidestream 
capnography continuously withdraws a sample of expired air and transports it 





One significant advantage of sidestream capnography is that it can be used in 
an MRI setting. Due to components within the CO2 sensor being MRI-
incompatible, the sensor cannot be placed within a magnetic field as would be 
required when attempting to use mainstream capnography in an MRI 
experiment. However, a side-stream capnography set-up allows all MRI-
incompatible components to be placed outside the magnetic field while 
maintaining the ability to divert expired air from the participant/animal 
through a long sample tube to the sensor. However, the fundamental design of 
side-stream capnographs introduces several issues that can lead to the 
observation of inaccurate and unreliable ETCO2 values. Diffusion-driven 
dispersion of the sample gas as it travels through the sample tubing can lead to 
inaccurate ETCO2 values (Epstein et al. 1980). Additionally, high sample rates 
and high flow rates of supplementary gases can lead to the dilution of the 
sample and result in the observation of low, false ETCO2 values (Jaffe 2002; 
Marshall 2004). Loose fittings and cracks within the sample tubing and sample 
filter can also lead to the entrainment of ambient air and cause dilution of the 
expired gas sample, leading to the observation of low ETCO2 values and 
abnormalities within the capnogram (Body et al. 2000; Tripathi and Pandey 
2000; Zupan et al. 2006). Most of these issues are also exacerbated by long 
sample tube lengths and when used in animals with small tidal volumes.  
 
Micro-sampling side-stream capnographs represent a sub-category of side-
stream capnographs that are considered more appropriate for use in animals 
with small tidal volumes because they operate with smaller sample rates than 
standard capnographs. This minimises the sampling of supplementary gases and 
dilution of the expired gas sample that would otherwise occur with larger 
sample rates in mechanically ventilated small animals. However, establishing 
side-stream capnography in a preclinical MRI setting requires the use of long 
sample lines, which may still introduce challenges when attempting to 




3.1.4. Study aims 
The ability to accurately and non-invasively monitor PaCO2 using ETCO2 as a 
surrogate measure in rodents would benefit our planned fMRI study (Chapter 5) 
by minimising the amount of invasive preparatory surgery required to monitor 
blood gases and allowing continuous monitoring of PaCO2. Given that 
cerebrovascular reactivity may vary depending on the type of anaesthetic 
used, and the current lack of studies assessing the effects of CO2 on the BOLD 
signal under a combined medetomidine-isoflurane anesthesia, the aims of the 
studies included in this chapter were to: 
1) Assess the ability of microsampling side-stream capnography to non-
invasively monitoring ETCO2 as a surrogate measure for PaCO2 in the 
anaesthetised rat 
2) Assess the effect of varying the PaCO2 on the stimulus-evoked BOLD 




3.2.1 Study 1 – Non-invasive monitoring of PaCO2 using side-stream 
capnography to measure ETCO2 
3.2.1.1 Animals 
Naïve, male Sprague Dawley rats weighing between 350−500g were used in this 
pilot experiment. Experiments were carried out on the benchtop with the 
animal lying prone to simulate the position of the animal when lying in the MRI 
cradle during scanning. All experiments were non-recovery. 
 
3.2.1.2 Anaesthesia 
Animals were anaesthetised as described in Section 2.2.2, and the femoral 
artery cannulated as outlined in Section 2.3.2. 
 
3.2.1.3 Side-stream capnography 
Two different capnographs were trialled in this experiment, the MicroCapStar 
(CWE Instruments) and the C1240 Micro Capnograph (Columbus Instruments).  
 
MicroCapStar 
ETCO2 measurements using the MicroCapStar involved 4 different set ups using 
2 different sample line lengths and 2 different sample sites within the 
ventilation pathway. These consisted of: 
1. 1 m sample line sampling between the intubation tube and breathing 
circuit (n = 4) 
2. 1 m sample line sampling from exhalation line only (n = 4) 
3. 7 m sample line sampling between intubation tube and breathing circuit 
(n = 3) 
4. 7 m sample line sampling from exhalation line only (n = 4) 
The 1 m sample line is the standard length supplied with the capnograph and 
was used to confirm whether ETCO2 could accurately monitor PaCO2 in a 
benchtop experiment setting using a short sample line. It was assumed that 
any effects of line length would be minimised using this length of sample 
tubing and therefore act as a ‘proof of concept’ if accurate measurements 
were successfully recorded. The 7 m sample line was the required length for 
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use in an fMRI experiment, with the capnograph being placed outside the 
magnet room and the sample line reaching into the magnet and was therefore 
used to assess whether ETCO2 could accurately monitor PaCO2 in a MRI 
experiment. While sampling between the intubation tube and ventilation 
tubing is the recommended position as per the manufacturer’s instruction, 
sampling from the exhalation line only was also investigated because when 
assessing the various set-ups in an MRI setting, it was noted that the design of 
our MRI cradle and position of the transmit/receiver coil when scanning would 
cause the sample tubing to kink and obstruct airflow when placed at the 
recommended sample site. However, sampling from the exhalation line would 
not encounter these issues. Therefore, if the ETCO2 values achieved when 
sampling from the exhalation line were similar to those from the recommended 
sample site, then we could easily sample from the exhalation line and still 
achieve reliable and accurate ETCO2 readings. If not, we would need to 
consider significant modifications to our MRI cradle to facilitate sampling from 
the recommended position. 
 
When the sample site was located between the intubation tube and ventilation 
tubing, a T-piece adapter was used to connect the intubation tube, sample line 
Y-piece adapter and ventilation Y-piece adapter (Figure 3.2A). This is the 
recommended sampling position as it minimises the additional dead space and 
therefore, we will henceforth refer to this sampling site as the recommended 
sampling site. The distance between the end of the intubation tube and the 
sample line adapter in this set-up was approx. 10 mm. When the sample site 
was located in the exhalation line, the sample line Y-piece adapter was placed 
in a small hole in the exhalation line of the ventilation tubing (Figure 3.2B). A 
small amount of modelling clay (Plasticine, UK) was placed around the sample 
line adapter and secured in place, providing a seal to prevent the sampling of 
any ambient air. When secured in place, the distance between the end of the 
intubation tube and sample line adapter was approx. 22 mm. The 
measurements for the 1 m sample tubing were 0.79 mm internal diameter, 
2.38 mm outer diameter with a wall thickness of 0.79 mm. When this tubing 
size was tested at a length of 7 m, the MicroCapStar was unable to maintain 
sufficient flow and encountered a pump error. Therefore we were unable to 
use this tubing size at a 7 m length but rather had to use tubing with an 
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internal diameter of 1.27 mm, an external diameter of 2.29 mm and a wall 

















Figure 3.2: Overview of the two sampling sites used with the MicroCapStar. 
For the recommended sample site (A), the sampling line was integrated into 
the ventilation circuit via a T-piece connector joined to intubation tube and 
ventilation tubing. For the exhalation line only site, (B) the sampling tubing Y-









At the start of each experiment, the sampling rate was set at 7.5 cc/min, 
which was recommended to be suitable for small animals according to the 
manufacturer’s guidelines, with averaging set to every 4 breaths. The 
MicroCapStar zero value was set using room air and calibration was achieved 
using 5% CO2 prior to the start of each experiment. Correct calibration was re-
confirmed at the end of each experiment using 5% CO2. 
 
C1240 Micro Capnograph 
Due to the design of the C1240 Micro Capnograph, ETCO2 measurements were 
made using two different sample line lengths, each with a unique sample rate:  
1. 1 m sample line sampling at 20 ml/min 
2. 5 m sample line sampling at 5 ml/min 
Due to the design of the C1240 Micro Capnograph sample line tubing, ETCO2 
measurements were only sampled from the expiration line. Animals that were 
monitored by the C1240 Micro Capnograph were trialled on both sample line 
lengths (n = 5). Prior to the start of each experiment, the Micro Capnograph 
zero value was set using room air and calibration was performed using 5% CO2. 
The 1 m and 5 m sample tube lengths were chosen as these were the shortest 
and longest lengths available, respectively. 
 
3.2.1.4 Measuring ETCO2 and PaCO2 
ETCO2 and PaCO2 measurements were both taken every 15 minutes and 4 – 5 
measurement pairs were taken in total for each animal. Prior to taking a blood 
sample for blood gas analysis, the ETCO2 measurement displayed on the 
capnograph was recorded. A blood sample was then taken and passed through 
the blood gas analyser (RAPIDLabTM248 System, Siemens) and the PaCO2 
measurement recorded.  
 
3.2.1.5 Data analysis 
The agreement between PaCO2 and ETCO2 measurements was assessed using 
the Bland-Altman comparison method (Bland and Altman 1999). Bland-Altman 
analysis is commonly used to assess agreement between two methods that 
typically measure the same variable. Generally, this analysis is used to 
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compare a novel measurement technique with a ‘Gold Standard’ technique 
that is known to acceptably measure the variable of interest. Since there will 
always be some difference between measurements by two different 
techniques, Bland-Altman analysis aims to quantify how much two methods 
differ on average (bias) and define boundaries within which most (95%) of 
those differences fall, referred to as the 95% limits of agreement (LOA). The 
user is then required to interpret whether the average difference and range of 
differences between the two methods are acceptable. 
 
In our experiment we collected multiple measurement pairs for each animal. 
The standard Bland-Altman comparison method is appropriate when only one 
measurement from each method per participant/animal is collected (Bland and 
Altman 1999). Therefore, we adopted the Bland-Altman comparison method for 
multiple observations (Bland and Altman 2007). This method takes into 
consideration variances for the repeated difference between the two methods 
on a single subject and for the differences between the averages of the two 
methods across subjects. 
 
Both the standard and multiple observations Bland-Altman comparison methods 
assume there is no correlation between the average of the two methods and 
the difference between those two methods. In cases where this is violated, 
proceeding with the analysis would result in the generation of LOA that are 
wider than the true LOA. The suggested method for analysing data that 
violates this assumption is to model the variance in the standard deviation 
using residuals from linear regression (Bland and Altman 1999). However, this 
approach assumes there is only one observation for each method per 
participant/animal. To our knowledge, there is currently no suggested 
approach for dealing with data that consists of multiple observations data and 
that violates the assumption of no correlation. Therefore, to analyse such data 
with a regression-based approach would require ignoring the multiple 
observations and treating each observation as if it were individual. This would 
generate LOA that are narrower than the true LOA. However, if both the 
multiple comparisons method and the regression-based approach are 
performed on any data that violated the assumption of no correlation, this 
would generate two sets of LOA, one that is narrower and another that is wider 
that the true LOA. From these limits, we could assess where the true LOA may 
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lie and come to an informed conclusion as to whether those limits would be 
acceptable. Therefore, in addition to using the Bland-Altman comparison 
method for multiple observations, a regression-based approach was also 
adopted in cases where the data both: 
- Violated the assumption that there is no correlation between the 
average of the two methods and the difference between the two 
methods 
- The correlation could not be removed by logarithmic transformation of 
the data 
The regression-based approach does not provide a discrete upper and lower 
value for the LOA like those produced in the multiple comparisons approach. 
Rather, the LOA vary over the range of the measurements to accommodate the 
correlation within the data, thereby making it difficult to compare the LOAs 
between the two methods. However, we can calculate the difference between 
the upper and lower LOA to define the effective range of the LOA for both 
analysis approaches, which can then be compared. 
 
Statistical advice for this study was sought from Dr J. McClure, Institute of 
Cardiovascular and Medical Sciences, University of Glasgow. 
 
A power analysis was not performed for the Bland-Altman plot as the it is 
generally accepted that the two measures being compared are different, the 
aim is to quantify by how much these two measures vary and whether this is 
clinically acceptable. 
3.2.2 Study 2 - Evaluating the effects of varying PaCO2 on the stimulus-
evoked BOLD signal 
3.2.2.1 Animals 
In this pilot experiment naïve, male WKY rats (n=4) weighing between 250–360 
g were used. Experiments were performed in a Bruker Biospec 7T/30 cm 
system with a BGA12 integrated 400 mT/m gradient (ID) system. The 
anaesthetic protocol followed in this experiment is outlined in Section 2.4. 
Once the animal was secured in the MRI cradle, two needle electrodes were 
inserted into the animal’s right forepaw, as described in Section 2.3.3.  
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3.2.2.2 Stimulation parameters 
Forepaw stimulation was achieved using a Grass S48 square pulse stimulator 
with output running through a constant current unit. The stimulation intensity 
was set at 6 mA, the pulse width at 0.3 ms and the pulse frequency at 3 Hz. 
These stimulation parameters were chosen based on the most commonly 
reported values in the literature that were most relevant to our anesthetic 
protocol (Gyngell et al. 1996; Silva et al. 1999; Keilholz et al. 2004; Liu et al. 
2004; Sanganahalli et al. 2008; Zhao et al. 2008). The stimulation protocol 
consisted of a block design with 6 on-off blocks where the stimulus was on for 
22 s and off for 38 s. There was a 10 s baseline period prior to the start of the 
first stimulus once scanning was started.  
 
3.2.2.3 Monitoring and varying PaCO2 
PaCO2, PaO2 and blood pH levels were monitored using a blood gas analyser 
(RAPIDLabTM248 System, Siemens). Hypocapnic, normal and hypercapnic 
conditions were induced by varying the ventilation frequency. Hypocapnia was 
defined as a PaCO2 below 35 mmHg, the normal condition was defined as a 
PaCO2 between 35 – 45 mmHg and hypercapnia was defined as a PaCO2 above 
45 mmHg. A small blood sample was withdrawn and analysed prior to each 
stimulus-evoked fMRI scan to ensure the blood gas profile was within the 
desired parameters. All animals were subjected to all three conditions and the 
order of the conditions was randomised. Following hypocapnic and hypercapnic 
conditions, the animal’s blood gas profile was allowed to recover to within 
normal PaCO2 limits for 5 mins before the next condition was started. 
 
3.2.1.4 Data analysis 
Functional MRI data was initially analysed in MATLAB using in-house scripts. 
Significantly activated voxels were calculated using a t-test thresholded at 
p<0.05. A cluster threshold was applied to the resultant probability maps to 
remove single voxels of activation. The time courses for the remaining 
significant voxels were then extracted, normalised to the pre-stimulus baseline 
and averaged to produce a single time course for each run. The data was then 
imported to Graphpad Prism (Version 6) where the integral and peak BOLD 
responses for each condition were calculated and statistically analysed by one-
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way repeated measures ANOVA. Pairwise comparisons between the 3 
conditions were assessed using Tukey’s multiple comparisons test.  
 
A post-hoc power calculation indicated that there was a 30.0% probability of 
correctly rejecting the null hypothesis (Effect size f, 0.43; α error probability, 
0.05; correlation, 0.5; nonsphericity, 1). To achieve a 95.0% probability of 




3.3.1 Study 1 – Non-invasive monitoring of PaCO2 using side-stream 
capnography to measure ETCO2 
 
3.3.1.1 Agreement between ETCO2 and PaCO2 using the MicroCapStar 
Agreement between PaCO2 and ETCO2 when assessed by the MicroCapStar with 
a 1 m sample line sampling between the intubation tube and breathing circuit 
produced a bias of 4.13 mmHg, indicating that on average PaCO2 was 4.13 
mmHg higher than ETCO2. The 95% LOA were calculated to range from -1.98–-
10.25 mmHg (Figure 3.3A). This gave an effective range of 12.23 mmHg 
between the upper and lower limits. However, this data set violated the 
assumption of the absence of a correlation between the average and the 
difference of the two methods indicating that these LOA are wider than the 
true LOA. A regression-based analysis approach resulted in LOA with a slightly 
narrower range of 10.28 mmHg (Figure 3.3B), indicating the range between the 
true LOA lies between 10.28 and 12.23 mmHg. 
When the 1 m sample line sampled from the exhalation line only, we observed 
a larger bias of 6.19 mmHg, compared to that observed when sampling from 
between the intubation tube and ventilation tubing. The 95% LOA were also 
wider, ranging from -5.33 to 17.71 mmHg and giving an effective range of 
23.04 mmHg (Figure 3.4A). This data set also violated the assumption of the 
absence of a correlation. A regression-based analysis approach gave a narrower 
effective range of 14.03 mmHg (Figure 3.4B), indicating the range between the 
true LOA is between 14.03 and 23.04 mmHg. 
 
Assessing the agreement between PaCO2 and ETCO2 when using the 
MicroCapStar with the longer 7 m sample line and sampling at the 
recommended sampling site resulted in a large bias of 17.18 mmHg. The 95% 
LOA were also considerably large and ranged from 2.97 to 31.39 mmHg, giving 
an effective range of 28.42 mmHg (Figure 3.5). This data set did not exhibit a 
correlation between the average and the difference between the two methods, 
and therefore a regression-based analysis was not conducted. 
When the 7 m sample line length sampled from the exhalation line only, we 
observed a bias of 9.29 mmHg and LOA between -0.73 and 19.31 mmHg, giving 
an effective range of 20.04 mmHg (Figure 3.6A). This data set violated the 
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assumption of the absence of a correlation and therefore a regression-based 




Figure 3.3: Bland-Altman plots comparing PaCO2 and ETCO2 measured by the 
MicroCapStar with 1 m sample line sampling at the recommended position. Data 
was analysed using a (A) multiple observation approach and (B) regression-based 
approach. A multiple observations analysis approach resulted in an effective 
range of 14.2 mmHg between upper and lower LOA while a regression-based 
analysis approach resulted in range of 10.3 mmHg. (A) Dashed lines indicate 95% 
limits of agreement; solid line indicates bias. (B) Upper and lower lines indicate 







Figure 3.4: Bland-Altman plots assessing agreement between PaCO2 and ETCO2 
measured by the MicroCapStar with a 1 m sample line sampling from the 
exhalation line only. (A) Multiple observations method resulted in an effective 
range of 22.04 mmHg between the upper and lower limits. (B) A regression-
based approach produced an effective range of 14.03 mmHg. (A) Dashed lines 
indicate 95% limits of agreement; solid line indicates bias. (B) Upper and lower 













Figure 3.5: Bland-Altman plot showing agreement between PaCO2 and ETCO2 
measured by the MicroCapStar with a 7 m sample line and sampling from 
between the intubation tub and ventilation tubing. The bias was 17.18 mmHg 
and 95% limits of agreement ranged from 2.97 to 31.39 mmHg, giving an 
effective range of 28.42 mmHg Dashed lines indicate 95% limits of agreement; 








Figure 3.6: Bland-Altman plots showing agreement between PaCO2 and ETCO2 
measured by the MicroCapStar with the 7 m sample line sampling from the 
exhalation line only. (A) Multiple comparisons approach resulted in an effective 
range of 20.04 mmHg between the upper and lower LOA. However, this data set 
violated the assumption of no correlation and therefore a regression-based 
analysis approach resulted in an effective range of 15.4 mmHg, as shown in B. 
(A) Dashed lines indicate 95% limits of agreement; solid line indicates bias. (B) 





3.3.1.2 Measuring agreement between ETCO2 and PaCO2 when using C1240 
Micro Capnograph with various sample line lengths 
The C1240 Micro Capnograph sampling lines had specific sampling rates unique 
to the sample line length and therefore we could not change the sample rate. 
When using the 1 m sample line with a sampling rate of 20 ml/min, we observed 
a relatively small bias of 5.96 mmHg but wide limits of agreement ranging from -
9.30 to 21.25 mmHg, giving an effective range of 30.55 mmHg (Figure 3.7A). 
However, this data violated the assumption of the absence of a correlation and 
therefore a regression-based analysis resulted in a considerably smaller effective 
range of 14.75 mmHg (Figure 3.7B). 
 
When using the longer 5 m sample line with a lower sampling rate of 5 ml/min, 
we observed a large bias of 13.87 mmHg and LOA ranging from -0.94 to 28.67 
mmHg, giving an effective range of 29.91 mmHg (Figure 3.8). This data did not 
exhibit a correlation between the average and the difference of the two 
methods and so regression-based comparison was not conducted. The bias and 
LOA for each set-up is summarised in table 3.1.
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Figure 3.7: Bland-Altman plots showing agreement between PaCO2 and ETCO2 
measured by the C1240 Micro Capnograph with the 1 m sample line sampling 
from the exhalation line with a sample rate of 5 ml/min. The data in A) was 
analysed with a multiple comparisons approach and resulted in an effective 
range of 30.55 mmHg between the upper and lower limits. This data set violated 
the assumption of no correlation and therefore a regression-based analysis 
approach resulted in an effective range of 14.75 mmHg, as shown in B. (A) 
Dashed lines indicate 95% limits of agreement; solid line indicates bias. (B) 








Figure 3.8: Bland-Altman plots showing agreement between PaCO2 and ETCO2 
measured by the C1240 Micro Capnograph with the 5 m sample line sampling 
from the exhalation line with a sample rate of 20 ml/min. We observed a bias of 
13.87 mmHg, with 95% LOA ranging from 0.94 to 29.91 mmHg. Dashed lines 







Table 3.1 – Summary showing the mean bias, upper and lower limits of agreement, effective range and regression-based range for each 
capnography set up. The recommended position sampled expired air from between the intubation tube and ventilation tubing. 
 
 









1 m (Recommended 
position) 
4 4.13 -1.98 10.25 12.23 Yes 10.28 





7 m (Recommended 
position) 
3 17.18 2.97 31.39 28.42 No  
7 m (Exhale line) 4 9.29 -0.73 19.31 20.04 Yes 15.4 
C1240 Micro Capnograph 
1 m (20 ml/min)a 5 5.98 -9.3 21.25 30.55 Yes 14.75 
5 m (5 ml/min)a 5 13.87 0.94 28.67 29.91 No  
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aMeasurements taken in the same animals. L.O.A, Limits of agreement 
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3.3.2 Study 2 - Evaluating the effects of PaCO2 on the stimulus-evoked 
BOLD signal 
3.3.2.1 Inducing hypocapnia and hypercapnia 
PaCO2 was modified by changing the ventilator stroke frequency; reducing the 
frequency induced hypercapnia and increasing the frequency-induced 
hypocapnia (Figure 3.9A). Hypocapnia was defined as a PaCO2 <35 mmHg and 
the group average was 24.8 mmHg under this condition. The normal condition 
was defined as a PaCO2 between 35–45 mmHg, with a group average of 40.38 
mmHg being achieved. Hypercapnia was defined as a PaCO2 >45 mmHg and the 
group average was 54.55 mmHg (Figure 3.9A). The PaCO2 significantly differed 
between each of the hypocapnic, normocapnic and hypercapnic conditions 
(p<0.05). 
 
The PaO2 generally remained consistent under each manipulation with group 
averages of 110.18 mmHg, 99.03 mmHg and 103.45 mmHg for hypocapnic, 
normal and hypercapnic conditions, respectively (Figure 3.9B). Repeated 
measures ANOVA confirmed that PaO2 did not statistically differ between any 
of the conditions (p=0.2242). Blood pH was found to be significantly different 
between conditions when assessed by repeated measures ANOVA (p=0.0019). A 
post-hoc Tukey test revealed there was no significant difference in blood pH 
between hypocapnic and normal conditions or between the normal and 
hypercapnic conditions. However, blood pH did significantly differ between 












Figure 3.9: Overview of blood gas profiles. (A) PaCO2 (B) PaO2 and (C) blood 
pH under hypocapnic, normal and hypercapnic conditions. (A) *p<0.05 vs all 
other conditions (B) *p<0.05 vs hypercapnic condition only; RM one-way ANOVA 








3.3.2.2 Assessing the effects of varying PaCO2 on the stimulus-evoked BOLD 
signal 
The effect of inducing hypocapnia and hypercapnia on the stimulus-evoked 
BOLD signal was assessed by measuring the peak BOLD response and the 
integral of the BOLD response (area under the curve) during stimulation (Figure 
3.10). We observed group-averaged peak BOLD responses of 3.42%, 3.16% and 
1.7% for hypocapnic, normal and hypercapnic conditions, respectively. The 
integrals of the BOLD responses for hypocapnic, normal and hypercapnic 
conditions were 41.7, 37.18 and 23.19, respectively. Repeated measures 
ANOVA revealed no significant difference for either the peak BOLD response 
(p=0.1387) or the integral of the BOLD response (p=0.3367), between any 


























Figure 3.10: Group-averaged time courses for the stimulus-evoked BOLD signal 
in response to forelimb stimulation under hypocapnic, normal and hypercapnic 
conditions. N=4; all animals were assessed for each gas condition (i.e. 
hypocapnia, normocapnia and hypercapnic). Group averages for PaCO2 under 
each condition were 24.8 mmHg, 40.38 mmHg and 54.55 mmHg for hypocapnic, 
normal and hypercapnic, respectively. Grey Section indicates when stimulation 
was applied. Error bars represent standard deviation. BOLD signal change 








Figure 3.11: (A) Peak BOLD and (B) integral of the BOLD response under 
hypocapnic, normocapnic and hypercapnic conditions. No significant 
differences were observed in peak BOLD or integrated BOLD values between 
any condition when assessed by RM one-way ANOVA. Individual data points 








In our first study, we attempted to establish non-invasive monitoring of PaCO2 
in the anaesthetised rat by measuring ETCO2 using two different micro-
sampling side-stream capnographs. PaCO2 values provided by blood gas analysis 
were compared with ETCO2 values obtained from micro-sampling side-steam 
capnographs. Agreement between the two techniques was assessed and used to 
determine whether monitoring ETCO2 via side-stream capnography could 
provide a practical and accurate method to monitor and maintain PaCO2 values 
within normal physiological limits. We also assessed how hypocapnia and 
hypercapnia affected the stimulus-evoked BOLD signal. 
 
3.4.1 Non-invasive monitoring of PaCO2 using side-stream capnography to 
measure ETCO2 
When comparing blood gas analysis measurements with the MicroCapStar and 
C1240 Micro Capnograph measurements, we generally observed poor 
agreement between PaCO2 and ETCO2 under all configurations tested. The 
range between the lower and upper 95% LOA in all configurations was greater 
than 10 mmHg, indicating that the differences between PaCO2 and ETCO2 
measurements were highly variable. This observation is clinically relevant since 
the range between the PaCO2 physiological limits is 10 mmHg (35 – 45 mmHg). 
Therefore, this value represented the largest range between the 95% LOA that 
could theoretically be accepted to ensure PaCO2 remained within normal 
physiological limits. However, this would require maintaining the ETCO2 at an 
exact value throughout an experiment, which in our experience is highly 
unlikely. To be practically feasible, the range between the 95% LOA for any 
given side-stream configuration would need to be smaller than 10 mmHg. Given 
that PaCO2 is known to be 2–5 mmHg higher than ETCO2, these values 
represented the optimum lower and upper LOA that a given side-stream 
configuration could achieve. Under such circumstances, maintaining the ETCO2 
between 33–40 mmHg would ensure the corresponding PaCO2 value is 
maintained within normal physiological limits, considering the difference 
between the two measures could vary by as little as 2 mmHg or as much as 5 
mmHg. However, side-stream capnography is known to underestimate ETCO2 
(Schieber et al. 1985; Chan et al. 2003), and therefore larger bias values and 
wider LOA were expected in our experiment. The 1 m sample line sampling at 
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the recommended position demonstrated the smallest effective range between 
upper and lower LOA, with the range indicated to lie between 10.28–12.23 
mmHg. Given that this range is marginally outside the theoretically acceptable 
10 mmHg, it is possible that with further optimisation, this configuration could 
provide an acceptable method to non-invasively monitor PaCO2 for bench top 
experiments where short sample lines can be used. Additionally, the range 
between upper and lower LOA when using the 7 m sampling line were generally 
larger than those observed when using the 1 m sampling line, suggesting that 
the variability in differences between PaCO2 and ETCO2 increases with line 
length. Therefore, a shorter sampling line, such as 0.75 m or 0.5 m, may be 
achievable in a bench top experiment and may provide narrower 95% LOA. 
Further studies could confirm this observation, however this was not 
achievable in the current study due to time constraints.  
 
The large variation in differences between PaCO2 and ETCO2 measurements 
observed in our study are likely underpinned by several physical laws affecting 
the transport of a gas sample. As a sample of gas passes through a tube, it is 
subjected to dispersal by diffusion and convention which subsequently causes a 
loss of the lowest and highest concentration peaks (Scammen and Fishbaugh 
1986; Pascucci et al. 1989). Dispersal is proportionate to the length of the tube 
and results in the underestimation of ETCO2, especially when used in 
individuals or animals with small tidal volumes. Higher breathing frequencies 
(>31 breaths/min) and low sample flow rates can further contribute to the 
underestimation of ETCO2 (From and Scamman 1988). Furthermore, a high flow 
of supplementary gases can lead to dilution of the expired CO2 sample. 
Considering our experiment involved long sample line lengths, used high 
breathing frequencies (approx. 60 - 70 breaths/min) and involved small animals 
with small tidal volumes, it is likely that the combination of these factors 
contributed to the underestimation and variability of ETCO2 values that we 
observed in all configurations.  
 
3.4.2 Evaluating the effects of varying PaCO2 on the stimulus-evoked BOLD 
signal 
In the current study, we observed that the stimulus-evoked BOLD response did 
not significantly differ under hypocapnic (PaCO2 = 25 mmHg), normal (PaCO2 = 
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40 mmHg) or hypercapnic (PaCO2 = 55 mmHg) conditions, when the peak BOLD 
response and integral of the BOLD response were assessed. However, it is 
worth noting that both measured characteristics of the BOLD response were 
numerically smaller during hypercapnia compared with normal and hypocapnic 
conditions, suggesting a trend for higher PaCO2 values to reduce the stimulus-
evoked BOLD response (Figure 3.10). In humans and rats, significant reductions 
in the stimulus-evoked BOLD signal have been observed under mild hypercapnic 
(PaCO2: 50-55 mmHg) and severe hypercapnic conditions (PaCO2 approx. 70 
mmHg), with the stimulus-evoked BOLD signal being virtually absent under 
severe hypercapnic conditions (Posse et al. 2001; Cohen et al. 2002; Sicard and 
Duong 2005; Nasrallah et al. 2015). Such severe hypercapnia is generally 
induced with breathing 10% CO2 and it has previously been observed that 
baseline CBF is similar between 10-15% CO2 (Sicard and Duong 2005). The lack 
of increased baseline CBF suggests that cerebral blood vessels are maximally 
dilated which likely underpins the severely attenuated/virtually absent 
stimulus-evoked BOLD response at these levels of hypercapnia. However, the 
lack of a statistically significant reduction in the current study under mild 
hypercapnia is likely a result of the considerable intersubject variability within 
our normal group (Figure 3.11) and the small study sample size. However, it is 
also important to note that the use of anaesthesia, in particular isoflurane, 
may also introduce confounds in to such preclinical studies. Isoflurane is a 
known vasodilator previously been shown to suppress neural activity and 
cerebral reactivity to CO2 (Kety and Schmidt 1948; Brevard et al. 2003; Sicard 
et al. 2003). Therefore, this may have also contributed to the lack of 
significant differences between normocapnic and hypercapnic conditions.  
 
Interestingly, our observation during hypocapnia opposes that reported by 
Sicard et al. (2005) who observed a significantly attenuated stimulus-evoked 
BOLD response (0.7% ΔBOLD) during hypocapnia (PaCO2 = 26 mmHg) when 
animals were exposed to a 9% O2 challenge. Under a similar hypocapnic 
condition (PaCO2 = 25 mmHg), we observed a larger group-averaged BOLD 
signal change of 3.42%, which was found to not significantly differ from the 
responses observed under our normal and hypercapnic conditions. The 
discrepancy between our observations and those observed by Sicard et al. 
(2005) is likely due to differences in PaO2 levels. PaO2 was maintained around 
normal values within all our conditions however, under 9 % O2, Sicard et al. 
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(2005) reported a PaO2 of approximately 33 mmHg. Since CMRO2 was observed 
to be similar under both the normal (21% O2) and 9% O2 condition, it is likely 
that the reduced BOLD signal change observed at 9% O2 is due to hypoxia-
induced attenuation of neurovascular coupling, as the author suggests.  
 
The effects of PaCO2 on baseline global blood flow are well established with 
many studies observing non-linear increases in baseline BOLD, CBF and MRI 
signals at various PaCO2 intervals between 20 – 70 mmHg (Posse et al. 2001; 
Brevard et al. 2003; Sicard et al. 2003; Sicard and Duong 2005). While reduced 
stimulus-evoked BOLD responses have generally been reported under 
hypercapnic conditions, some studies have reported contradictory findings. We 
observed no difference in the stimulus-evoked BOLD response between PaCO2 
values of 25 – 55 mmHg, although as previously stated, there were several 
limitations to our study but we observed a trend towards a smaller stimulus-
evoked response at higher PaCO2 values. Various human fMRI studies have 
observed consistent stimulus-evoked BOLD and CBF responses between 
normocapnic and hypercapnic conditions suggesting that stimulus-evoked BOLD 
and CBF responses are independent of baseline blood flow (Hoge et al. 1999; 
Corfield et al. 2001; Uludag et al. 2004; Whittaker et al. 2016). However, these 
findings are opposed by observations that an inverse relationship exists 
between baseline CBF and stimulus-evoked BOLD responses (Wong and 
Bandettini 1997; Cohen et al. 2002; Stefanovic et al. 2006). Conversely, other 
studies have observed a non-linear relationship between baseline CBF and 
stimulus-evoked responses, with reduced BOLD responses only being observed 
at severe hypocapnic and hypercapnic conditions (Sicard and Duong 2005). The 
discrepancies between these results likely arise from differences in study 
methodologies, such as different CO2 concentrations being used and for varying 
durations, the use of anaesthesia and whether free-breathing or mechanical 
ventilation is used. Furthermore, few of these studies report PaCO2 or ETCO2 
values with some only reporting the percentage of CO2 being administered to 
the breathing gases, which in cases or free breathing, may result in different 
PaCO2 values being achieved between studies due to differences in individual 
tolerance to CO2 and various compensatory effects. The inclusion of either 
PaCO2 of ETCO2 in such studies may provide more insight into understanding 
the relationship between PaCO2, baseline CBF and stimulus-evoked responses. 
Additionally, the matter is further complicated within the pre-clinical research 
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field as these studies typically involve the use of anaesthesia which provides 
another variable that could confound the data. Therefore, to elucidate the 
relationship between PaCO2, baseline CBF and stimulus-evoked responses, 
further studies that use consistent variables and control for potential 
confounds are required. 
 
In conclusion, we observed that the microsampling side-stream capnographs 
assessed under the current experimental set-ups did not provide an accurate 
and reliable surrogate marker of PaCO2 for use in an MRI setting, although 
there could be potential for use in a bench top setting with further 
optimisation of the 1 m sample line length. We also observed that hypocapnia 
(PaCO2 = approx. 25 mmHg) and hypercapnia (PaCO2 = approx. 55 mmHg) did 
not significantly affect the peak or integral of the BOLD response suggesting 
that the acceptable physiological range of PaCO2 could be widened without 
affecting the BOLD response in fMRI experiments using medetomidine-
isoflurane anaesthesia. However, given the large variability and low sample 
size of this study, further study is warranted. Ultimately, given the lack of 
accuracy and reliability between ETCO2 and PaCO2 in the current study, we did 
not implement side-stream capnography as a non-invasive measure of PaCO2 
and therefore retained the arterial blood gas analysis method for the 






Assessing the effect of varying stimulation 
parameters on stimulus-evoked BOLD, neural and 
CBF responses 
4.1 Introduction 
Pre-clinical fMRI studies often use anaesthesia to minimise the movement and 
stress of the animal during scanning, which could otherwise lead to the 
generation of artefacts and non-specific activations (Lahti et al. 1998; Peeters 
et al. 2001; Sicard et al. 2003). However, any anaesthetic used in a fMRI study 
must be carefully considered since different anaesthetics can have various 
effects on the underlying neural activity, hemodynamic response and the 
coupling mechanisms that link them, thereby also affecting the BOLD signal. 
Therefore, in studies assessing the stimulus-evoked BOLD or CBF response 
under anaesthesia, it is often necessary to characterise and optimise stimulus 
parameters in cases where the anaesthetic protocol is not currently 
represented within the literature. Additionally, assessing BOLD, CBF and neural 
responses under a specific anaesthetic protocol may inform on its effect on 
neurovascular coupling. In this chapter, data are presented to characterise the 
effects of varying forelimb electrical stimulation parameters on stimulus-
evoked BOLD, CBF and neural responses. 
4.1.1 Anaesthesia and neurovascular coupling 
Alpha-chloralose (α-chloralose) has previously been favoured for preclinical 
fMRI studies since it exhibits minimal effects on respiratory and reflex 
functions and preserves neurovascular coupling (Lees 1972; Ueki et al. 1992; 
Austin et al. 2005; Franceschini et al. 2010). However, α-chloralose can cause 
acidosis, seizure-like activity and a prolonged and poor recovery, and therefore 
cannot be used for longitudinal studies. Isoflurane is a commonly used volatile 
anaesthetic often favoured for its ease of use, that has also been used in fMRI 
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experiments (Liu et al. 2004; Sicard and Duong 2005; Kim et al. 2010; Nasrallah 
et al. 2015).  However, isoflurane is a potent vasodilator that has been shown 
to increase resting CBF at doses >1%, as well as suppress neural activity (Eger 
1984; Masamoto et al. 2007). It has been noted that at concentrations <1%, 
isoflurane does not strongly affect baseline CBF or CBV, and hemodynamic 
responses are only marginally smaller than those evoked under α-chloralose 
(Franceschini et al. 2010). However, at these concentrations, animals are 
inadequately anaesthetised and have been reported to exhibit reflex responses 
and unintentional limb movements which can interfere with recordings 
(Franceschini et al. 2010; Kortelainen et al. 2016). Medetomidine is an 
injectable anaesthetic that has gained some popularity in recent years with 
several fMRI studies reporting robust stimulus-evoked BOLD responses under 
this anaesthetic (Weber et al. 2006; Zhao et al. 2008; Pawela et al. 2009). 
However, the dosage of medetomidine needs to be periodically increased for 
longer experiments due to pharmacokinetic changes over time which would 
otherwise result in the animal regaining consciousness after 3 – 4 hours (Pawela 
et al. 2008; Zhao et al. 2008). 
 
4.1.2 Optimal stimulation parameters  
Due to the varying effects of different anaesthetics on neurovascular coupling, 
there is a great variation within the preclinical literature concerning stimulus 
parameters for optimal BOLD, CBF and neural responses. Studies using α-
chloralose have demonstrated maximal responses at stimulus frequencies of 1 
and 3 Hz with stimulus intensities as low as 0.5 mA (Gyngell et al. 1996; Silva 
et al. 1999; Keilholz et al. 2004; Sanganahalli et al. 2008), while other studies 
using isoflurane have observed maximal responses at 12 Hz with stimulus 
intensities of 1.4 – 1.5 mA (Masamoto et al. 2007; Kim et al. 2010). Maximal 
responses under medetomidine have also been demonstrated at stimulus 
frequencies of 9 Hz with stimulus intensities as low as 1 mA (Zhao et al. 2008). 
It is important to note that under α-chloralose, BOLD, CBF and neural 
responses decline as stimulus frequency increases, becoming completely 
abolished at 9-10 Hz. Therefore, if the optimal stimulus frequency for maximal 
responses under isoflurane (12 Hz) was applied in a study using α-chloralose, 
little to no responses would be observed. Collectively, these observations 
indicate that optimal stimulus parameters for one anaesthetic should not be 
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applied to a different anaesthetic and therefore, optimal stimulus parameters 
should be determined specifically for each protocol, if no optimisation has 
been previously performed in the literature.  
 
4.1.3 Medetomidine-isoflurane anaesthesia 
Previously, a novel anaesthetic protocol combining dexmedetomidine (an 
active enantiomer of medetomidine) and isoflurane was observed to provide 
stable anaesthesia for several hours and enable the acquisition of robust 
resting state networks and stimulus-evoked BOLD responses in the rat (Lu et al. 
2012). These observations were also confirmed in our own lab, as well as the 
ability of animals to recover well from this anaesthesia, thereby confirming its 
potential for longitudinal fMRI experiments (Hollyer 2016). However, to our 
knowledge, no study has yet characterised the effects of varying stimulus 
parameters on stimulus-evoked BOLD, CBF or neural responses under this 
adapted anaesthetic protocol. Such observations would not only prove helpful 
in establishing the optimum stimulus parameters under this anaesthesia, but 





4.1.4 Study Aims  
Given the lack of studies in the literature characterising the effects of varying 
forelimb stimulation parameters on BOLD, CBF and neural responses in rodents 
under a combined medetomidine-isoflurane anaesthesia, it was important to 
perform the following experiments to characterise how these responses were 
affected and to identify the optimal stimulation parameters for this anesthetic 
protocol that could be used in future studies. The aims of the experiments 
described in this chapter were to: 
1. Characterise the effects of varying stimulus frequency, stimulus 
intensity and pulse duration on the stimulus-evoked BOLD signal using 
fMRI and identify the optimal stimulation parameters 
2. Characterise the effects of varying stimulus frequency and stimulus 
intensity on neural activity by measuring various components of the 
somatosensory-evoked potential (SEP) and identify the optimal 
stimulation parameters 
3. Characterise the effects of varying stimulus frequency and stimulus 
intensity on the stimulus-evoked CBF response using laser speckle 




4.2.1 Study 1 – Investigation and optimisation of stimulus parameters for 
BOLD fMRI using forelimb stimulation 
 
4.2.1.1 fMRI preparation 
Wistar Kyoto (WKY) rats (n=9) weighing between 275 – 370 g were 
anaesthetised as outlined in Section 2.2.2. The femoral artery was cannulated 
as detailed in Section 2.3.2 to allow continuous monitoring of blood pressure, 
heart rate, and to allow periodic arterial blood sampling for the analysis of 
blood gas and pH levels. The animal was then transferred to the MRI cradle and 
secured, according to Section 2.4. Body temperature was monitored using a 
rectal probe and maintained at 37oC ± 0.5 using a heated water jacket. One 
animal was excluded from the study due to complications with the arterial line 
that prevented monitoring of the animal’s blood pressure, heart rate and blood 
gas profile.  
 
4.2.1.2 fMRI forelimb stimulation 
Two needle electrodes were inserted subcutaneously in the right forepaw at 
the second and fourth digits, as described in Section 2.3.3. Forepaw 
stimulation was achieved using a Grass S48 square pulse stimulator with output 
running through a constant current unit. For each stimulus run, either the 
stimulus frequency, pulse duration or stimulus intensity was systematically 
varied in reference to a set of baseline parameters. When one stimulus 
parameter was changed, the other parameters were maintained at a standard 
set of values. The standard reference parameter values were 3 Hz for stimulus 
frequency, 0.3 ms for pulse duration and 6 mA for stimulus intensity. 
Additional variation in the stimulus parameters were investigated as follows: 
(1) Stimulus intensity: the intensity of the stimulus was varied at 2 and 4 mA 
with the stimulus frequency set at 3 Hz and the pulse duration at 0.3 ms  
(2) Stimulus frequency: the frequency of the stimulus was varied at 6, 9 and 
12 Hz with the stimulus intensity set at 6 mA and the pulse duration at 0.3 
ms 
(3) Pulse duration: the pulse duration was varied at 0.6 and 1 ms while the 
stimulus frequency was set at 3 Hz and the stimulus intensity at 6 mA  
 106 
Only these three stimulation parameters were assessed as these are the 
parameters that are typically modified in rodent fMRI forelimb stimulation 
studies (Gyngell et al. 1996; Silva et al. 1999; Keilholz et al. 2004; 
Sanganahalli et al. 2008). The values investigated for each parameter were 
generally identified based on those assessed in these studies. The reference 
parameter values were chosen based on the most commonly used. However, it 
should be noted that while low stimulus intensities were commonly assessed 
and used (i.e. <2 mA), these studies were often performed under α-chloralose. 
Other studies using isoflurane or medetomidine have investigated higher 
stimulus intensities and observed larger BOLD responses at higher intensities 
(Liu et al. 2004; Zhao et al. 2008). Therefore, stimulus intensities of 2 mA, 4 
mA and 6 mA were investigated, and 6 mA chosen as the reference value 
based on these studies, given they were more appropriate to our own. 
 
Each run of the experiment consisted of a block design with 6 on-off periods 
where the stimulus was on for 22 seconds and off for 38 seconds. The start of 
each run was also preceded by a 10 second baseline period. The order at 
which the stimulus parameters were tested was randomised for all animals.  
 
4.2.1.3 MRI experiments 
MRI experiments were performed using a Bruker Biospec 7T, as detailed in 
Section 2.4. A fast low angle shot (FLASH) sequence was used to verify correct 
positioning of the animal within the scanner as well as coil positioning. Local 
shimming was performed using a fieldmap-based algorithm (‘MAPSHIM’). 
Functional echo planar image (EPI) series were acquired during the forelimb 
stimulation paradigm to assess the stimulus-evoked BOLD (TR 750 ms, TE 20 
ms, FOV 3.2 x 2.4 cm2, matrix 64 x 48, 15 slices of 1mm thickness, in-plane 
spatial resolution 500 µm2). A 320 x 240 um2 rapid acquisition with relaxation 
enhancement (RARE) T2 sequence was used for anatomical reference. 
 
4.2.1.4 Data analysis 
Data analysis was initially performed in MATLAB using in-house scripts. 
Significantly activated voxels were calculated using a t-test thresholded at 
p<0.05. A cluster threshold was applied to the resultant probability maps to 
remove single voxels of activation. The time courses for the remaining 
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significant voxels were then extracted, normalised to the pre-stimulus baseline 
and averaged to produce a single time course for each run. Each run was then 
averaged across the 6 on-off blocks to produce a single event-related average 
for each stimulus condition for each animal. The single event-related time 
courses from all animals were then grouped by stimulus parameter and used to 
extract the peak %BOLD for each animal. The single event-related time course 
values were then exported to Prism 6 where the integral of the BOLD response 
was calculated (area-under-curve, AUC). A threshold was applied during AUC 
calculation so that only positive peaks larger than 10% of the maximal Y value 
were measured. Additionally, only peaks that had a start point within the 
stimulus time period (i.e. 10 – 32 seconds) were included in the calculation. 
Peak %BOLD data for all stimulus conditions were analysed using a repeated 
measures one-way ANOVA (RM one-way ANOVA). Multiple comparisons between 
datasets within their respective stimulus category were made using a Tukey’s 
multiple comparisons test (e.g. 2 mA vs 4 mA vs 6 mA (reference), 3 Hz 
(reference) vs 6 Hz vs 9 Hz vs 12 Hz, 0.3 ms (reference) vs 0.6 ms vs 1 ms). The 
integrals of the BOLD response were analysed using a Friedman test. 
 
A post-hoc power analysis revealed that the current study had an 89.6% 
probability of correctly rejecting the null hypothesis (Effect size f, 0.40; α 
error probability, 0.05; correlation, 0.5; nonsphericity, 1). 
 
4.2.2. Study 2 – Evaluating the effects of varying stimulus parameters on 
the somatosensory evoked potential 
4.2.2.1 Animals 
Wistar Kyoto (WKY) rats (n=6) were anaesthetised according to Section 2.2.2. 
The femoral artery was cannulated to enable the monitoring of blood pressure 
and heart rate, as outlined in Section 2.3.2. Body temperature was monitored 
using a rectal probe and was maintained at 37oC ± 0.5 using a heating pad and 
radiant heat lamp. 
 
4.2.2.2 Laminectomy and craniotomy 
A laminectomy was performed to remove C4-C6 vertebra and expose the 
underlying spinal cord for the recording of cord dorsum potentials (CDPs). A 
 108 
craniotomy was performed to create a cranial window over the S1FL area for 
the recording of SEPs. Both procedures are outlined in Section 2.3.4 and were 
performed by Mrs Lindsay Gallagher. 
 
4.2.2.3 Forelimb Stimulation 
Two needle electrodes were inserted into the right forepaw at the 2nd and 4th 
digits, as outlined in Section 2.3.3. Forelimb stimulation was achieved using a 
custom Grass stimulator with output running through a constant current unit. 
For each stimulus run, the stimulus frequency or the stimulus intensity were 
systemically varied while other stimulus parameters were kept constant. To 
maintain consistency and allow comparisons with the fMRI experiment, the 
same stimulus intensities and frequencies were assessed. The effect of varying 
the pulse duration on the SEP was not investigated, as the same pulse 
durations could not be replicated with the different stimulus equipment. 
Variation in the stimulus parameters were investigated as follows: 
(1) Stimulus intensity: the intensity of the stimulus was varied at 2, 4 and 6 
mA with the stimulus frequency set at 3 Hz and the pulse duration at 0.2 
ms 
(2) Stimulus frequency: the frequency of the stimulus was varied at 3, 6, 9 
and 12 Hz with the stimulus intensity set at 6 mA and the pulse duration 
at 0.2 ms 
Due to pre-set pulse duration configurations in the stimulator, we were unable 
to replicate the 0.3 ms pulse duration as used in the fMRI study, with the 
closest available option being 0.2 ms. When assessing the effect of stimulus 
frequency on the SEP, the stimulus paradigm followed that as previously 
described in Section 4.2.1.2. Briefly, each run consisted of 6 on-off blocks 
where the stimulus was on for 22 seconds and off for 38 seconds. When 
assessing the effect of stimulus intensity on SEPs, each run consisted of a single 
on-off block where the stimulus was on for 22 seconds and off for 38 seconds. 
For all conditions, the first stimulation block was preceded by a 10 second 
baseline period. Total run time for each stimulus frequency run was 6 minutes 
and 10 seconds, while total run time for each stimulus intensity run was 1 
minute and 10 seconds. The order at which the stimulus parameters were 
tested was randomised. 
 
 109 
4.2.2.4 Recording CDPs and SEPs 
To confirm the activation of ascending somatosensory white matter tracts in 
the dorsal column, CDPs were recorded from the surface of the ipsilateral 
dorsal column at approximately C5. Recordings were made using silver ball 
electrodes with the indifferent electrode being placed on nearby back muscles. 
SEPs were recorded from the surface of the contralateral somatosensory cortex 
at the stereotaxic co-ordinates 0 mm AP, -4 mm ML relative to bregma. The 
indifferent electrode was placed on scalp muscles located under the retracted 
skin. The amplitude of the first positive deflection, first negative deflection 
and second positive deflection of the SEP were measured. We use the terms 
P1, N1 and P2 to refer to these components of the SEP, respectively. Responses 
were recorded using Spike2 Software (Cambridge Electronic Design Limited, 
UK). 
 
4.2.1.5 Data Analysis 
Spike2 acquisition files (.csg) were exported to MATLAB using the Spike2 
software. In-house scripts were used to measure the amplitude of the 
individual components of the SEP in MATLAB. Briefly, for each animal and 
condition, segments of the SEP data trace were sequentially isolated at 
frequency-defined intervals (e.g. every 0.333 ms from baseline start time for 3 
Hz runs). Within the isolated data segments, boundaries were defined to 
identify the expected positions of P1, N1 and P2. All isolated data segments 
were then displayed in a grid and visually checked to ensure that the 
frequency-defined intervals correctly captured SEPs along the data trace, 
where applicable, and that the individual components fell within the relevant 
boundaries (Figure 4.1A). Due to the lack of any responses during the stimulus 
‘off’ period, only data segments containing SEPs from the stimulus ‘on’ period 
could be used to visually confirm correct positioning. Upon visual confirmation, 
all isolated data segments were displayed individually with the measured P1, 
N1 and P2 amplitude values to ensure that correct measurements had been 
obtained (Figure 4.1B). The subsequent P1, N1 and P2 values were normalised 
to the first pre-stimulus baseline period and a correction factor, obtained by 
measuring a 100 µA calibration pulse after each experimental session, was 
applied. 
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For runs relating to variations in stimulus frequency, acquired amplitude values 
for P1, N1 and P2 were individually averaged across the 6 on-off stimulation 
blocks to produce a single event-related amplitude plot for each animal and 
each condition. For runs relating to variations in stimulus intensity, SEP 
amplitude values from the single on-off block were used. From these single 
event-related amplitude plots, the first peak amplitude for each SEP 
component (P1, N1, P2) was measured. While informative, these amplitude SEP 
measurements represent the mean neuronal response to each stimulus pulse 
whereas BOLD and CBF data represent integrated responses, which are a 
function of stimulus number and neural activity per stimulus. Therefore, we 
also calculated the individual sum of the SEP (ΣSEP) for P1, N1 and P2 as an 
index of integrated neuronal activity by summing the amplitude values evoked 
after each stimulus pulse. The data was then imported to Prism GraphPad 6 
where the integral of the amplitude plots (AUC) was calculated for each animal 
and each stimulus condition. AUC was calculated as previously described in 
Section 4.2.1.4, with the exception that for N1 measurements, only negative 
peaks were included in the calculation. Data within the respective stimulus 
parameter category for each component was then analysed by a repeated 
measures one-way ANOVA. 
 
A post-hoc power calculation indicated that there was a 50.8% probability of 
correctly rejecting the null hypothesis (Effect size f, 0.43; α error probability, 



















Figure 4.1: Measurement of individual SEP components using MATLAB. (A) A representative section of the grid containing isolated data 
segments. N1 was measured as the minimum value between the two dashed lines, with P1 and P2 being measured as the maximum 
values to the left of the first dashed line or right of the second dashed line, respectively. (B) Upon visual confirmation of correct 
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positioning within the relevant boundaries, SEPs were displayed individually with the measured amplitude values to ensure correct 
measurement of the relevant components. 
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4.2.3. Study 3 – Evaluating the effects of varying stimulus parameters on 
cerebral blood flow as assessed by laser speckle contrast imaging 
4.2.3.1 Animals 
In a separate cohort, WKY rats (n=6) weighing 315g - 400g were anaesthetised as 
outlined in Section 2.2.2. The femoral artery was cannulated as detailed in 
Section 2.3.2 to allow continuous monitoring of blood pressure and heart rate 
and to enable periodic blood sampling for analysis of blood gases. Body 
temperature was monitored using a rectal probe and was maintained at 37oC ± 
0.5 using a heating blanket and radiant heat lamp. 
 
4.2.3.1 Skull thinning 
The animal was secured in a stereotaxic frame and skull thinning performed as 
outlined in Section 2.3.5. 
 
4.2.3.2 Recording of CBF 
Laser speckle contrast imaging was performed to measure stimulus-evoked CBF 
responses using PIMSoft Software (Perimed, Stockholm, Sweden). ROIs were 
drawn over the ipsilateral and contralateral somatosensory cortices to monitor 
and inform on blood flow changes within these areas during the course of the 
experiment. Given that unilateral stimulation may evoke bilateral responses in 
the relevant brain areas, an additional ROI was drawn over the ipsilateral visual 
cortex as a control area. 
 
4.2.3.3 Forelimb stimulation 
Needle electrodes were inserted at the 2nd and 4th digits of the right forepaw as 
detailed in the Section 2.3.3. Similar to the fMRI forelimb stimulation study, for 
each stimulus run, either the stimulus frequency or stimulus intensity was 
systematically varied in regard to a reference set of stimulus parameters. To 
maintain consistency and allow comparisons with the fMRI and electrophysiology 
experiments, the same stimulus intensities and frequencies were investigated. 
The effect of varying the pulse duration on the SEP was not investigated. The 
reference parameters were 3 Hz for stimulus frequency, 6 mA for stimulus 
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intensity and 0.3 ms for pulse duration. Variation in the stimulus parameters 
were then investigated as follows: 
(1) Stimulus intensity: the intensity of the stimulus was varied at 2 and 4 mA 
with the stimulus frequency set at 3 Hz and the pulse duration at 0.3 ms  
(2) Stimulus frequency: the frequency of the stimulus was varied at 6, 9  
and 12 Hz with the stimulus intensity set at 6 mA and the pulse duration  
at 0.2 ms 
Each run consisted of 3 on-off blocks where the stimulus was on for 22 seconds 
and off for 38 seconds. For all conditions, the first stimulation block was 
preceded by a 10 second baseline period. Each run was separated by 5 mins to 
allow any stimulus-induced effects to return to baseline and to reduce any 
effects of habituation between runs. The order at which the stimulus parameters 
were tested was randomised. 
 
4.2.3.4 Data analysis 
Analysis was initially carried out using PIMSoft. ROIs were established over the 
contralateral and ipsilateral S1FL areas, as well as over the ipsilateral visual 
cortex. The position and size of the ROIs were defined based on the Paxinos and 
Watson rat atlas (Paxinos and Watson 1998). For the contralateral S1FL ROI, a 3 
x 2 mm oval was centred at 0 mm AP and -4 mm ML to Bregma and another 
centred at 0 mm AP and 4 mm ML to Bregma for the ipsilateral S1FL area. For 
the visual cortex ROI, a 3 x 2 mm oval was centred at -6 mm AP and 4 mm ML to 
bregma. The time course of each ROI was then separated according to stimulus 
condition and normalised to the first pre-stimulus baseline for each condition. 
The data was then averaged across the 3 on-off blocks to produce a single event-
related average for each stimulus condition for each animal. The single event-
related time courses for all animals were then grouped by stimulus condition and 
used to extract the peak %ΔCBF. The data were then imported to Prism 6 and 
the AUC for each stimulus condition for every animal was calculated, as 
previously described in Section 4.2.1.4. The data were then analysed using a 
repeated measures one-way ANOVA. 
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A post-hoc power calculation indicated that there was a 99.0% probability of 
correctly rejecting the null hypothesis (Effect size f, 0.82; α error probability, 
0.05; correlation, 0.5; nonsphericity, 1). 
4.3 Results 
4.3.1. Study 1 – Investigation and optimisation of stimulus parameters for 
BOLD fMRI using forelimb stimulation 
4.3.1.1.  Stimulus-evoked BOLD response 
To assess the effect of varying stimulus parameters on the stimulus-evoked BOLD 
response, we systematically varied either the stimulus frequency, pulse duration 
or stimulus intensity in regard to a reference set of stimulus values. For each 
condition tested, we observed a consistent activation cluster within the left 
S1FL area, being contralateral to the stimulated forelimb (Figure 4.2). The 
group-averaged time courses for most stimulus conditions produced a similar 
temporal profile, showing an increase in the BOLD signal shortly after stimulus 
onset, which gradually declined and plateaued over the course of stimulation 
and then returned to baseline shortly after stimulation was stopped (Figure 4.3). 
Higher frequencies of 6 Hz and above demonstrated a more pronounced peak in 
the BOLD response following stimulus onset, which declined rapidly after 





Figure 4.2: Anatomical RARE scans with the corresponding fMRI activation map 
overlaid for a representative animal. All variations in the stimulus parameters 
elicited an increased BOLD response within the contralateral somatosensory 






2 mA 4 mA Baseline  
6 Hz 9 Hz 12 Hz 
0.6 ms 1 ms 
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Figure 4.3: Group-averaged time courses showing the effects of varying (A) 
stimulus frequency, (B) stimulus intensity and (C) pulse duration on the ΔBOLD 








We observed a significant effect of varying the stimulus parameters on the peak 
ΔBOLD signal (RM one-way ANOVA, p = 0.0335). However, no significant pairwise 
comparisons were observed when stimulus conditions were compared within 
their respective stimulus category (Figure 4.4). The group-averaged BOLD time 
courses were similar in size and shape for the reference, stimulus intensity (2 
mA, 4 mA) and pulse duration conditions (0.6 ms, 1 ms), indicating that the 
stimulus-evoked BOLD responses remained consistent between these tested 
parameters. However, mean peak amplitude demonstrated a trend to increase 
with stimulus frequency, peaking at 9 Hz with a marginally smaller mean peak 
amplitude observed at 12 Hz (Figure 4.4). While this trend is clearly 
demonstrated when observing the mean peak amplitude values for each stimulus 
frequency, we observed a large variation in the peak amplitude values between 
individual animals for higher frequencies (≥6 Hz), which was generally not 
observed in any of the other stimulus conditions.   
 
We did not observe a significant effect of varying the stimulus parameters on the 
integral of the BOLD response (Figure 4.5) or the TTP (Figure 4.6). The TTP for 
most conditions varied between 6 – 6.7 seconds on average, however, for the 
lower stimulus intensities of 2 mA and 4 mA, we observed an averaged TTP of 






Figure 4.4: Peak ΔBOLD for variations in (A) stimulus frequency, (B) stimulus 
intensity and (C) pulse duration. A significant effect was observed when data 
were analysed using RM one-way ANOVA (p=0.036), however no significant 
pairwise comparisons were observed within each stimulus category when using 








Figure 4.5: The effect of varying (A) stimulus frequency, (B) stimulus intensity 
and (C) pulse duration on the integral of the BOLD response. No significant 
effect was observed for any stimulus condition tested (Friedman test, p=0.49). 
Data presented as mean ± standard deviation. Data organised into stimulus 







Figure 4.6: The effect of varying (A) stimulus frequency, (B) stimulus intensity 
and (C) pulse duration on the time-to-peak. No significant effect of any stimulus 
variation on the time-to-peak was observed (Friedman test, p=0.78). Data 
presented as mean ± standard deviation. 
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4.3.2. Study 2 – Investigation and optimisation of stimulus parameters for 
somatosensory evoked potentials using electrophysiology 
4.3.2.1 Stimulus intensity 
To assess the effect of varying the stimulus parameters on the various 
components of the SEP, we varied either the stimulus intensity or stimulus 
frequency while keeping all other stimulus parameters constant. All stimulus 
variations produced observable cord dorsum potentials (CDPs) in the ipsilateral 
dorsal column and measurable SEPs in the left somatosensory cortex, being 
contralateral to the site of stimulation. Figure 4.7 shows the SEP traces from a 
representative animal for the first 10 seconds of stimulation during the 2 mA,  
4 mA and 6 mA conditions. For all stimulus intensities tested, each stimulus 
pulse typically evoked a corresponding SEP. However, during recording sessions 
for all animals, we observed bursts of spontaneous activity within the SEP trace 
that either distorted or entirely abolished the SEP. Therefore in some instances, 
we did not observe a corresponding SEP to the stimulus pulse due to the on-
going spontaneous activity. These bursts of activity were observed to occur 
during both stimulus ‘off’ and stimulus ‘on’ periods and were only observed in 




Figure 4.7: SEPs traces showing 2 seconds of pre-stimulus baseline and the first 
10 seconds of stimulation at 2 mA (A), 4 mA (B) and 6 mA (C). Stimulus 
frequency was 3 Hz and pulse duration 0.3 ms. Spontaneous activity can be seen 
at various instances during all traces. In trace A, the arrow indicates 
spontaneous activity prior to stimulus onset. In trace B, the arrow indicates an 
absent SEP that has been abolished by the on-going spontaneous activity. In 





1 s  
0.5 mV 
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When the amplitudes of P1, N1 and P2 were measured, we observed that the 
shape of the amplitude plot remained relatively consistent between all 
components of the SEP (Figure 4.8). For all components examined, the 
amplitude rapidly increased from baseline values with the appearance of the SEP 
following stimulus onset. Peak amplitudes were generally observed within the 
first few pulses, however once the peak amplitude was achieved, there was a 
decline in amplitude over the remaining duration of the stimulation period. The 
downward slope of the amplitude decline over the course of stimulation 
appeared to differ between the positive and negative components. Group-
averaged P1 and P2 amplitudes demonstrated a gradual decline over the course 
of stimulation while group-averaged N1 amplitudes demonstrated a much more 
pronounced and sharper decline over the course of stimulation, almost returning 




Figure 4.8: Group–averaged stimulus intensity time courses for (A) P1, (B) N1 
and (C) P2 waveform components at 2, 4 and 6 mA. Stimulus frequency was 3 Hz 






When comparing the characteristics of P1, N1 and P2, we observed that the peak 
amplitude did not significantly differ between any of the stimulus intensities 
tested (Figure 4.9). There was a significant effect of stimulus intensity on ΣP1 
(p=0.04), with values increasing with stimulus intensity, however no significant 
pairwise comparisons were observed (11.57 mV vs. 14.48 mV vs. 15.55 mV; 2mA 
vs. 4mA vs. 6mA). The lack of any significant comparisons is likely underpinned 
by the low sample size and large variability observed in our data. A significant 
effect of stimulus intensity was also observed on the ΣN1 values, (-16.67 mV vs. 
-25.05 mV vs. -26.60 mV; 2mA vs. 4mA vs. 6mA, p = 0.02) with ΣN1 at 4 mA 
being significantly larger than that at 2 mA (adjusted p=0.04). There was also a 
trend for ΣN1 at 6 mA to be larger than that at 2 mA (adjusted p=0.05). ΣP2 was 
also significantly affected by stimulus intensity (8.90 mV vs. 11.01 mV vs. 11.30 
mV; 2mA vs. 4mA vs. 6mA, p=0.01) with ΣP2 values at both 4 mA and 6 mA being 
significantly larger than those observed at 2 mA (p<0.05 for both). A summary of 
ΣP1, ΣN1 and ΣP2 is shown in Figure 4.10.  
 
There was a significant effect of varying the stimulus intensity on the amplitude 
of N1 (p=0.02) and P2 (p=0.01) components over the course of the stimulation 
period, with the integrals of N1 and P2 being significantly larger at 4 mA and 6 
mA (adjusted p<0.05 for both), respectively, compared with 2 mA (Figure 4.11). 
No significant effect of stimulus intensity on the integral of P1 was observed 
however there was a trend for values to increase with stimulus intensity 
(p=0.06). Collectively our findings indicate that larger individual components of 
the SEP and therefore, larger SEPs in general, are evoked and maintained at the 
higher stimulus intensities of 4 mA and 6 mA. However, it is worth noting that 
for all measured characteristics (e.g. peak, sum and integral) of the SEP, the 
increase in each measure with increasing stimulus intensity appears to be non-
linear, as mean increases were numerically larger between 2 mA and 4 mA than 
between 4 mA and 6 mA. Therefore, while higher intensities evoked larger SEPs 
at the stimulus intensities investigated, it is likely that there is a limit to which 






Figure 4.9: Peak amplitude values for (A) P1, (B) N1 and (C) P2 waveform 
components at 2, 4 and 6 mA. No significant effect of varying the stimulus 
intensity on the peak amplitude of P1 (RM one-way ANOVA, p=0.16), N1 (RM one-
way ANOVA, p=0.27) or P2 (RM one-way ANOVA, p=0.84) at any stimulus intensity 







Figure 4.10: The effect of varying stimulus intensity on (A) ΣP1, (B) ΣN1 and (C) 
ΣP2. All SEP components demonstrated a trend to increase with stimulus 
intensity. ΣN1 at 2 mA was significantly smaller compared to 4 mA (p=0.02). ΣP2 
at 2 mA was significant smaller compared to 4 mA and 6 mA (p<0.01). A 
significant effect of stimulus intensity on ΣP1 was observed (p = 0.04) but no 
significant pairwise comparisons. Data analysed using RM one-way ANOVA with 
Tukey’s multiple comparisons test. *p<0.05 vs 4 mA; †p<0.05 vs 4 mA and 6 mA. 








Figure 4.11: The effect of varying stimulus intensity on the integral of (A) P1, 
(B) N1 and (C) P2. Larger responses were generally maintained at higher stimulus 
intensities (≥4 mA) compared to 2 mA. N1 at 2 mA was significantly smaller 
compared to 4 mA (p=0.02). ΣP2 at 2 mA was significant smaller compared to 6 
mA (p=0.01). No significant effect of stimulus intensity on ΣP1 was observed (p = 
0.0574). Data analysed using RM one-way ANOVA with Tukey’s multiple 
comparisons test. *p<0.05 vs 4 mA; †p<0.05 vs 6 mA. Individual data points 







4.3.2.2 SEPs and stimulus frequency 
Changing the stimulus frequency between 3, 6, 9 and 12 Hz had varying effects 
on the resultant SEPs over the course of stimulation. Examples of SEP traces 
during the first 10 seconds of the first stimulation period for a representative 
animal are shown in Figure 4.12. During 3 Hz stimulation, each stimulus pulse 
generally evoked an SEP, however as previously noted, there were instances of 
spontaneous activity that in some cases abolished the SEP. When the stimulus 
frequency was 6 Hz, we observed a one-to-one ratio of stimulus pulse-to-SEP for 
most animals. However in 3 animals, after an initial period of stable, consistent 
responses, the amplitude of N1 exhibited an oscillatory pattern of amplitude 
changes, noticeably increasing and decreasing periodically over the course of 
stimulation. This can been seen in the SEP trace shown for the representative 
animal in Figure 4.12B. Interestingly, this oscillatory pattern of activity was most 
prominent in the N1 waveform for 3 animals but was also demonstrated by 2 
animals for the P2 waveform. None of the examined animals exhibited this 
oscillatory pattern of amplitude change for the P1 waveform, which maintained 
a stable presence with only a gradual reduction in amplitude over the course of 
stimulation. During 9 Hz stimulation, we again observed an oscillatory pattern of 
amplitude changes over the course of stimulation, however, at this stimulus 
frequency all animals and all components demonstrated this pattern of response. 
Interestingly, N1 demonstrated this effect most notably and exhibited clear 
periodic bursts of SEP activity interspersed with periods where N1 was abolished. 
These bursts of activity typically demonstrated a gradual increase in SEP 
amplitude with subsequent stimulus pulses, building towards a peak amplitude 
and then gradually declining in amplitude. While P1 and P2 demonstrated this 
oscillatory change in amplitude, both components maintained a stable presence 
even during the ‘quiescent’ oscillatory periods, although during these periods 
their amplitude was severely attenuated. During 12 Hz stimulation, we observed 
an initial burst of SEPs with relatively large amplitude immediately following 
stimulus onset. However, this burst of activity was quickly attenuated and 





Figure 4.12: SEP data traces for the first 10 seconds of stimulation at (A) 3 Hz, 
(B) 6 Hz, (C) 9 Hz and (D) 12 Hz. 3 Hz stimulation generally maintained a 
consistent stimulus pulse to SEP. SEPs during 6 Hz stimulation demonstrated an 
oscillatory pattern in amplitude with a gradual decline over the course of 
stimulation. 9 Hz stimulation demonstrated a strong oscillatory effect of 
amplitude changes of the SEPs which periodically appeared and disappeared. 12 
Hz stimulation resulted in a short burst of SEP activity at the beginning of 
stimulation that quickly disappeared and remained absent for the remainder of 
the stimulation period. 
  
 132 
The shape of the amplitude plot for each frequency generally reflects the 
pattern of SEP activity described above. At 3 Hz, amplitude values demonstrated 
a rapid increase after stimulus onset with the appearance of the SEP, which 
remained elevated but demonstrated a gradual decline over the course of 
stimulation. The values quickly returned to baseline following cessation of the 
stimulus and absence of the SEP (Figure 4.13A). Stimulus frequencies above 3 Hz 
exhibited a more profound effect on the components of the SEP over the course 
of stimulation. During 6 Hz, group-averaged measurements revealed that all SEP 
components exhibited an initial amplitude peak shortly after stimulus onset, 
which declined more noticeably over the course of stimulation, almost returning 
to baseline values at the end of the stimulation period (Figure 4.13B). During the 
9 Hz stimulus condition, we initially observed a large peak in amplitude values 
after stimulus onset that rapidly returned to baseline and then exhibited an 
oscillatory pattern of changes, with the amplitude increasing and decreasing as 
bursts of SEPs periodically appeared and disappeared for the remaining duration 
of stimulation (Figure 4.13C). This effect was observed for all SEP components in 
all animals during the 9 Hz stimulation but was most noticeable in the N1 
component. During the 12 Hz stimulus condition, we again observed a large peak 
in amplitude values following stimulus onset that rapidly returned to baseline 
and then remained very low for the remainder of the stimulation period as the 
SEPs remained virtually absent (Figure 4.13D)
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Figure 4.13: Group-averaged amplitude plots for (A) 3 Hz, (B) 6 Hz, (C) 9 Hz and (D) 12 Hz stimulation. 3 Hz maintained the most stable 
amplitudes during stimulation for each waveform component while higher frequencies resulted in a suppression of the SEP response. 9 







Figure 4.14 shows the individual peak amplitude values for all measured 
components of the SEP at each stimulus frequency tested. We observed that 
varying the stimulus frequency did not have a significant effect on either the P1 
peak amplitude (0.6179 mV vs. 0.5019 mV vs. 0.5602 mV vs. 0.5941 mV, 3 Hz vs. 
6 Hz vs. 9 Hz vs. 12Hz; p = 0.15) or the peak P2 amplitude (0.3934 mV vs. 0.3617 
mV vs. 0.3914 mV vs. 0.3950 mV, 3 Hz vs. 6 Hz vs. 9 Hz vs. 12Hz; p = 0.31). 
However, there was a significant effect of stimulus frequency on the peak N1 
amplitude (-1.170 mV vs. -1.113 mV vs. -1.486 mV vs. -1.466 mV, 3 Hz vs. 6 Hz 
vs. 9 Hz vs. 12Hz; p = 0.0006), with 9 Hz evoking a larger N1 peak amplitude 
than that observed at 3 Hz and 6 Hz (adjusted p<0.05 and p<0.01, respectively). 
12 Hz was also observed to evoke a larger peak N1 amplitude compared that that 
evoked at 6 Hz (adjusted p<0.05).  
 
Both ΣP1 and ΣP2 demonstrated a trend to increase with stimulus frequency but 
only until 9 Hz (Figure 4.15). The mean values observed at 12 Hz for both ΣP1 
and ΣP2 were notably smaller than those observed at all other test frequencies 
(ΣP1, 27.2 mV vs. 31.9 mV vs. 33.3 mV vs. 22.2 mV; ΣP2, 19.9 mV vs. 22.7 mV vs. 
24.5 mV vs. 16.4 mV; 3 Hz vs. 6 Hz vs. 9 Hz vs. 12 Hz).  However, we did not 
observe a significant effect of stimulus frequency on these measurements (ΣP1, 
p = 0.11 and ΣP2, p = 0.07, Friedman test). Unlike the positive SEP components, 
ΣN1 did not demonstrate a clear trend to increase with stimulus frequency. 
However, there was a significant effect of varying the frequency on ΣN1 with the 
ΣN1 observed at 12 Hz being significantly smaller than that observed at the 
lower stimulus frequencies of 3 Hz and 6 Hz (adjusted p<0.05).  
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Figure 4.14:  The effect of varying stimulus frequency on the peak amplitudes 
of (A) P1, (B) N1 and (C) P2. Peak amplitudes remained consistent for P1 and P2 
waveforms but 9 and 12 Hz evoked significantly larger peak amplitudes than 
those observed at the lower stimulus frequencies. Individual responses with 







Figure 4.15: Effect of varying stimulus frequency on (A) ΣP1, (B) ΣN1 and (C) 
ΣP2 values. Both positive components demonstrated a trend to increase with 
stimulus intensity, peaking at 9 Hz and then declining at 12 Hz. N1 at examined 
frequencies ≤9 Hz remained similar but N1 at 12 Hz was significantly lower than 
that at 3 Hz and 9 Hz. Data analysed using Friedman test. Individual responses 
with mean and standard deviation shown. *p<0.05 vs 3 Hz and 6 Hz. 
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Given that higher frequencies will contain more stimulus pulses than lower 
frequencies, it is difficult to separate the effect of frequency from stimulus 
number when calculating ΣSEP. Therefore, we also assessed the integral of P1, 
N1 and P2 responses by calculating the AUC of the individual amplitude plots, to 
better isolate the effects of frequency on amplitude over the course of 
stimulation (Figure 4.16). There was a significant effect of varying stimulus 
frequency on the integrated measurements for all SEP components (P1, p=0.03, 
N1, p<0.01, P2, p<0.0001, RM one-way ANOVA) with higher frequencies of 6 Hz 
and above demonstrating smaller values than that observed at 3 Hz. 
Collectively, our observations indicate that higher frequencies of 9 and 12 Hz 
evoke larger peak amplitudes in the N1 waveform than those evoked at 3 Hz and 
6 Hz. However, these high amplitudes are not maintained over the course of 
stimulation but become attenuated, either periodically in the case of 9 Hz or 
completely in the case of 12 Hz. 
 138 
 
Figure 4.16: The effect of stimulus frequency on the integral of the SEP for (A) 
P1, (B) N1, and (C) P2 waveforms. A significant effect of varying stimulus 
frequency was observed on P1 (p=0.03), N1 (p<0.01), and P2, (p<0.0001). The 
integrals of N1 and P2 were significantly larger at 3 Hz compared to other 
stimulus frequencies. Individual responses with mean and standard deviation 








** ** † 
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4.3.3. Study 3 – Investigation and optimisation of stimulus parameters for CBF 
using laser speckle contrast imaging 
4.3.3.1 Stimulus-evoked CBF response 
To assess the effect of varying stimulus parameters on the rCBF response to 
forepaw stimulation, we systematically varied either the stimulus frequency or 
the stimulus intensity with regard to a reference set of stimulus parameters. For 
each stimulus condition tested, we observed an increased blood flow response 
on the surface of the cortex within the somatosensory area (Figure 4.17).  The 
group-averaged time courses for most stimulus conditions showed a similar 
response shape with the CBF peaking shortly following stimulus onset, gradually 
declining over the course of stimulation and then returning to baseline following 
cessation of the stimulus (Figure 4.18). Group–averaged responses for the higher 
frequencies of 9 Hz and 12 Hz demonstrated a noticeable delay in the CBF 
response returning to baseline following the end of stimulation. However, this 
observation is underpinned by responses from 3 animals during the 9 Hz 
condition, and one animal during 12 Hz condition that demonstrated 
considerably large rCBF responses that were slow to return to baseline. The 
group-averaged rCBF response for the 12 Hz condition demonstrates a sharp and 
clear peak following stimulus onset followed by a plateau for the remainder of 
the stimulation period. This effect was observed in all animals during the 12 Hz 
run. We generally did not observe stimulus-induced responses in the ipsilateral 
S1FL area or the ipsilateral visual cortex ROIs, however 2 animals during the 9 Hz 
condition and 1 animal during the 12 Hz condition exhibited stimulus-induced 
CBF increases in the ipsilateral S1FL area of a similar shape to that observed in 







Figure 4.17: Laser speckle images showing top-down view of the brain. (A) An averaged image of 10 raw images during the pre-stimulus 
baseline period. (B) An averaged image during stimulation. (C) The difference image, created by subtracting pre-stimulus baseline and 
stimulation images. The contralateral S1FL ROI boundary is outlined in black/white. Scale bar indicates arbitrary units.
      
0 400 -400 400 
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Figure 4.18: Group-averaged time courses from the S1FL area ROI showing ΔCBF 
under different (A) stimulus frequencies and (B) stimulus intensities. Data was 






4.3.3.2 Peak change in CBF 
Assessment of the peak ΔCBF revealed a significant effect of frequency and 
intensity in the contralateral S1FL area (p<0.001). We observed a trend for the 
peak ΔCBF to increase with stimulus frequency, peaking at 9 Hz and then 
plateauing at 12 Hz (Figure 4.19A). Indeed, the peak ΔCBF evoked at 9 Hz and 12 
Hz was found to be significantly larger than that evoked at 3 Hz (p<0.01 and 
p<0.05, respectively). Similarly, we observed that the peak ΔCBF increased with 
stimulus intensity (Figure 4.19B), with peak ΔCBF at 6 mA being significantly 
larger than that at 4 mA (p<0.05). The peak ΔCBF values remained consistent 
between all the tested stimulus intensity and stimulus frequency conditions 





Figure 4.19: The effect of varying (A) stimulus frequency and (B) stimulus 
intensity on peak ΔCBF in the contralateral S1FL area. A significant effect of 
varying stimulus parameters was observed on peak CBF (p<0.001) with larger 
increases observed at 9 Hz (p<0.01) and 12 Hz (p<0.05) compared to 3 Hz, as 
well as 6 mA compared to 4 mA (p<0.05). 3 Hz and 6 mA data represent the 
same reference dataset. Individual data with mean ± standard deviation shown. 









Figure 4.20: The effects of varying stimulus frequency on peak ΔCBF in the (A) ipsilateral S1FL area and (B) ipsilateral visual cortex, as 
well as the effects of varying stimulus intensity on the (C) ipsilateral S1FL area and (D) ipsilateral visual cortex. (Ipsilateral S1FL, 
p=0.18; Ipsilateral visual cortex, p=0.26; RM one-way ANOVA). 3 Hz and 6 mA data represent the same reference dataset. Individual 






4.3.3.3 Integral of CBF 
Analysis of the integral of the CBF response for the contralateral S1FL area also 
revealed a significant effect of frequency and intensity (Figure 4.21; p<0.01, RM 
one-way ANOVA). The group-averaged integral values of the CBF response 
demonstrated a trend to increase with stimulus intensity (111.5% vs. 173.7% vs. 
289.8%; 2 mA vs. 4 mA vs. 6 mA) and stimulus frequency, peaking at 9 Hz and 
notably declining at 12 Hz (289.8 vs. 381.2 vs. 1081.0 vs. 764.5; 3 Hz vs. 6 Hz vs. 
9 Hz vs. 12 Hz). However, no significant pairwise comparisons were observed 
(Tukey’s multiple comparison test, alpha = 0.05). The integral of CBF responses 
for ipsilateral S1FL and ipsilateral visual cortex were consistent between all 
conditions tested (p=0.24, p=0.11, RM one-way ANOVA; Figure 4.22). 
 
The main results from each of the previously described studies in this chapter 




Figure 4.21: The effect of varying (A) stimulus frequency and (B) stimulus 
intensity on the integral of the CBF response in the contralateral S1FL area. 
There was a significant effect of varying stimulus frequency and intensity on the 
integral of the CBF response (p<0.01) but no significant pairwise comparisons 
were observed when data were compared within their respective stimulus 
category e.g. frequency or intensity. 3 Hz and 6 mA data represent the same 










Figure 4.22: The effects of varying stimulus frequency on the integral of the CBF response in the (A) ipsilateral S1FL area and (B) 
ipsilateral visual cortex, as well as the effects of varying stimulus intensity in the (C) ipsilateral S1FL area and (D) ipsilateral visual 
cortex. There was no significant effect of varying stimulus frequency or stimulus intensity on the integral of the CBF response at either 
the ipsilateral S1FL (p=0.24) or visual cortex (p=0.11). 3 Hz and 6 mA data represent the same reference dataset for their respective 









 Stimulus Frequency Stimulus intensity Pulse duration 
 3 Hz* 6 Hz 9 Hz 12 Hz 2 mA 4 mA 6 mA* 0.3 ms 0.6 ms 1 ms 
MRI measurements 
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Table 4.1: A summary of the main results from each of the studies in this chapter. Data presented are mean (standard deviation). Pulse 
duration not assessed for electrophysiology and laser speckle studies. *3 Hz and 6 mA measurements were from the same run for MRI 




In this chapter, data are presented demonstrating how SEPs and stimulus-
evoked BOLD and CBF responses are affected by varying the stimulus 
parameters during forelimb stimulation under combined medetomidine-
isoflurane anaesthesia.  
 
4.4.1 The use of anaesthesia in rodent fMRI studies 
Most pre-clinical fMRI studies in rodents use anaesthesia to minimise movement 
and stress in the animal during scanning, which could otherwise lead to the 
generation of artefacts and non-specific activations (Lahti et al. 1998; Peeters 
et al. 2001; Sicard et al. 2003). While protocols for assessing awake animals 
have been introduced, and have demonstrated larger hemodynamic and neural 
responses when compared with anaesthetised animals (Brevard et al. 2003; 
Sicard et al. 2003; Aksenov et al. 2015), these are more labour-intensive and 
time-consuming. Furthermore, spontaneous movement and stress responses 
may still occur despite the animal undergoing extensive acclimatisation 
training (Paasonen et al. 2018). The use of anaesthesia overcomes these 
potential confounds but there are several different anaesthetics that are often 
used in preclinical fMRI studies, each with their own advantages and potential 
confounds. In general, anaesthetics can depress neuronal activity and cerebral 
metabolism, and alter vascular reactivity and dynamics, thereby affecting 
neurovascular coupling (Masamoto and Kanno 2012; Aksenov et al. 2015). Such 
effects are often produced by suppression of excitatory synaptic activity or 
enhancement of inhibitory activity (Richards 2002). However, the degree of 
these effects is often determined by the type and dosage of the anaesthetic 
used. Given the variety of anaesthetics used in preclinical fMRI studies and 
that such studies may further vary in their dosage, route of administration and 
set-up, it is difficult to compare findings between studies, even when the same 
anaesthetic is used.  
 
In a systematic review assessing the effects of anaesthetic regime on the BOLD 
response, the most commonly used anaesthetics in rat fMRI studies were 
isoflurane, dex-medetomidine/medetomidine and α-chloralose, with isoflurane 
being the most popular (Steiner et al. 2021). Other anaesthetics used included 
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urethane, propofol, isoflurane-medetomidine and ketamine. It is unsurprising 
that isoflurane is the most commonly used anaesthetic in rat fMRI studies given 
its ease of use and fast induction and recovery times (Liu et al. 2004; Sicard 
and Duong 2005; Kim et al. 2010; Nasrallah et al. 2015). However, as 
previously described, isoflurane is a potent vasodilator that could confound the 
fMRI readout due to its effects on baseline BOLD and CBF at doses >1% (Eger 
1984; Masamoto et al. 2007; Steiner et al. 2021). Few studies identified in the 
systematic review used isoflurane-medetomidine, yet this is the anaesthetic 
protocol used in the current study and all studies described throughout.  
 
The medetomidine-isoflurane anaesthetic protocol described throughout this 
thesis was previously established in our lab (Hollyer 2016), and was based on 
the original protocol first introduced by Weber et al. 2006 and a subsequent 
adaptation by Lu et al. 2012. The use of combined isoflurane-medetomidine 
has previously been shown to sedate rats for several hours without the need to 
increase the dose of medetomidine (a potential limitation of using 
medetomidine alone), produce robust stimulus-evoked responses and allow 
imaging of resting-state networks in rats (Lu et al. 2012; Hollyer 2016). 
However consistent, robust BOLD responses under this anaesthetic protocol are 
only observed after 90 mins following anaesthetic induction, with responses 
before this time being variably smaller (Lu et al. 2012). This temporal 
variability of the BOLD response has also been observed under a 
medetomidine-only protocol, with responses within the first 2 hours following 
medetomidine administration being variably smaller when compared with 
responses measured during 2-4 and 4-6 hours post-medetomidine (Sirmpilatze 
et al. 2019). Of note, this observed temporal evolution of the BOLD response 
was dependent on the route of administration as well as the dose. Temporal 
variability was observed when medetomidine was continuously infused 
subcutaneously and a pre-dose bolus given, when infused intravenously without 
a pre-dose bolus, and when administered intravenously with a lower dose bolus 
and infusion than that described in the original protocol by Weber et al. 2006. 
Consistent, robust BOLD responses were observed at all assessed time windows 
when medetomidine was infused intravenously with a pre-dose bolus at the 
same dosage described in the original protocol. The difference in the timing of 
the temporal variability of the BOLD response between these two studies (90 
mins vs. 2 hours) may be due to several factors such as the use of a lower dose 
 152 
of medetomidine, a different route of administration (intramuscular) and the 
addition of isoflurane in the Lu et al. 2012 study. However collectively, these 
two studies indicate that temporal variability of the stimulus-evoked BOLD 
response may occur when medetomidine is used and therefore this should be 
factored into the study design to ensure consistent BOLD responses are 
recorded and measured. 
  
Based on the observations of Lu et al. 2012, no recordings in the current study 
or in any study described in this thesis were made until at least 90 mins had 
passed following the administration of the medetomidine bolus. Given that the 
findings of Sirmpilatze et al. 2019 were not published until after completion of 
the studies in this thesis, we were not aware that the temporal variability of 
the BOLD response may extend within the first 2 hours following medetomidine 
administration. However, as the current study used medetomidine-isoflurane 
and not medetomidine-only, it is possible that the timing of the temporal 
variation of the BOLD signal described by Lu et al. 2012 may be more 
comparable to our own study. Yet, it is worth noting that the anaesthetic 
protocol followed in all experiments in this thesis used a higher dose of 
medetomidine (0.05 mg/kg bolus; 0.1 mg/kg/hr infusion), a different route of 
administration (subcutaneous) and a higher dose of isoflurane (1%) compared 
with the study by Lu et al. 2012. Therefore, given that our anaesthetic 
protocols do not exactly match, it is unclear whether the timing of the 
temporal variation of the stimulus-evoked BOLD signal is the same and 
therefore we cannot completely rule out that this may have led to some 
variation within our results. Future work should assess the temporal evolution 
of the BOLD response under this specific anaesthetic protocol to confirm such. 
 
4.4.2 Dependency of the BOLD response on stimulus parameters   
In our study we observed a trend for the peak BOLD amplitude to increase with 
stimulus frequency, evoking the largest peak amplitude at 9 Hz and then 
plateauing at 12 Hz. The peak BOLD response at 12 Hz while statistically 
similar to 9 Hz was numerically lower, suggesting that the peak response may 
begin to decline above a stimulus frequency of 12 Hz. These findings are 
consistent with previous rodent forepaw stimulation studies that observed 
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maximal peak BOLD amplitudes at 9 Hz and 12 Hz when using medetomidine 
and isoflurane respectively (Zhao et al. 2008; Kim et al. 2010).  
 
Similar to previous studies using these anaesthetics, we did not observe a 
significant effect of stimulus frequency on the integrated BOLD values. While 
an increase in stimulus frequency up to 9 Hz evoked a larger peak in the BOLD 
response, the overall size of the response, as measured by the integral of the 
response, remained consistent between the stimulus frequencies. However, 
this observation is likely dependent on the stimulus duration. Both BOLD and 
CBF responses to stimulus durations of 15 seconds or more have been observed 
to peak within the first 10 seconds of stimulation, and then plateau for the 
remainder of the stimulation period, similar to our own observations (Ureshi et 
al. 2004; Zhao et al. 2008; Kim et al. 2010). When integrated BOLD values were 
calculated for each 10-second period during 30 seconds of stimulation, Kim et 
al. (2010) observed a significant effect of frequency for the first 10 seconds, 
with the largest signal change occurring at 12 Hz. However, there was no 
significant effect of frequency on integrated BOLD values for the second (11 – 
20 seconds) or third periods (21 – 30 seconds), when the response had 
plateaued, and the largest signal change was observed to occur at 6 Hz (Kim et 
al. 2010). Collectively, these observations indicate that stimulus duration 
should also be considered when assessing the optimum stimulus parameters for 
integrated BOLD. 
 
While we identified 9 Hz as the optimum stimulus frequency for achieving the 
maximal peak BOLD amplitude, it is considerably higher than the optimum 
stimulus frequencies observed under α-chloralose anaesthesia, which have 
been observed to range between 1.5 – 5 Hz (Brinker et al. 1999; Silva et al. 
1999; Keilholz et al. 2004; Sanganahalli et al. 2008). Both isoflurane and 
medetomidine have been observed to depress excitatory synaptic transmission 
(Larsen et al. 1997; Larsen and Langmoen 1998; Richards 2002; Sinclair 2003; 
Sandstrom 2004; Angenstein et al. 2010), while α-chloralose enhances 
inhibitory activity by potentiating GABAA receptor activity (Garrett and Gan 
1998). Furthermore, α-chloralose has been observed to prolong neural 
refractory periods while isoflurane maintains short refractory periods 
(Masamoto et al. 2007; Masamoto et al. 2009; Kim et al. 2010). The different 
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target sites and mechanisms of action of these anaesthetics likely underpin the 
differences in the required stimulus frequency to evoke a maximal response. 
 
Peak and integrated BOLD values remained consistent at all stimulus intensities 
examined. Peak BOLD responses have previously been observed to 
monotonically increase at stimulus intensities of 1, 2 and 4 mA in 
medetomidine-sedated rats, with higher stimulus intensities of 6 and 8 mA 
exhibiting no further increases (Zhao et al. 2008). However, aside from using a 
different anaesthetic protocol, Zhao et al. (2008) assessed the various stimulus 
intensities at 9 Hz while in our study, the various stimulus intensities were 
assessed at a stimulus frequency of 3 Hz. This observation introduces the 
possibility of an interaction between stimulus intensity and stimulus frequency, 
where a combination of a higher stimulus intensity and higher frequency may 
evoke larger peak amplitudes. Most fMRI studies assessing optimal stimulus 
parameters typically assess variations in one parameter category at a time, as 
is the case with our own study. However, few assess all possible comparisons to 
determine whether interactions between parameters may exist. While this may 
be due to various reasons, including time-constraints for scanning, future 
studies could focus on assessing multiple combinations between a small 
number of commonly used stimulus parameters to assess any interactions 
between them.  
 
4.4.3 Dependency of the SEPs on stimulus parameters   
In our study we assessed the effects of varying stimulus parameters on cortical 
neural activity by measuring the individual SEP components. P1, N1 and P2 
were separated and measured individually because these waveforms originate 
from different subpopulations of pyramidal cells (Kulics and Cauller 1986; Di 
and Barth 1991; Staba et al. 2003; Jellema et al. 2004), and as such, respond 
differently under various experimental conditions, stimulus paradigms and 
drugs (Kublik et al. 2001; Staba et al. 2003; Stienen et al. 2004; McElhone et 
al. 2006). We observed that peak P1, N1, and P2 values remained invariable 
under all stimulus intensities tested. However, the individual ΣSEP and integral 
values demonstrated a trend to increase with stimulus intensity.  
 
 155 
Electrophysiological studies examining stimulus-evoked field potentials (FP) 
have reported that peak amplitude increases with stimulus intensity, with the 
ΣFP also demonstrating a non-linear increase with intensity (Ureshi et al. 2005; 
Franceschini et al. 2008). However, these studies were performed under α-
chloralose and assessed at stimulus intensities at various increments below 2.5 
mA. It is possible that in our study, a ceiling effect was achieved, with the 
response at 2 mA representing a maximal or near-maximal peak response. 
Assessing stimulus intensities at various increments below 2 mA may have 
revealed an effect of intensity on peak SEP amplitude. However, data from 
individual animals, as shown in Figure 4.9, demonstrates a wide variability 
between animals. This variability may mask any effect of stimulus intensity on 
peak amplitude within our study. Therefore, a larger sample size with smaller 
variability in the data may reveal an underlying relationship between stimulus 
intensity and peak SEP amplitudes.  
 
Peak amplitude values for both positive waveforms also remained consistent 
when the stimulus frequency was varied, however higher N1 peak amplitudes 
were observed at 9 Hz and 12 Hz compared with lower frequencies. Both ΣP1 
and ΣP2 demonstrated a clear trend to increase with frequency, peaking at 9 
Hz and then declining at 12 Hz, while ΣN1 remained consistent at stimulus 
frequencies of 3, 6 and 9 Hz, but declined at 12 Hz. Previous studies have 
shown that P1 originates from thalamo-cortical input-derived excitatory 
postsynaptic activity in cortical neurons of layer IV, while N1 and P2 generally 
arise from cortico-cortical activity in the more superficial layers I-III (Kulics 
and Cauller 1986; Di and Barth 1991). Given the shared origin of N1 and P2, 
similar response patterns have been reported for both waveforms to various 
stimulus parameters (Franceschini et al. 2008). Our findings do not mimic this 
observation, but rather we observed similar response patterns between both 
P1 and P2 components, that typically differed from N1. It is possible that this 
discrepancy is underpinned by the difference in our anaesthetic protocols and 
the variability within our data. Therefore, further investigation would be 
required to verify our observation. 
 
We observed that each stimulus pulse generally evoked a corresponding SEP at 
3 and 6 Hz, however SEPs were periodically abolished at 9 Hz and quickly 
abolished at 12 Hz. Several electrophysiology studies using α-chloralose have 
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also observed that the one-to-one response of stimulus pulse-to-FP remains 
intact until 5 Hz and breaks down at higher stimulus frequencies (Matsuura and 
Kanno 2001; Ureshi et al. 2005). However, the next stimulus frequency 
assessed after 5 Hz in both these studies was 10 Hz. Therefore, it is possible 
that the one-to-one relationship remains intact at frequencies higher than 5 Hz 
but lower than 10 Hz. The similar range at which the one-to-one relationship 
breaks down between our study and previous  
α-chloralose studies suggests that this observation may arise from a common 
underlying mechanism that is robust to different anaesthetics. 
 
4.4.4 Dependency of CBF on stimulus parameters   
Using LSCI to measure stimulus-evoked CBF changes on the S1FL cortical 
surface, we observed that peak amplitude and integrated CBF values increased 
with both stimulus intensity, up to 6 mA, and stimulus frequency, peaking at 9 
Hz and declining at 12 Hz. Previous LSCI studies in the rat have also observed 
that the peak CBF response to forelimb stimulation increases with stimulus 
intensity, however these studies were performed under  
α-chloralose and only stimulus intensities of up to 2 mA were assessed 
(Durduran et al. 2004; Dunn et al. 2005; Royl et al. 2006). While there were 
slight differences in the stimulus frequency (3-4 Hz), pulse duration (0.3-0.4 
ms) and dose of α-chloralose between these studies, the CBF responses were 
generally similar, with peak changes of approximately 10-15% and 20-25% being 
observed at 1 mA and 2 mA, respectively. In the current study, the mean peak 
change in the CBF response was 8.36% at 2 mA, 12.53% at 4 mA and 17.96% at 6 
mA, when stimulus frequency was 3 Hz and pulse duration 0.3 ms. Thus, under 
the current anaesthetic protocol, the peak CBF at 2 mA was substantially 
smaller to that observed in studies using α-chloralose. This difference is to be 
expected given the different mechanisms of action of these anaesthetics. A 
previous study observed that the peak CBF response to forelimb stimulation, as 
assessed by fMRI, was 84% lower under isoflurane compared with α-chloralose 
(Masamoto et al. 2007). The strong reduction in the peak amplitude of the CBF 
response was attributed to the change in baseline CBF, which increased by 54% 
under isoflurane compared with  
α-chloralose. Therefore, it is likely that the use of isoflurane in the current 
study underpins the substantially smaller BOLD response when compared with 
 157 
responses observed under α-chloralose. Collectively, these studies further 
support that stimulus parameters should be optimised to the individual 
anaesthetic protocol and also indicate that comparisons between studies using 
different anaesthetic protocols should be interpreted with caution. 
  
The effects of changing stimulation parameters on the stimulus-evoked CBF 
response to forelimb stimulation in the rat somatosensory cortex have also 
been investigated using laser-Doppler flowmetry. Under α-chloralose 
anaesthesia, a trend for the peak and integrated CBF response to increase with 
stimulus intensity up to 2.5 mA has been observed (Detre et al. 1998; Silva et 
al. 1999; Ureshi et al. 2005). Interestingly, Detre et al. 1998 observed that the 
CBF response at 2.5 mA was accompanied with an increase in MABP, while Silva 
et al. 1999 observed an increase in MABP at 2.0 mA. The difference between 
the two studies as to the stimulus intensity at which increase in MABP were 
observed may be due to the difference in the dose of anaesthetic used; a lower 
dose of α-chloralose was used by Detre et al. 1998. These increases in MABP 
suggest that the stimulus had become noxious, which can confound 
neuroimaging measures as a result of global changes in CBF and neurovascular 
coupling (Jeffrey-Gauthier et al. 2013; Uchida et al. 2017).  Similar 
observations have been made under isoflurane anaesthesia, with CBF responses 
increasing with stimulus intensity up to 8 mA, but eliciting increases in MABP at 
this higher stimulus intensity (Liu et al. 2004). Collectively, these studies 
indicate that stimulus-evoked CBF responses increase with stimulus intensity, 
however higher stimulus intensities, which are likely relative to the dose and 
type of anaesthetic being used, can become noxious and induce changes in 
MABP and global CBF.  
 
While we did not analyse the effects of stimulation on MABP, we did not 
observe any spikes or increases in the MABP trace during stimulation. We also 
observed that CBF increases with stimulus intensity between 2 mA and 6 mA, 
with no indication of the response plateauing at the latter stimulus intensity. 
Therefore, it is likely that increasing the stimulus intensity above 6 mA could 
have resulted in a further increase in stimulus-evoked CBF response. However, 
this current study did not assess stimulus intensities >6 mA given that such high 
intensities are rarely used in the literature and changes in MABP and global CBF 
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have been observed at 8 mA in rats anaesthetised with 1.1-1.2% isoflurane (Liu 
et al. 2004).  
 
When assessing the effect of stimulus frequency on the CBF response, we 
observed that integrated and peak CBF increased with stimulus frequency, 
peaking at 9 Hz and declining at 12 Hz. To our knowledge, there are no LSCI 
studies that have assessed the effects of changing stimulus frequency on the 
stimulus-evoked CBF response in the rat somatosensory cortex. However, 
several studies have used laser-Doppler flowmetry to investigate such changes 
in rats under α-chloralose.  Such studies have observed both peak and 
integrated CBF values increase with frequency, peaking at an optimal 
frequency typically dependent on the anaesthetic, then declining at above-
optimal frequencies (Detre et al. 1998; Ngai et al. 1999; Silva et al. 1999; 
Ureshi et al. 2004; Masamoto et al. 2007). Collectively, these studies highlight 
that different anaesthetic protocols do not affect the general pattern of CBF 
response to variations in stimulus frequency, as all show a tendency for CBF 
measures to peak at an optimal frequency and then decline at higher 
frequencies. However, the chosen anaesthetic does appear to influence the 
optimal frequency, with each unique anaesthetic protocol demonstrating a 
different optimal frequency.   
 
4.4.5 Relationship between BOLD, SEP and CBF 
To accurately characterise the relationship between BOLD, SEPs and CBF, it is 
typically favourable to measure these components simultaneously under similar 
conditions. Due to experimental constraints, we did not acquire these 
measurements simultaneously and while efforts were made to ensure most 
aspects of the experiments were consistent, there were some differences that 
may have introduced additional variability into the data. These included 
different invasive surgical preparations e.g. intact skull for fMRI, craniotomy 
for electrophysiology and skull thinning for LSCI, and the use of different 
cohorts between studies with differing sample sizes. In our case, the latter 
restricts our ability to statistically assess correlations between the data since 
observations are not related between measures of interest. Additionally, the 
sample sizes within our experiments were relatively small and therefore this 
may also affect variability and statistical significance within our study. 
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However, measuring these key components of neurovascular coupling 
individually can still provide useful insights, if interpreted with caution.  
 
Several studies have previously shown that neural responses, as measured by 
ΣSEP or ΣFP, are highly correlated with CBF increases (Ngai et al. 1999; Kim et 
al. 2010). The summed neural measure is typically used when assessing the 
correlation between neural and hemodynamic responses as it is generally 
accepted that hemodynamic responses are underpinned by integrated neural 
activity, rather than average or peak activity. Indeed, when the effect of 
stimulus frequency on mean peak amplitude was studied, an inverse 
relationship between peak neural and peak CBF values has been observed (Ngai 
et al. 1999; Kim et al. 2010). While we cannot report on the correlation 
between changes in frequency-dependent ΣSEP and integrated CBF responses 
in our study, we speculate that one does exist between these measures, owing 
to the observation that both demonstrate a similar trend to increase with 
frequency, peak at 9 Hz and then decline at 12 Hz. Previous studies that report 
a high correlation between CBF and neural measures observed similar patterns 
of responses, however, since most of these studies were performed under 
alpha-chloralose, the peak occurred at a lower stimulus frequency of 5 Hz.  
 
Since the stimulus-evoked BOLD response is generally underpinned by a local 
increase in CBF, it is reasonable to assume that the frequency-dependent 
integrated BOLD responses would exhibit a similar pattern to the integrated 
CBF responses. However, we observed that integrated BOLD values remained 
relatively constant at stimulus frequencies of 6 Hz and above, and did not 
demonstrate the previously seen 9 Hz peak and subsequent decline at 12 Hz. 
This discrepancy likely arises from our small sample size and high variability 
within the data and therefore further investigation is required. 
 
4.4.6 Conclusion 
In conclusion, we observed that the largest stimulus-evoked BOLD and CBF 
responses were evoked at a stimulus frequency of 9 Hz. While the largest 
summed responses of the SEP components were also observed at this 
frequency, we observed that the amplitude of the overall neural response 
decreases with increasing stimulus frequency and there is a loss of the one-to-
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one stimulus to SEP ratio when higher frequencies are used. While the 
stimulus-evoked BOLD response evoked at 3 Hz was generally smaller than 
those evoked at higher frequencies, there was less variation in the size of the 
BOLD responses at this frequency and SEPs were generally consistent in 
amplitude and maintained throughout the course of stimulation. Thus, 3 Hz 
was selected as the optimum stimulus frequency after considering the data 
from all modalities. Larger CBF responses were generally observed at a 
stimulus intensity of 6 mA, however there was no statistical difference 
between any of the stimulus intensities when measuring the stimulus-evoked 
BOLD response or any components of the SEP, although there was a general 
trend for the summed and integral of the SEP components to increase with 
stimulus intensity. Therefore, 6 mA was chosen as the optimal stimulus 
intensity. Stimulus pulse duration was only assessed in the fMRI study and we 
observed no effect of varying the pulse duration on the stimulus-evoked BOLD 
response. Therefore, 0.3 ms was selected as the optimum pulse duration given 
that this is also commonly used in the literature. These optimum parameters 




Assessing the hemodynamic response in the 
SHRSP: A model of cerebral small vessel disease 
 
5.1 Introduction 
The SHRSP is a model of malignant hypertension, stroke and cerebral SVD. The 
aim of this study was to assess whether changes in the hemodynamic response 
(BOLD, CBF) can be detected in this model of cerebral SVD and therefore could 
provide a biomarker of endothelial function and an indicator of therapeutic 
response.  
 
5.1.1 Cerebral small vessel disease 
Lacunar stroke infarcts are common in cerebral SVD and account for 
approximately 20% of all strokes (Sudlow and Warlow 1997b). Lacunar strokes 
are characterised by small infarcts (<20 mm in diameter) in deep brain 
structures that include cerebral white matter, basal ganglia or pons (Bamford 
et al. 1988). Additionally, cerebral SVD is characterised by WMHs (Kynast et al. 
2018), lacunes of vascular origin (Vermeer et al. 2007), microbleeds 
(Cordonnier et al. 2007) and cortical microinfarcts (Smith et al. 2012). The 
cause of cerebral SVD and resultant pathology is unclear, owing to the 
difficulty of studying the disease in humans; lacunar strokes are rarely fatal 
and pathological changes, which include small focal infarctions in the brain, 
can be mild and go unnoticed (Hainsworth and Markus 2008). Furthermore, 
death may occur long after stroke and other pathological changes, leading to 
limited tissue for analysis that is difficult to interpret.  
5.1.2 SHRSP 
The SHRSP is a model of cerebral SVD that demonstrates similarities to human 
SVD pathology (Bailey et al. 2011a). Interestingly, WMHs are commonly 
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observed and regarded as a typical sign of cerebral SVD in human patients, (Shi 
and Wardlaw 2016), yet a MRI study of 10-month old SHRSPs did not observe 
any WMHs in a stroke-free cohort (Brittain et al. 2013). However, SHRSPs and 
patients with cerebral SVD have both demonstrated dysfunctional endothelial 
cells and BBB leakage, both of which contribute to many of the pathological 
features of cerebral SVD (Quick et al. 2021). Compared with WKYs, SHRSPs 
exhibit reduced claudin-5, an endothelial tight junction protein, from 5 weeks 
of age indicating that BBB dysfunction in these animals precedes the onset of 
hypertension and may be an initial driver of disease (Bailey et al. 2011a). 
Furthermore, the expression of tight junction proteins, including claudin-5, has 
previously been observed to remain consistent in SHRs, compared with WKYs, 
following 4-hour middle cerebral artery occlusion (Hom et al. 2007). While the 
use of surgical intervention to induce ischemic stroke may complicate 
interpretation of this observation, such findings suggest that the reduced 
expression of claudin-5 observed in SHRSPs compared with SHRs may underlie 
the ‘stroke prone’ phenotype of these animals.  
 
The assessment of pathological changes in the SHRSP occurring at later, 
chronic stages of this disease are rare. A systematic review showed that the 
majority of the studies assess SHRSPs between 9-16 weeks of age, during the 
acute stages of hypertension and SVD progression (Bailey et al. 2011a). 
Furthermore, almost a quarter of studies fed animals a Japanese diet or added 
salt (‘salt-loading’) to the drinking water to accelerate the hypertensive 
pathology (Bailey et al. 2011b; Di Nicolantonio and Silvapulle 1988). Severe 
hypertension is established at a younger age in salt-loaded animals, which 
subsequently do not typically live beyond 28-weeks of age (Bailey et al. 
2011b). One study compared salt-loaded WKYs and SHRSPs and observed 
changes in gene and protein expression in networks affecting inflammatory 
pathways, vascular structure and myelin integrity that, in the case of the salt-
loaded WKY, were observed in the absence of an increase in blood pressure 
(Bailey et al. 2018). Furthermore, expression of CLDN11, a gene that encodes 
the tight junction protein Claudin-11, was significantly down-regulated in salt-
loaded SHRSPs compared with non-salt-loaded SHRSPs. This observation, 
coupled with the reduced claudin-5 expression previously observed in SHRSPs 
(Bailey et al. 2018), suggest that salt-loading in SHRSPs may further 
compromise the integrity of the BBB compared with non-salt-loaded SHRSPs. 
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Whether these changes reflect an accelerated disease pathology or a 
potentially different pathology to salt-naïve SHRSPs is not clear. The difficulty 
in evaluating this lies in part to the lack of studies assessing pathological 
changes in SHRSPs occurring later in SVD progression and in the absence of 
potential confounds, such as salt loading. Therefore, assessing the normal 
pathological development in these animals at this later time point may better 
inform on disease progression and further support how SHRSPs can model 
human disease pathology, which is typically associated with older individuals 
over the age of 65 years (Pantoni 2010). 
 
5.1.3 Small vessel disease and BOLD 
Most neuroimaging studies in patients with SVD assess structural characteristics 
associated with the disease, such as small infarcts, lacunes of vascular origin, 
WMHs, microbleeds and brain atrophy (Wardlaw et al. 2013). However, there is 
a growing interest in using functional MRI to probe cerebrovascular reactivity in 
patients with cerebral SVD for use as a biomarker of cerebrovascular health 
and therapeutic response (Blair et al. 2015; Sleight et al. 2021; Stringer et al. 
2021). Given that endothelial dysfunction has previously been observed in 
young SHRSPs and presymptomatic patients with cerebral SVD (Bailey et al. 
2011a; Rajani et al. 2018), and that the endothelium plays a key role in 
controlling blood flow (Quick et al. 2021), assessing cerebrovascular reactivity 
may provide an early indicator of tissue at risk.  
 
A loss of vessel reactivity has previously been observed in cerebral SVD 
patients (Saji et al. 2016). Reduced stimulus-evoked BOLD responses have been 
observed in the visual cortex of patients with CAA (Dumas et al. 2012; Peca et 
al. 2013; van Opstal et al. 2017), and in the frontal-temporal and parietal 
cortices of patients with moderate-to-severe WMHs when performing an 
attention task (Atwi et al. 2018). Several studies have used a hypercapnic 
challenge to assess cerebrovascular reactivity in patients with moderate-to-
severe white matter disease and observed a reduced magnitude and speed of 
the vascular response in normal-appearing white matter that later progressed 
to WMH (Sam et al. 2016a; Sam et al. 2016b). Furthermore, age and 
hypertension are strong indicators of WMHs and cognitive decline in cerebral 
SVD (Khan et al. 2007; Abraham et al. 2016). These risk factors are known to 
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induce pathological stiffening of arterial vessels, which may precede the 
development of other features of cerebral SVD. In another study, a significant 
decrease in the BOLD response to a hand-tapping task was observed in the 
somatosensory cortex of patients with SVD who had previously suffered a 
lacunar stroke (Pineiro et al. 2002). Therefore, it is possible that the 
assessment of the hemodynamic response to stimulation may provide a 
biomarker of cerebrovascular health and an indicator of therapeutic response 
to therapies targeting the endothelium or cerebrovasculature in cerebral SVD. 
However, there has been a lag in the assessment of cerebrovascular reactivity 
in animal models of cerebral SVD and, to our knowledge, no study has yet 
assessed cerebrovascular reactivity using functional MRI in the SHRSP. 
Therefore, the assessment of stimulus-evoked BOLD and CBF responses in 
SHRSPs could provide insight on how the hemodynamic response, and thus 




5.1.4 Study Aims and Hypothesis 
To assess the potential of the stimulus-evoked BOLD response as a biomarker of 
cerebrovascular health and a potential marker of therapeutic response in the 
SHRSP, it was important to establish whether significant differences in the 
BOLD response could be observed between WKYs and SHRSPs. Furthermore, 
given that endothelial dysfunction occurs early in disease and cerebrovascular 
reactivity is known to decline with age, such changes were assessed in young 
and aged WKY and SHRSP cohorts to assess whether differences exist. As the 
BOLD response is not only dependent on changes in CBF, we also used LSCI to 
more directly assess any changes in the stimulus-evoked CBF response. Given 
the lack of studies accessing aged SHRSPs, and in the absence of salt-loading, 
we also aimed to acquire and assess structural MRI images to characterise any 
pathological changes. Therefore, in summary, the aims of this study were to:   
1. Evaluate any differences in the stimulus-evoked BOLD response to 
forelimb stimulation between WKYs and SHRSPs, and assess whether any 
differences exist between young and aged cohorts 
2. Evaluate any changes in the stimulus-evoked CBF response to forelimb 
stimulation, as assessed by LSCI, and assess whether any differences 
exist between young and aged cohorts 
3. Characterise any structural differences between young and old WKYs 
and SHRSPs using T2-weighted imaging, including the assessment of brain 
atrophy and the presence of WMHs 
 
Based on previous studies demonstrating endothelial dysfunction and reduced 
cerebrovascular reactivity and hemodynamic responses in patients with 
cerebral SVD and considering the SHRSP to be a valid model of this disease, the 
main hypothesis of this study was that SHRSPs would demonstrate reduced 




5.2.1 Experimental Design  
A 2x2 experimental design was utilised in this study to assess the effects of 
both age and disease on stimulus-evoked BOLD and CBF responses. The 4 
groups consisted of acute WKYs (aWKYs), chronic WKYs (cWKYs), acute SHRSPs 
(aSHRSPs) and chronic SHRSPs (cSHRSPs). Experiments were conducted on 
animals in the acute groups at 3-4 months of age, shortly after the onset of 
hypertension in SHRSPs, and aimed to provide insight into any changes 
occurring during the acute stages of disease. Animals assigned to the chronic 
groups were assessed at 11-12 months of age. At this age, SHRSPs are at an 
increased risk of suffering a spontaneous stroke.  
 
At the indicated ages, functional MRI with forelimb stimulation was used to 
assess changes to the stimulus-evoked BOLD response. While several fMRI 
studies in human patients with cerebral SVD have assessed BOLD responses to 
visual stimulation (Dumas et al. 2012; Peca et al. 2013; van Opstal et al. 2017), 
somatosensory stimulation was chosen for the current experiment due to the 
ease of setting up and implementing this stimulation method in the rat in an 
MRI setting. Furthermore, somatosensory stimulation can be replicated in 
human patients and blunted stimulus-evoked BOLD responses in the 
somatosensory cortex have been observed in patients with cerebral SVD during 
a hand tapping task (Pineiro et al. 2002). Thus, this method is appropriate and 
could easily translate for clinical assessment.  
 
Following fMRI scanning, animals were recovered and one week later, LSCI was 
conducted to measure the stimulus-evoked CBF response. Following LSCI, 
animals were perfused and fixated for future histological analysis, the scope of 
which is beyond this thesis due to time constraints. 
 
5.2.2 Experimental animals 
Animals were obtained from breeding colonies of WKYs and SHRSPs in the 
Institute of Cardiovascular and Medical Sciences, University of Glasgow. Shortly 
after weaning, animals were transferred to the Veterinary Research Facility 
(VRF) where they were kept until they were required for experiments at the 
appropriate age. WKYs and SHRSPs were fed on standard rat chow with food 
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and water available ad libitum. For the acute time point, 12 WKYs and 13 
SHRSPs were assigned while 12 WKYs and 20 SHRSPs were assigned to the 
chronic time point. Each experimental cohort was an independent group; none 
of the animals assigned to the acute time point were used in the chronic 
experiments.  
 
5.2.3 Blood pressure measurements 
To confirm the hypertensive and non-hypertensive phenotypes of SHRSPs and 
WKYs, respectively, systolic blood pressure was measured 1-3 days prior to 
fMRI scanning using tail cuff plethysmography while animals were conscious, as 
previously described in Section 2.6. The mean systolic blood pressure for each 
animal was calculated from 10 individual blood pressure measurements, which 
were compiled for each experimental group. 
In a subgroup of cWKYs (n=5) and cSHRSPs (n=7), systolic blood pressure was 
measured at 3, 4, 5, 6, 7, 9 and 11 months of age to inform on any longitudinal 
changes in blood pressure. 
 
5.2.4 Functional MRI 
5.2.4.1 fMRI preparation 
Animals were anaesthetised, intubated and the femoral artery cannulated for 
blood pressure monitoring and blood gas measurements. The animals were 
then transferred and secured in the MRI cradle, as described in Section 2.4. 
5.2.4.2 Forelimb stimulation 
Needle electrodes were inserted in the right forepaw as detailed in Section 
2.3.3. Stimulation parameters were set at 3 Hz, 6 mA, and 0.3 ms for stimulus 
frequency, stimulus intensity and pulse duration, respectively. The stimulus 
paradigm consisted of 6 on-off blocks where the stimulus was on for 22 seconds 
and off for 38 seconds. The first stimulation block was preceded by a 10 second 
baseline period. 
 
5.2.4.3 Monitoring of physiological variables 
During the experiment, the following variables were monitored and, where 
applicable, maintained within normal limits: 
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• Body temperature - maintained at 37oC ± 0.5 
• Arterial paO2 – normal range: 80-100 mmHg 
• Arterial paCO2 – normal range: 35-45 mmHg 
• Arterial pH – normal range: 7.45-7.55 
• Mean arterial blood pressure 
• Heart rate 
• Breathing rate 
PaO2 was generally higher (110 mmHg-130 mmHg) than the upper normal limit 
as additional O2 was supplemented in the inhalation gas mixture during 
anaesthesia at 30%. Blood gas measurements were assessed in arterial blood 
samples withdrawn via the arterial cannula (approx. 80 µl). Between 3 and 6 
blood samples were taken for each animal during the scanning session, the 
total number depending on the ability to maintain physiological variables 
within normal limits. If blood gas measurements fell outside of the normal 
physiological limits, the ventilator settings were adjusted to return blood gas 
levels back within normal range. Stimulus-evoked BOLD runs were only 
performed when physiological variables were all within normal limits, with the 
exception of PaO2 as previous mentioned.  
 
5.2.4.4 MRI protocol 
MRI experiments were carried out using a Bruker Pharmascan 7T. A FLASH 
sequence was used to verify correct positioning of the animal in the scanner 
and correct positioning of the coil. Local shimming was performed using a 
fieldmap-based algorithm (‘MAPSHIM’). Functional echo planar image (EPI) 
series were acquired during the forelimb stimulation paradigm to assess the 
stimulus-evoked BOLD (TR 750 ms, TE 20 ms, FOV 3.2 x 2.4 cm2, matrix 64 x 
48, 15 slices of 1 mm thickness, in-plane spatial resolution 500 µm2).  
A 320 x 240 µm2 RARE T2 sequence was acquired for structural analysis. T2 
scans were visually assessed to detect any vascular lesions. These were defined 
as regions of hyperintense signal with or without a hypointense region. T2 scans 
were also imported into ImageJ where the whole brain volume (excluding 
ventricles) and the volume of the lateral ventricle were measured. The 
boundaries of the ‘whole brain’ measurement were limited between the 
cerebellum and the interrhinal fissure. 
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5.2.4.4 Recovery following MRI 
Following scanning, animals were removed from the MRI cradle and transferred 
back to the surgical theatre bench top. The arterial cannula was removed, the 
artery sealed and the animal recovered from anaesthesia as described in 
Section 2.6.1. This procedure was performed by Mrs. Lindsay Gallagher. 
  
5.2.5 Laser speckle contrast Imaging experiments 
5.2.5.1 LSCI preparation 
Animals were anaesthetised, intubated and the femoral artery was cannulated 
(opposite femoral artery to that previously cannulated in the fMRI 
experiment). Animals were secured in a stereotaxic frame and the skull was 
exposed and thinned as described in Section 2.3.5. The laser speckle camera 
was subsequently set up as detailed in Section 2.5. 
 
5.2.5.2 Forelimb Stimulation 
Forelimb stimulation was carried out similar to that described in the fMRI 
experiment (Section 4.2.4.2), except that only 3 on-off stimulation blocks were 
performed.  
 
5.2.6 Data Analysis 
5.2.6.1 fMRI 
Data analysis was performed in MATLAB using custom-written scripts, SPM12 
(https://www.fil.ion.ucl.ac.uk/spm/) and AFNI. All MRI datasets were first 
converted from Paravision to NifTI format. A 6-parameter rigid body spatial 
transformation was then applied to each dataset to realign all images to the 
first in the series to correct for scanner drift during the functional scans (SPM). 
A structural image from a WKY was chosen as a target reference space to 
which all other WKY structural scans were registered (SPM) and then averaged 
to produce a structural reference image. The image was re-sliced to match the 
resolution of the functional datasets and fMRI scans from all animals were 
subsequently registered to this reference image. A high pass filter of 0.01 Hz 
was applied to all functional datasets (AFNI). 
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Using the structural reference image, a ROI was drawn in the forelimb area of 
the somatosensory cortex as defined in the Paxinos and Watson atlas (Paxinos 
and Watson 1998). This was then applied to all functional dataset sets to 
extract the BOLD time course from the S1FL area. The 6 on-off stimulation 
blocks were averaged to produce a single stimulus-event from which the peak 
BOLD and integrated BOLD (AUC) values were calculated. Integrated values 
were calculated in Prism Graphpad 8. Only positive peaks were included in the 
AUC measurement and any peaks with a start time outside of the stimulation 
period were excluded from the calculation.  
 
5.2.6.2 LSCI  
Analysis was initially carried out using PIMSoft (Perimed, Stockholm, Sweden). 
ROIs were established over the contralateral and ipsilateral S1FL areas, as well 
as over the ipsilateral visual cortex. The position and size of the ROIs were 
defined based on the Paxinos and Watson rat atlas (Paxinos and Watson 1998). 
For the contralateral S1FL ROI, a 3 x 2 mm2 oval was centred at 0 mm AP and -
4 mm ML to bregma and another centred at 0 mm AP and 4 mm ML to bregma 
for the ipsilateral S1FL area. For the visual cortex ROI, a 3 x 2 mm2 oval was 
centred at -6 mm AP and 4 mm ML to bregma. Relative CBF time courses from 
each ROI were then extracted and normalised to the respective baseline period 
for each ROI. The ROI dataset was averaged across the 3 on-off blocks to 
produce a single event-related average for each animal. The single event-
related time courses for all animals were used to extract the peak %CBF. The 
data was then organised by experimental group and imported to Prism 8 where 
the integral of CBF response (AUC) for every animal was calculated, as 
previously described (Section 4.2.6.1). 
  
5.2.6.3 Statistical Analysis 
All statistical analysis was performed in Prism Graphpad v8.1. Animal 
physiology (e.g. body weight, blood pressure) was assessed by two-way ANOVA 
with the measured variable as the dependent variable and age (acute vs 
chronic) and strain (WKY vs SHRSP) as independent variables. Animal age, 




Functional MRI data and laser speckle data were assessed using a two-way 
ANOVA with the measured characteristic (e.g. peak value or AUC) as the 
dependent variable and strain (WKY or SHRSP) and age (acute or chronic) as 
independent variables. Where applicable, additional pairwise comparisons 
were assessed using Tukey’s multiple comparison’s test, unless otherwise 
stated. Due to the violation of homoscedasticity for two-way ANOVA, both 
BOLD and CBF data were log transformed and subsequent statistical analysis 
performed on the transformed data. Log transformation was chosen as this has 
been previously recommended for fMRI data sets (Lewis et al. 2005). Both log 
transformed and back transformed data values are reported. 
 
Assessment of the main effect of strain on the BOLD and CBF response and 
whether a significant difference could be observed between the two strains 
was the main interest of this study. Based on previous fMRI data in SHRs and 
patients with cerebral SVD, a total sample size of 42 animals across the 4 
groups was required to achieve 0.95 β error probability (effect size f, 0.577; α, 
0.05). Due to exclusions and deaths, this was not achieved in the study and 
based on the actual sample size of the study, there was an 83% probability of 
correctly rejecting the null hypothesis of no difference in the stimulus-evoked 
BOLD response in the MRI study and a 76% probability of correctly rejecting the 





For the acute time point, 3/13 SHRSPs were excluded from fMRI analysis due to 
technical issues that affected the stimulator and prevented reliable 
stimulation of the forelimb. No animals were excluded from the WKY 
population at this time point. Therefore, the total numbers of animals included 
in the fMRI analysis for the acute time point were 12/12 WKYs and 10/13 
SHRSPs.  
 
For the acute follow-up laser speckle experiment, 1/12 WKYs and 2/13 SHRSPs 
were not included in the analysis group. The SHRSPs previously excluded from 
the fMRI analysis (n=3) were included in the laser speckle experiment since 
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they were only excluded for technical issues and had recovered well following 
the fMRI experiment. One (1) WKY and one (1) SHRSP did not recover well 
following the MRI experiment and were subsequently culled. Another SHRSP (1) 
died during surgery due to complications with the arterial line. Therefore, the 
final sample size of the laser speckle analysis group at the acute time point 
was 11/12 WKYs and 11/13 SHRSPs.  
 
For the chronic time point, 3/12 WKYs and 13/20 SHRSPs were not included in 
fMRI analysis. 2 WKYs sustained severe injuries and were subsequently culled 
prior to reaching the designated scanning time point, and 1 WKY was excluded 
due to technical issues that prevented accurate monitoring of body 
temperature. 7 SHRSPs died from spontaneous stroke prior to reaching the 
designated scanning time point and 4 SHRSPs were excluded following scanning 
due to the presence of stroke within the somatosensory cortex. One (1) animal 
showed a hyperintense region in the posterior cortex of the ipsilateral 
hemisphere to stimulation. Since this was only observed in a few slices and did 
not intrude on the S1FL, this animal was included in the analysis. One (1) 
SHRSP did not respond well to anaesthetic induction and was subsequently 
terminated without any scanning. One (1) SHRSP was excluded due to a 
technical error that prevented the stimulation of the forelimb. Therefore, the 
final sample sizes for the chronic fMRI study were 9/12 WKYs and 7/20 SHRSPs.  
 
For the chronic laser speckle follow-up experiment, any animal previously 
excluded from fMRI analysis due to technical issues could again be included in 
the laser speckle study population. Therefore, the total numbers of animals 
available were 10/12 WKYs and 8/20 SHRSPs. However, 1/10 WKY and 2/10 
SHRSPs were not included in laser speckle analysis due to complications during 
surgery that either prevented the acquisition of robust and reliable data or 
resulted in the death of the animal prior to data acquisition. Therefore, the 
total numbers of animals included in the laser speckle analysis group for the 
chronic time point is 9/10 WKYs and 6/10 SHRSPs.  
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3.3.2 Physiological Variables 
3.3.2.1 Animal baseline physiology prior to scanning 
For the acute time point, animals were scanned at an average age of 20 and 18 
weeks for WKYs and SHRSPs, respectively. For the chronic time point, animals 
were scanned at an average age of 54 and 51 weeks for WKYs and SHRSPs, 
respectively (Figure 5.1). As expected, WKYs and SHRSPs at their respective 
acute or chronic time points did not significantly differ in age, however both 
strains at the chronic time point were significantly older compared to the both 
acute groups (p<0.0001 for all comparisons).  
Two-way ANOVA revealed a significant effect of strain on body weight 
(p<0.0001), with SHRSPs generally demonstrating a lower body weight than 
WKYs at both acute and chronic time points (aWKY, 384.6 g; aSHRSP, 290.0 g; 
cWKY, 425.6 g; cSHRSP, 330.0 g; Figure 5.2). Significantly lower body weights 
were observed in aSHRSPs compared to aWKYs (p=0.0017) and cWKYs 
(p<0.0001), while cSHRSPs demonstrated significantly smaller body weights 
compared to cWKYs only (p=0.0006). A significant effect of age was also 
observed (p=0.0012) with older animals generally weighing more than their 
younger counterparts. However, this was only significant between aWKYs and 
cWKYs (p=0.0170). While cSHRSPs body weight was higher than aSHRSPs, this 
was not found to be statistically significant (p=0.3447).  
 
A summary of systolic blood pressure, as assessed by tail cuff plethysmography, 
is shown in Figure 5.3. Acute and chronic SHRSPs had similar systolic blood 
pressures as no difference was found between the two groups (p=0.99). The 
average systolic blood pressure was 213.3 mmHg and 208.7 mmHg for aSHRSPs 
and cSHRSPs, respectively. Both acute and chronic SHRSPs had significantly 
higher systolic blood pressure than aWKYs (149.4 mmHg; p<0.0001 for both) 
and cWKYs (130.5 mmHg; p<0.0001 for both). Interestingly, cWKYs displayed 
significantly lower blood pressure than their acute counterparts (p=0.04).  
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 Figure 5.1: An overview of animal ages for each experimental group. aWKY and aSHRSP animals were similar in age (p=0.1458) but 
both groups were significantly younger than cWKY and cSHRSP (p<0.0001). cSHRSP and cWKY animals were also similar in age 
(p=0.0637). Statistical comparisons performed with one-way ANOVA with Tukey’s multiple comparison’s test. Individual data points for 





Figure 5.2: Overview of animal body weight for each experimental group prior to scanning. A significant effect of age (p=0.0012) and 
strain (p<0.0001) on weight was observed but no interaction (p=0.4648, two-way ANOVA). aWKYs weighed significantly more than 
aSHRSPs (p<0.0017) and cWKYs weighed significantly more than aWKYs (p=0.0170), aSHRSPs(p<0.0001) and cSHRSPs (p=0.0006; Tukey’s 
multiple comparison test). cSHRSPs did not significantly differ from aWKYs or aSHRSPs. Individual data points for each animal shown 




Figure 5.3: Overview of blood pressure for each experimental group prior to scanning as assessed by tail cuff plethysmography. A 
significant effect of strain (p<0.0001) and age (p<0.0428) on blood pressure was observed but no interaction (p=0.1120). Both aSHRSPs 
and cSHRSPs exhibited significantly higher blood pressures than aWKYs and cWKYs (p<0.0001) but did not significantly differ from each 





5.3.2.2 Longitudinal blood pressure 
In a subset of WKYs (n=5) and SHRSPs (n=7) allocated to the chronic time point, 
systolic BP was monitored periodically from 3 months of age until 11 months of 
age. Systolic BP was significantly higher in SHRSPs compared to WKYs at all time 
points investigated (Figure 5.4). Systolic BP measurements in the cSHRSP groups 
were generally above 200 mmHg for all time points, with a mean of 215 mmHg 
being observed throughout. The group-averaged MABP measurements for SHRSPs 
were 209.7 mmHg at 3 months and 210.8 mmHg at 11 months. A mean of 160 
mmHg was observed for WKYs throughout all studied time points however, a 
gradual decrease in systolic BP was observed over time with the first group 
averaged measurement at 3 months showing 171 mmHg and the final 
measurement at 11 months showing 144 mmHg.
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Figure 5.4: Longitudinal systolic BP measurements for aWKY and aSHRSPs at 3, 4, 5, 6, 7, 9 and 11 months. Systolic BP measurements 
were significantly higher in SHRSPs compared to WKYs at all time points investigated. Data was analysed using multiple t-tests with 
statistical significance being determined by the Holm-Sidak method to correct for multiple comparisons. Data presented as mean ± 
standard deviation. *p<0.05; **p<0.01; ***p<0.0001. 
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5.3.2.3 Blood pressure and heart rate during MRI 
Medetomidine is known to affect heart rate and blood pressure (Hollyer 2016). 
Therefore, to inform on such changes following medetomidine administration, 
MABP and HR measurements over a 1-minute period were averaged at 2 minutes 
prior to and 5 minutes after medetomidine bolus administration in a subgroup of 
aWKYs (n = 10) and aSHRSPs (n = 7).  
 
An overview of MABP and HR prior to and following medetomidine administration 
is shown in Figure 5.5. Prior to medetomidine administration, animals were 
maintained on 1.5% isoflurane in medical air supplemented with 30% oxygen. 
Under this initial anaesthesia, group-averaged MABP measurements were 145.8 
mmHg and 196.3 mmHg for aWKYs and aSHRSPs, respectively. Following 
administration of the medetomidine bolus, a significant decrease in MABP was 
observed for both aWKYs (81.7 mmHg, p<0.0001, paired t-test) and aSHRSPs 
(106.5 mmHg, p=0.0008, paired t-test). A similar response pattern was observed 
for HR with group-averaged values of 303 bpm and 335 bpm being observed prior 
to medetomidine administration and 234 bpm and 192 bpm being observed 5 
mins following medetomidine administration for aWKY and aSHRSP, respectively. 
MABP measurements before medetomidine bolus administration were not 
recorded for cWKYs and cSHRSPs. Therefore a comparison of MABP before and 
after medetomidine in these chronic experimental groups is not possible, 
although similar decreases in MABP and HR were generally observed following 
the bolus during the scanning sessions. 
 
MABP was monitored for all groups throughout the scanning session. Due to 
technical issues, MABP and HR measurements from 3 aSHRSPs and 1 cSHRSP were 
not recorded. Under combined medetomidine-isoflurane anaesthesia, MABP was 
similar between aWKYs, cWKYs and cSHRSPs (aWKY, 92.38 mmHg; cWKY, 88.1 
mmHg; cSHRSP, 98.1 mmHg), while aSHRSPs (111.3 mmHg) demonstrated a 
significantly higher MABP than cSHRSPs (p=0.0069) and cWKYs (p=0.0017; Figure 
5.6A). Heart rate measurements between aWKY, cWKY and cSHRSP were also 
similar with aSHRSPs demonstrating higher HR measurements compared to 
aWKY, cWKY and cSHRSPs (Figure 5.6B; aWKY, 207 bpm; aSHRSP, 251 bpm; 
cWKY, 217 bpm; cSHRSP, 224 bpm).  
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Figure 5.5: Blood pressure (A, C) and heart rate (B, D) prior to and following medetomidine administration for aWKY (A, B) and aSHRSPs 
(C, D). Blood pressure was significantly lower following medetomidine administration in both aWKY (p<0.0001, paired t-test) and 
aSHRSP (p<0.001, paired t-test). Heart rate was also significantly lower following medetomidine administration in aWKY (p<0.0001, 




















Figure 5.6: MABP (A) and HR (B) measurements during scanning for all study groups. Both MABP and HR significantly differed between 
experimental groups (p=0.0018 and p =0.0007, respectively). Under medetomidine-isoflurane anaesthesia, MABP was similar for aWKY, 
cWKY and cSHRSP groups. aSHRSPs demonstrated significantly higher MABP values compared to aWKY (p=0.0069) and cWKYs (p=0.0017). 
Similarly, HR s similar between aWKY, cWKY and cSHRSPs but aSHRSPs demonstrated significantly higher HR compared to aWKY 
(p=0.0008), cWKY (p=0.002) and cSHRSP (p=0.0222). Data was analysed using one-way ANOVA with Tukey’s multiple comparisons test. 
















5.3.2.4 Blood pressure and heart rate during LSCI 
MABP and HR were monitored during LSCI (Figure 5.7). Data was not collected 
for 1 aWKY, 2 aSHRSPs, 1 aWKY and 1 cSHRSP. Similar to previous findings during 
MRI, there was a significant difference in MABP between the experimental 
groups (p<0.0001, one-way ANOVA). Under combined medetomidine-isoflurane 
anaesthesia, MABP did not significantly differ between aWKYs, cWKYs, and 
cSHRSPs (aWKY, 85.81 mmHg; cWKY, 75.79 mmHg; cSHRSP, 87.05 mmHg), 
however MABP was significantly higher in aSHRSPs (108.5 mmHg) compared to 
aWKYs and cWKYs (p<0.01 and p<0.0001, respectively). Similar to MABP, mean 
HR over the duration of the experiment was observed to significantly differ 
between the experimental groups (p<0.01, one-way ANOVA). Mean HR did not 
differ between aWKYs, cWKYs, and cSHRSPs (aWKY, 225 bpm; cWKY, 232 bpm; 
cSHRSP, 254 bpm), however HR was significantly higher in aSHRSPs (265 bpm) 







Figure 5.7: MABP (A) and mean HR (b) during LSCI. Both MABP and HR significantly differed between experimental groups (p<0.0001 and 
p<0.01, respectively, one-way ANOVA). MABP was similar for aWKY, cWKY and cSHRSP groups. aSHRSPs demonstrated significantly 
higher MABP values compared to aWKY (p<0.01) and cWKYs (p<0.001). Similarly, no significant differences in HR were observed between 
aWKY, cWKY or cSHRSP but aSHRSPs demonstrated significantly higher HR compared to aWKY (p<0.001), cWKY (p<0.01) and cSHRSP 
(p<0.05). Data was analysed using one-way ANOVA with Tukey’s multiple comparisons test. Adjusted p-values are indicated. Individual 















5.3.3 – Structural Characterisation of WKYs and SHRSPs 
5.3.3.1 T2 Imaging 
T2 imaging was used to detect any vascular lesions. Ischemic lesions showed as 
areas of hyperintense signal (oedema) with or without a localised hypointense 
region. Vascular lesions were not observed in any aWKY, aSHRSP or cWKY 
animals (Figure 5.8). However, in 5 cSHRSPs various vascular lesions were 
identified, 4 of which were located caudally in the left hemisphere and 1 of 
which was located in the right hemisphere. All infarcts were generally confined 
to the cortex. In 1 cSHRSP, a large hyperintense cyst-like structure, indicative of 
a recent infarct, was identified in the left hemisphere and was present 
throughout most of the imaged brain (Figures 5.9). Interestingly, this large 
infarct was generally confined within the cortex, although substantial tissue 
compression was observed. Two animals also demonstrated evidence of recent 
haemorrhages in penetrating cortical arteries, identified by hypointense areas 
(Figure 5.11). Another cSHRSP demonstrated small hypointense ‘spots’ within 
the striatum, indicative of small infarcts (Figure 5.12). In 3 of the 5 cSHRSPs, 
hyperintense areas were clearly defined in the cortex with localised hypointense 
cores (Figures 5.10−5.12). In these animals, hyperintensities were also observed 




Figure 5.8: Overview of selected brain slices from a representative animal from each experiment group. For the cSHRSP group, one of 










Figure 5.9: T2-weighted scan of cSHRSP. Animal had previously suffered a substantial stroke in the left hemisphere that had 







Figure 5.10: T2-weighted scan of cSHRSP. Evidence of a stroke can be observed in the left hemisphere. Single arrow indicates a 





Figure 5.11: T2-weighted scan of cSHRSP. Stroke had occurred in the left hemisphere. Single area indicates a hypointense 





Figure 5.12: T2-weighted scan of a cSHRSP. Stroke in the left hemisphere. Single arrow indicates a hypointense region from a previous 
infarct. Double arrows indicate hyperintensity around the corpus callosum of the affected hemisphere. Three arrows indicate small 
hypointense ‘spots’ within the striatum due to infarct.
 191 
5.3.3.2 Brain volume measurements 
Brain and ventricle volumes were calculated for each experimental group. Two-
way ANOVA found a significant effect of strain (p<0.0001) on brain volume but 
no effect of age (p=0.36) or any interaction (p=0.81).  Mean brain volumes for 
aWKYs (1462 mm3) and cWKYs (1487 mm3) were generally larger than both 
aSHRSPs (1350 mm3) and cSHRSPs (1365 mm3; Figure 5.13A). Brain volumes 
between aWKYs and cWKYs, as well as aSHRSPs and cSHRSPs did not significantly 
differ (p=0.94 and p=0.99, respectively). However, aWKYs had significantly 
larger brain volumes compared to aSHRSPs (p=0.002) and cSHRSPs (p=0.02). 
Brain volumes for cWKYs were also significantly larger compared to aSHRSP and 
cSHRSPs (p<0.001 and p=0.004, respectively).  
 
Lateral ventricle volume followed a similar pattern to that observed in the brain 
volume measurements. Mean lateral volume measurements were generally larger 
in aWKYs (47.28 mm3) and cWKYs (67.56 mm3) compared to both aSHRSPs (14.76 
mm3) and cSHRSPs (26.11 mm3; Figure 5.13B). Two-way ANOVA revealed a 
significant effect of strain (p<0.0001) and age (p=0.0324) on lateral ventricle 
volume with WKYs generally demonstrating larger ventricle volumes than SHRSPs 
and older animals demonstrating larger ventricle volumes compared to younger 
animals. However, no interaction was observed (p=0.8708). Lateral ventricle 
volumes were significantly larger in aWKYs compared to aSHRSP (p<0.0001) and 
cSHRSP (p=0.0003). Similarly, cWKYs demonstrated significantly larger lateral 
ventricle volume compared to aSHRSP and cSHRSP (p<0.0001 for both). Despite 
being larger in both chronic WKYs and SHRSPs, compared to their acute 
counterparts, lateral ventricle volume was not found to significantly differ 






Figure 5.13: Brain and lateral ventricle volumes. (A) Both aWKY and cWKYs had significantly larger brain volumes than aSHRSPs and 
cSHRSPs. A significant effect of strain (p<0.0001) on brain volume was observed but no effect of age (p=0.1525) or interaction 
(p=0.8285; Two-way ANOVA). (B) A significant effect of strain (p<0.0001) and age (p=0.0324) on lateral ventricle volume was observed 
but no interaction (p=0.8708). Both aWKYs and cWKYs had significantly larger lateral ventricle volumes compared to aSHRSPs and 
cSHRSPs. Older animals exhibited numerically larger lateral ventricle volumes but these were not found to significantly differ. (A) 
*p<0.01 vs aSHRSP; †p<0.05 vs cSHRSP; **p<0.001 vs aSHRSP; ¶p<0.01 vs cSHRSP.  (B) *p<0.001 vs cSHRSP; †p<0.0001 vs aSHRSP; 
**p<0.0001 vs aSHRSP and cSHRSP. 





5.3.4 Assessing the effect of acute and chronic hypertension on the stimulus-
evoked BOLD response 
Electrical forelimb stimulation was used to assess the effects of acute and 
chronic disease duration on the stimulus-evoked BOLD signal in young and aged 
WKYs and SHRSPs. Group-averaged BOLD responses are shown in Figure 5.14. 
Both aWKY and cWKY group-average BOLD responses demonstrated a similar 
temporal profile, slowly increasing following stimulus onset to achieve a plateau 
that persisted for the remainder of stimulation and for several seconds once 
stimulation was switched off, but then declined back to baseline. In the aSHRSP 
group, a gradual increase in BOLD peaked shortly following the onset of 
stimulation, declined slightly and then achieved a plateau that was generally 
maintained for the remainder of the stimulation period and then gradually 
declined back to baseline once the stimulus was switched off. The group-
averaged BOLD response for cSHRSPs shows a large increase in the BOLD 
response following stimulus onset, that peaks approximately half-way through 
the stimulation period, and then exhibits a gradual decline for the remainder of 
stimulation, and returns to baseline shortly following the end of stimulation.  
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Figure 5.14: Group-averaged %BOLD time courses in S1FL area. Shaded area indicates stimulation period. Data presented as 
mean ± standard deviation.
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When the characteristics of the BOLD response were assessed, SHRSPs generally 
demonstrated larger BOLD responses, exhibiting larger peak %BOLD and larger 
integrated BOLD values. Both aSHRSPs and cSHRSPs demonstrated significantly 
larger peak %BOLD values than those observed in the aWKY group (Figure 5.15). 
While the mean peak %BOLD observed in the cWKY (0.9%) group was lower than 
both aSHRSPs (1.8%) and cSHRSPs (2.1%), and marginally higher the aWKY group 
(0.7%), it was only observed to be significantly smaller than the cSHRSP group 
and did not significantly differ from the aSHRSP group.  
 
The integrals of BOLD responses were also found to be significantly higher in the 
aSHRSP (23.5%) and cSHRSP (34.5%) groups compared aWKY (8.5%), indicating 
that a larger BOLD response was maintained over the course of stimulation for 
these groups (Figure 5.16). Integrated BOLD measurements for the cWKY (12.4%) 
group were again lower than both SHRSP groups and only marginally higher than 
aWKYs, however no significant difference was observed between cWKY and 
SHRSP groups. While both peak %ΔBOLD and integrated BOLD measurements 
demonstrated an effect of strain, no effect of age or any interaction between 




Figure 5.15: (A) peak %BOLD and (B) log of peak %BOLD in the S1FL area. A two-way ANOVA revealed a significant effect of strain on 
peak %BOLD (p<0.0001) but no significant effect of age (p=0.0998) and no interaction (p=0.1623). Significantly higher peak responses 
were observed in aSHRSPs compared aWKY (p=0.0005) and cWKYs (p=0.0051). Significantly higher peak BOLD values were also observed 
in cSHRSPs compared to aWKY (p<0.0001) and cWKY (p=0.0001). Adjusted p-values are indicated. Individual data points presents with 







Figure 5.16: Integrated (A) BOLD and (B) log of integrated BOLD measurements in the S1FL area. Two-way ANOVA revealed a significant 
effect of strain on integrated BOLD measurements (p=0.0003) but no significant effect of age (p=0.1131) and no interaction (p=0.4357). 
Integrated BOLD measurements were significantly larger in cSHRSPs compared to aWKY (p=0.0020) and cWKY (p=0.0157) when assessed 
by Tukey’s multiple comparisons test. Adjusted p-values are indicated. Individual data points are shown with mean ± standard deviation 




5.3.5 Assessing the effect of acute and chronic hypertension on the stimulus-
evoked CBF response using LSCI 
In a follow-up experiment one week after MRI scanning, we assessed the effects 
of acute and chronic disease duration on the stimulus-evoked CBF response in 
young and aged WKYs and SHRSPs using LSCI. Electrical stimulation of the right 
forepaw evoked a CBF response in the contralateral S1FL area for all animals. 
Raw laser speckle and difference images for a representative aWKY and aSHRSP 
are shown in Figure 5.17. The responses for all experimental groups 
demonstrated a similar temporal profile, peaking shortly after stimulus onset, 
declining slightly over the course of stimulation, and then exhibiting a delayed 
and gradual decline back to baseline once stimulation was stopped (Figure 5.18). 
The ipsilateral S1FL and ipsilateral visual cortex were also monitored as control 
areas to assess any non-specific changes in CBF, however most animals did not 
exhibit responses in these areas during forelimb stimulation (Figure 5.19). 
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Figure 5.17: Raw (top row) and difference (bottom row) laser speckle images before and during stimulation for a representative aWKY 
and aSHRSP. Black and white ROIs indicates contralateral S1FL. Raw images were captured at 10 frames per second, with averaging 
every 10 frames giving an effective frame rate of 1 frame per second.
WKY SHRSP 






















Figure 5.18: Contralateral S1FL area group-averaged %CBF time course for all experimental groups. Shaded area indicates stimulation. 





Figure 5.19: Group-averaged ΔCBF time courses for (A) ipsilateral S1FL and (B) ipsilateral visual cortex. Shaded area indicates 
stimulation. Data presented as mean ± standard deviation.  
B A 
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When the characteristics of the stimulus-evoked CBF response in the 
contralateral S1FL area were assessed by two-way ANOVA, a significant effect of 
strain (p=0.0009) and age (p=0.0003) was observed on CBF peak values, but no 
interaction (p=0.1470). Generally, CBF responses with larger peaks were 
observed in chronic groups compared to younger groups and in SHRSPs compared 
to WKYs. Both aSHRSPs (13.9%) and cSHRSPs (32.7%) demonstrated higher peak 
CBF changes compared to their respective aWKY (9.4%) and cWKY (15.3%) 
counterparts. The largest group-average peak CBF change was observed in the 
cSHRSP group, being significantly higher than aWKY (p<0.0001), aSHRSP 
(p=0.0042) and cWKY (p=0.0116) groups. No significant differences were 
observed between any other experimental groups. 
 
Similar findings were observed when assessing the integral of the CBF response. 
Two-way ANOVA revealed a significant effect of strain (p=0.0093), age 
(p<0.0001) and a significant interaction (p=0.0017). Group-averaged integrated 
CBF values were similar for aWKY (139.5%) and aSHRSPs (134.8%) indicating that 
CBF responses between these two acute groups were similar over the course of 
stimulation. Higher integrated CBF values were observed in the cWKY group 
(228.1%) compared to both acute groups, although the highest integrated CBF 
values, and hence largest CBF responses, were observed in the cSHRSP group 
(618.6%), being significantly larger than aWKY (p<0.0001), aSHRSP (p<0.0001) 






Figure 5.20: Peak %CBF in the contralateral S1FL area. A significant effect of strain (p=0.0009) and age (p=0.0003) were observed but 
no interaction (p = 0.1407; Two-way ANOVA). Larger %CBF peak values were evoked in cSHRSPs compared to aWKY (p<0.0001), aSHRSP 
(p=0.0042) and cWKY (p=0.0116). Adjusted p-values are indicated. Individual data points are shown with mean ± standard deviation 








Figure 5.21: (A) Integrated CBF and (B) log of integrated CBF in the contralateral S1FL. Integrated CBF measurements violated the 
assumption of normal distribution, which was corrected by logarithmic transformation of the data. An effect of strain (p=0.0093), age 
(p<0.0001) and an interaction (p=0.0017; Two-way ANOVA) was observed. Integrated CBF values were significantly larger in cSHRSPs 
compared to aWKY  (P<0.0001), aSHRSP (p<0.0001) and cWKY (p=0.0020). Adjusted p-values indicated. Individual data points shown 
with mean ± standard deviation overlaid. Statistical analysis was performed on log-transformed values only. Non-transformed values 
shown for display purposes.  
A B * 
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Ipsilateral S1FL and visual cortex areas were also monitored for non-specific CBF 
changes. Two-way ANOVA identified a significant effect of strain (p=0.0370) on 
peak %ΔCBF in the ipsilateral S1FL area but no significant effect of age 
(p=0.0987) or any interaction between these variables (0.0620). For most 
animals, CBF fluctuated around baseline values in the ipsilateral S1FL area 
during stimulation, and therefore peak CBF values were generally low. However 
one cSHRSP demonstrated a large response, with a peak CBF value that was 
similar to responses seen in the contralateral S1FL area. Despite this 
observation, no significant pairwise comparisons were found when data was 
further analysed by a Tukey’s multiple comparisons test. When assessing the 
integral of CBF responses in ipsilateral S1FL area, a significant interaction 
(p=0.0397) between age and strain was observed with cSHRSPs demonstrating 
numerically higher mean integrated CBF compared to all other experimental 
groups. This observation was again likely underpinned by the individual large 
response from the previously mentioned cSHRSP and the small size of this group. 
No significant pairwise comparisons were found when data were analysed using a 
Tukey’s multiple comparisons test. CBF in the ipsilateral visual cortex was 
maintained at baseline levels for all experimental groups and no responses were 
observed during stimulation. No significant effect of strain, age or any 
interaction was observed for peak %ΔCBF (p=0.0737, p=0.1235 and p=0.2416, 
respectively) or integrated CBF (p=0.4023, p=0.9509 and p=0.9143, respectively) 




Figure 5.22 Peak %ΔCBF in the ipsilateral S1FL. Two-way ANOVA identified a significant effect of strain (p=0.0370) but no significant 
effect of age (p=0.0987) or any interaction between the two variables (p=0.3620). All animals demonstrated no relevant changes in 
peak %ΔCBF, with the exception of one cSHRSP that exhibited a large CBF response in the ipsilateral S1FL. No significant pairwise 




Figure 5.23: (A) Integrated CBF and (B) log of integrated CBF measurements in the ipsilateral S1FL. Integrated CBF measurements 
violated the assumption of normal distribution, which was corrected by logarithmic transformation of the data. Two-way ANOVA 
revealed a significant interaction (p=0.0397) but no significant effect of strain (p=0.3558) or age (p=0.2406). Most animals exhibited no 
relevant response in the ipsilateral S1FL and therefore small integrated CBF values were observed. One SHRSP exhibited a large CBF 
response in the ipsilateral S1FL. No significant pairwise comparisons were observed (Tukey’s multiple comparisons test). Individual data 







Figure 5.24: Peak %ΔCBF in the ipsilateral visual cortex. Two-way ANOVA revealed no significant effect of strain (p=0.0737), age 
(p=0.8242) or any interaction between the two variables (p=0.2416). CBF activity was generally maintained around baseline with small 




Figure 5.25: (A) Integrated CBF and (B) log of integrated CBF in the ipsilateral visual cortex. Integrated CBF measurements violated the 
assumption of normal distribution, which was corrected by logarithmic transformation of the data. Two-way ANOVA revealed no 
significant effect of strain (p=0.4023), age (p=0.9509) or any interaction between the two variables (p=0.9143). CBF activity was 





The studies in this chapter were performed with the aim to assess the ability of 
the hemodynamic response to inform on changes occurring in a rodent model 
of cerebral SVD, and assess whether these changes could be used to provide a 
biomarker of cerebrovascular health or as an indicator of therapeutic response. 
Furthermore we characterised the radiological features of these animals given 
that few studies have assessed such in aged SHRSPs.  
 
5.4.1 Characterising WKY and SHRSPs 
5.4.1.1 Animal Physiology 
Generally, the assessed characteristics of WKYs and SHRSPs were as expected. 
SHRSPs weighed less than WKYs, a known difference between the two strains 
(Zanchi et al. 1997; Tarr 2012). SHRSPs were confirmed as hypertensive with a 
group-mean systolic blood pressure of 213.3 mmHg and 207.8 mmHg being 
observed for aSHRSPs and cSHRSPs, respectively. These observations are in 
agreement with literature values that reported elevated blood pressure of 
SHRSPs between 220−240 mmHg (Okamoto et al. 1974), marginally higher than 
the SHR, which generally demonstrates a systolic blood pressure between 
180−200 mmHg (Okamoto and Aoki 1963; Dickhout and Lee 1998). Group-
averaged systolic BP in cWKYs was also in agreement with literature values; in 
a plethysmography study an average systolic blood pressure of 114 mmHg was 
observed in normotensive rats (Olmstead et al. 1951). Younger aWKYs 
demonstrated marginally higher systolic blood pressure than older cWKYs when 
assessed by tail cuff plethysmography, with a group mean of 149.4 mmHg. A 
systolic blood pressure of 150 mmHg in the rat has previously been considered 
hypertensive (Okamoto and Aoki 1963), and therefore the younger aWKYs were 
marginally normotensive. Previous tail-cuff and telemetry studies in WKYs have 
observed mean systolic blood pressure values of 130 mmHg and 114 mmHg, 
respectively (Olmstead et al. 1951; Dickhout and Lee 1998), suggesting the 
blood pressure values in the current study were higher than normal. The 
observed higher systolic blood pressure in aWKYs could be due to stress-
induced increases in blood pressure during tail cuff plethysmography. Although 
animals were acclimatised to the tail cuff procedure, it is possible that this 
was not enough to completely acclimatise animals and reduce stress-induced 
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elevations in systolic blood pressure. Older animals would have been handled 
more over time than younger animals, and therefore it is possible that older 
animals were more familiar with human interaction and less stressed by the 
tail cuff plethysmography procedure compared to younger animals. This may 
underpin the decrease in systolic blood pressure observed over time in the 
current study, as opposed to the gradual increase in BP that is generally known 
to occur with ageing (O’Rourke and Nichols 2005). 
 
5.4.1.2 Brain volume 
In contrast to previous studies in hypertensive patients and rats, the lateral 
ventricle volume of SHRSPs at both time points was significantly smaller than 
WKYs. Enlarged ventricles have previously been reported in older, hypertensive 
patients (Salerno et al. 1992; Strassburger et al. 1997). Furthermore, SHRs 
have demonstrated significantly larger lateral ventricle volumes compared to 
WKYs at 35 weeks of age (Kaiser et al. 2014). In that study, the group-averaged 
lateral ventricle volume in WKYs was approx. 50-60 mm3 which is similar to the 
volumes observed in our study for aWKYs (47.28 mm3) and cWKYs (67.56 mm3), 
suggesting that the ventricle volumes in SHRSPs were smaller than normal. It is 
unclear as to why the lateral ventricle volumes in SHRSPs were significantly 
smaller than WKYs in this study. However, it is worth noting that while the 
WKYs in the current study demonstrated similar values to those previously 
reported in the literature, the lateral ventricles of WKYs in the current study 
appeared noticeably dilated on the T2-weighted images, especially in the cWKY 
group.  WKYs were originally bred from the Wistar colony at Kyoto University. 
Both congenital spontaneous hydrocephalus and spontaneous ventriculomegaly 
have been observed to occur in the Wistar rat strain (Tu et al. 2014). 
Hydrocephalus in rats is characterised by a ‘dome’ shaped head and substantial 
dilation of the ventricles that notably compresses the surrounding tissue and 
subsequently leads to a decrease in cortical thickness (Olopade et al. 2012). 
Ventriculomegaly is characterised by mildly dilated ventricles (Tu et al. 2014). 
WKYs did not demonstrate a ‘dome’ head shape or notable compression of 
brain tissue and therefore it is unlikely that these animals developed 
spontaneous hydrocephalus. However, dilation of the lateral ventricles 
appeared similar that with previously reported spontaneous ventriculomegaly 
in Wistar rats (Tu et al. 2014). If the lateral ventricles of WKYs in the current 
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study were indeed similar to those seen in spontaneous ventriculomegaly, this 
may explain why SHRSP lateral ventricle volumes were significantly smaller. 
However, further investigation would be required to assess this observation.  
 
5.4.1.3 T2-weighted Imaging 
In the current study, some of the animals that had suffered a stroke exhibited 
hyperintensity around the corpus callosum. In some instances, the corpus 
callosum appeared to have shifted and the hyperintense region appeared to 
follow the previous position of the white matter. WMHs are typically observed 
in the older and hypertensive populations and are an established characteristic 
of cerebral SVD (Fazekas et al. 1993; Dufouil et al. 2005; Schmidt et al. 2011; 
Wardlaw et al. 2013; Wardlaw et al. 2015). However, in human small vessel 
disease, white matter hyperintensities are generally hyperintense foci that 
appear in both hemispheres (Wardlaw et al. 2013). While some of the animals 
that had suffered a stroke demonstrated hyperintense areas in place of the 
corpus callosum, generally the hyperintense area was observed around the 
white matter and was limited to the affected hemisphere only. Therefore it is 
unlikely that we observed WMHs, as is generally defined in the clinical 
literature.  
 
A previous MRI study assessing white matter in SHRSPs from the same colony 
used in the current study observed no signs of WMH in 10-month old animals 
(Brittain et al. 2013). In the current study, animals were generally older at 
scanning (approx. 12 months), however hyperintensities were only observed in 
3 animals, all of which had suffered a stroke, as confirmed by MRI. In SHRSPs 
with no evidence of stroke in the current cohort, hyperintense areas were not 
observed. The SHRSP cohort examined by Britain et al. (2013) was also stroke-
free, defined by the absence of inactivity and lethargy, hunched appearance, 
piloerection, uncoordinated movements, loss of weight and appetite, and 
confirmed by MRI. Therefore, it is likely that the WMHs observed in the current 
study are associated with the occurrence of stroke, likely owing to the 
reduction in blood flow that occurs with ischemia.  
 
In cSHRSPs with cerebral infarcts, the infarcts in 4 animals were localised to 
the left hemisphere in the vicinity of the posterior/occipital cortex, while 1 
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cSHRSP exhibited an infarct in the right hemisphere. These consisted of a 
hyperintense area with evidence of old and recent haemorrhages. One animal 
also demonstrated evidence of small cortical infarcts within the striatum, 
consistent with the pathology of cerebral SVD (Wardlaw et al. 2013). A study of 
1278 SHRSPs observed that cerebrovascular insults occurred at specified 
predilection sites, with the majority occurring within the cortex (69.8%), with 
the second greatest frequency occurring in the basal ganglia (24.5%; (Yamori et 
al. 1976). Of the infarcts occurring within the cortex, 33.7% occurred the 
anteromedial cortex, 6.0% occurred in the lateral cortex and 30.1% occurred in 
the posterior/occipital cortex, with these areas being supplied by the anterior, 
middle and posterior cerebral artery, respectively. Furthermore, cerebral 
infarction occurred more frequently in the left hemisphere compared to the 
right hemisphere. These findings are consistent with previous observations in 
the literature and therefore confirm that cerebrovascular infarction in SHRSPs 
generally occurs in cortical areas supplied by the cerebral arteries. 
 
5.4.2 Stimulus-evoked BOLD and CBF responses 
Patients with CAA have previously shown dampened BOLD responses in the 
visual cortex to visual stimuli (Dumas et al. 2012; Peca et al. 2013; van Opstal 
et al. 2017). Furthermore, patients with cerebral SVD who had suffered a 
lacunar stroke demonstrated smaller stimulus-evoked BOLD responses in the 
somatosensory cortex in response to a finger-tapping task (Pineiro et al. 2002). 
Blunted CBF responses have also been observed in hypertensive patients 
(Maeda et al. 1993; Jennings et al. 2005). However, in the current study, 
aSHRSPs and cSHRSPs exhibited significantly larger responses compared to both 
aWKYs and cWKYs, as assessed by peak BOLD and integral BOLD values. 
Stimulus-evoked CBF responses were also significantly larger in cSHRSPs 
compared to all other study groups, with aSHRSPs exhibiting similar responses 
as aWKYs and cWKYs. Arteriosclerosis, thickening of the vessel wall, narrowing 
of the arterial lumen, endothelial dysfunction and a loss of vessel reactivity 
have all been reported in SHRSPs (Weber et al. 2006; Bailey et al. 2011b; Li et 
al. 2018; Rajani et al. 2018), and therefore a similar reduction of stimulus-
evoked BOLD and CBF responses was expected in the current study. The 
increased BOLD response in both SHRSP cohorts as well as the increased CBF 
response in cSHRSPs is therefore surprising. To our knowledge, no study has yet 
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examined the stimulus-evoked BOLD response to somatosensory stimulation in 
the SHRSP. While some studies have assessed vessel reactivity in SHRSPs, these 
have generally used vessel myography (Takemori et al. 2013; Wynne et al. 
2018; Kagota et al. 2019). However, several studies have assessed the 
hemodynamic response in the SHR, the parental strain of the SHRSP. 
Hypercapnia-induced CBF and BOLD responses in 3-4 month old SHRs were 
observed to be significantly larger compared to normotensive WKYs (Kim et al. 
2014). The authors attributed the lack of blunted BOLD and CBF responses in 
these hypertensive animals to the lack of hypertension-induced vascular 
remodelling at this early age. However, our observations suggest that this may 
not be the case as in the current study larger BOLD and CBF responses were 
observed in cSHRSPs, in which hypertension-induced vascular remodelling is 
established (Bailey et al. 2011). Furthermore, in a recent study, a significantly 
larger stimulus-evoked BOLD response was observed in 10-week old SHRs, and 
larger but non-significant responses in 40-week old SHRs, compared with age-
matched WKYs (Li et al. 2021). Additionally, cerebrovascular reactivity was 
similar between 10-week old SHRs and WKYs but decreased in 40-week old 
SHRSPs compared to 40-week old WKYs, while stimulus-evoked CBF responses 
were significantly higher in SHRSPs in both groups, compared with WKYs. These 
observations are in opposition to those generally observed in the cerebral SVD 
and hypertensive patient populations and raise questions regarding the 
appropriateness of the SHRSP as a model of cerebral SVD for assessing 
cerebrovascular reactivity. While hypertension is generally associated with 
outward hypertrophic remodelling and thickening of the vessel wall, arterial 
distensibility has been observed to increase in SHRSPs up to 12 weeks old, 
compared to age-matched WKYs, when intra-arterial pressure is approx. 120-
140 mmHg (Zanchi et al. 1997). However, when intra-arterial pressure is within 
the hypertensive range for these animals (180-200 mmHg), arterial 
distensibility is reduced compared to age-matched WKYs. Under the 
anaesthetic protocol in the current study, MABP was substantially decreased 
for SHRSPs during functional imaging, returning to normotensive values 
(approx. 100 mmHg). Therefore, it is possible that under these conditions, 
arterial distensibility was increased, which resulted in substantially larger CBF 
and BOLD responses to forelimb stimulation. Future studies are warranted to 
clarify the underlying mechanism.  
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Given that the SHRSP is also regarded as a model of hypertension, it is difficult 
to disentangle whether the changes in BOLD and CBF responses observed in the 
current study derive from the SVD pathology of this model or whether these 
may be attributable to hypertension alone. Such a distinction is likely difficult 
to ascertain given hypertension is an established risk factor for SVD and is 
typically comorbid with the disease (Khan et al. 2007; Abraham et al. 2016). 
However, the SHRSP is generally considered a viable model of human SVD 
disease (Bailey et al. 2011b) and is known to differ from the SHR (stroke-
resistant). The differences between these two models likely underlie the 
stroke-proneness of the SHRSP and its use as a model of SVD. Therefore, future 
studies could assess both SHRSPs and SHRs to separate any effects that may be 
due to SVD or hypertension alone. 
 
5.4.3 Variation in hemodynamic responses 
While the standard deviation was similar between most study groups when 
assessing peak and integral BOLD and CBF response values, cSHRSPs exhibited 
substantially larger standard deviation, highlighting the variability of responses 
in this data set, which subsequently violated the assumption of 
homoscedasticity and required transformation of the data. A variety of factors 
can affect baseline CBF and thereby affect the stimulus-evoked BOLD/CBF 
response (Whittaker et al. 2016). PaCO2 is one such factor (Cohen et al. 2002; 
Sicard and Duong 2005), however in the current study, it is unlikely that PaCO2 
underpinned the observed variation in responses since PaCO2 was maintained 
within normal limits. We have also shown that under this anaesthetic protocol, 
the BOLD response is robust to changes in PaCO2 even when the values fall 
outside the upper and lower normal limits (Chapter 3). Anaesthesia can also 
affect baseline CBF and thereby affect stimulus-evoked responses (Sicard et al. 
2003; Franceschini et al. 2010). However, the dosage and administration of 
isoflurane and medetomidine was kept constant between animals, and 
therefore it is unlikely that depth of anaesthesia contributed to the observed 
variation in responses. Given that this variation was exhibited only by the 
cSHRSP cohort, it is possible that individual variation in disease severity, 
potentially due to individual differences in cerebrovascular reactivity, underlie 
these observations. Investigation of vessel structure and assessment of baseline 
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CBF may provide further insight into possible mechanisms underpinning the 
variation of responses observed in these animals. 
 
5.4.4 Effect of age on BOLD and CBF responses 
An effect of age was not observed on the stimulus-evoked BOLD response while 
a significant effect of age was observed on the stimulus-evoked CBF response, 
but no significant pairwise comparisons were found. However, cWKYs and 
cSHRSPs generally exhibited larger BOLD and CBF responses (as assessed by 
peak and integral values) compared to their younger counterparts, although 
this was more pronounced for the CBF responses. The lack of significant 
pairwise comparisons is likely underpinned by the large variability observed 
within our data and low sample sizes, particularly within the cSHRSP group.  
 
5.4.5 Hypertension-induced neural alterations 
Interestingly, aSHRSPs exhibited significantly larger BOLD responses compared 
to both WKY cohorts, however stimulus-evoked CBF responses were similar. 
The difference between these observations may be underpinned by the 
difference between these two techniques. LSCI measures CBF at the cortical 
surface while the BOLD signal is the result of the interaction between changes 
in CBF, CBV and CMRO2, a marker of neural activity. While the stimulus-evoked 
CBF response in aSHRSPs was similar to that observed in WKY cohorts, the 
increased BOLD response suggests that CMRO2 and hence the neural response 
to forelimb stimulation may be reduced in these animals. Indeed, chronic 
hypertension has been shown to alter neural activity and induce neuronal loss 
in human patients and a mouse model of Alzheimer’s disease, respectively 
(Jennings and Zanstra 2009; Kruyer et al. 2015). A smaller increase in CMRO2 to 
stimulation would result in reduced oxygen extraction from the blood and 
therefore a higher concentration of oxygenated haemoglobin would remain in 
the blood and result in a larger BOLD response. However, whether these 
observations in the current study are due to neuronal loss or due to altered 




In this chapter, we have shown that the SHRSPs from the University of Glasgow 
colony demonstrate many of the pathological features seen in human SVD. We 
have also shown that SHRSPs exhibit larger BOLD and CBF responses to forelimb 
stimulation compared to aged-matched WKYs. These observations are in 
contrast to that typically observed in older, hypertensive patients and in 
patients with SVD. This observation may be underpinned by the anaesthetic 
protocol employed in this study, which reduced MABP to within normotensive 
values and may have affected arterial distensibility. However, the observed 
changes in the stimulus-evoked BOLD and CBF responses were specific to 
SHRSPs, thereby suggesting altered hemodynamic responses may provide a 
biomarker of SVD. Given the difference between the direction of the change in 
our study and that reported in human SVD patients, further investigation is 








In this thesis, work was undertaken to assess the hemodynamic response in a 
rodent model of cerebral SVD. The SHRSP develops hypertension around 3 
months of age and previous studies have shown that hypertension induces 
vascular remodelling which leads to a loss of vessel elasticity. Furthermore, 
dysfunction of the endothelium, which plays a key role in mediating the 
hemodynamic response, is impaired in both the SHRSP and patients with 
cerebral CVD (Rajani et al. 2018). The hemodynamic response in patients with 
cerebral SVD has previously demonstrated blunted stimulus-evoked BOLD 
responses and reduced cerebrovascular reactivity (Dumas et al. 2012; van 
Opstal et al. 2017). Interest is growing in using the hemodynamic response as a 
biomarker of endothelial function and marker of therapeutic impact. The 
assessment of cerebrovascular reactivity by measuring the BOLD response to a 
hypercapnic challenge has already been used as a primary endpoint in several 
clinical trials (Lavallée et al. 2009; NCT01821118; NCT03082014). However, no 
study has yet assessed the hemodynamic response in the SHRSP, a valid 
preclinical model of cerebral SVD. Therefore, the main study of this thesis 
aimed to assess the changes in the hemodynamic response in young and aged 
SHRSPs to confirm whether similar changes in the hemodynamic response exist 
and inform on its validity as a potential marker for therapeutic impact in this 
preclinical model. However, prior to this study, it was important to minimise 
or eliminate any other potential variables that may interfere with the BOLD 
signal prior to assessing the hemodynamic response in SHRSPs.  
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6.1 Carbon dioxide and capnography 
CO2 is one such factor that is known to affect the BOLD signal (Kety and 
Schmidt 1948; Brevard et al. 2003; Sicard and Duong 2005). In all studies 
described in this thesis, animals were anaesthetised and mechanically 
ventilated and therefore there was potential for the partial PaCO2 to vary over 
the course of an experiment since the animals were not free breathing. Blood 
gas analysis provides an accurate but discrete measure of PaCO2 and requires 
additional surgery which would not be required if a non-invasive measurement 
of PaCO2 could be established. In human fMRI, side-stream end tidal 
capnography is typically used to sample a participant/patients expired air. 
Given that ETCO2 is known to be 3-5 mmHg below PaCO2, this provides a way to 
non-invasively assess PaCO2 and ensure it remains within normal limits. 
However, acquiring reliable ETCO2 from animals with small tidal volumes 
through long sampling lines is difficult due to several physical laws that govern 
the transport of a gas through a tube (Pascucci et al. 1989). This was 
subsequently confirmed in our study in which we observed large variations in 
the differences between ETCO2 measures and PaCO2. It was this variability that 
presented the issue as under some of the set ups, the range between the upper 
and lower limits was approximately 20 mmHg. Monitoring ETCO2 under such 
circumstances could mean that for some measures the difference between 
PaCO2 and ETCO2 could be low and vary by a few mmHg but for others it could 
vary by 20 mmHg. Of course, it is unlikely that PaCO2 would vary to this degree 
in such a short period of time however the variability in the ETCO2 measure 
would make predicting the PaCO2 difficult. Even if a single blood gas 
measurement was taken at the start of the experiment so that PaCO2 was 
known, it would still be difficult to know when the PaCO2 had increased or 
decreased given the large variation in the ETCO2 measurements. Yet, we 
observed reduced variation between PaCO2 and ETCO2 when using the 1 m 
sampling line, compared to the 7 m line, and therefore it is likely that a 
further reduction in the sample line length may provide even narrower limits of 
agreement that could be used in a bench top experiment.  
 
The monitoring of an anesthetised animal’s PaCO2 is of particular importance 
during fMRI experiments given its vasodilatory properties and most studies 
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periodically sample blood from the tail or femoral artery for discrete blood gas 
analysis. Establishing a noninvasive and accurate method to monitor PaCO2  
could provide real-time measures and minimise any required invasive surgery 
however further investigation is required to optimise and assess the validity of 
side-stream capnography in small animals. 
 
6.2 Assessment of stimulus parameters on BOLD, CBF and neural response. 
The sequential assessment of BOLD, CBF and neural activity via separate fMRI, 
LSCI and electrophysiology studies provided an insight into how varying 
stimulus parameters affected these measures. This experiment was also 
required as forelimb stimulation had not previously been set up in our lab and 
given that we were using an anaesthetic protocol that is not commonly used, 
there was a need to characterise the effects of varying stimulation parameters 
and identify the optimal settings. We observed that the optimum parameters 
aligned with those that are commonly used in the literature relevant to our 
anaesthetic protocol i.e. those using medetomidine or low levels of isoflurane. 
However, it was also noted that due to the temporal instability of the BOLD 
signal under medetomidine anaesthesia and the lack of studies assessing the 
temporal evolution of the BOLD signal for our specific protocol, there may have 
been additional variation in our data. This observation highlights two issues; 
firstly, while the use of anaesthesia has many advantages for imaging 
preclinical animal models, it can introduce confounds into the data and 
therefore it is important to understand the effects of your anaesthetic of 
choice and minimise/eliminate any potential confounds as best as possible. 
Secondly, there is a wide variety of anaesthetic protocols in the literature that 
differ in type, dose and administration route. This makes it difficult to 
compare findings between studies and therefore, there is likely a need for 
some standardisation of protocols so that findings will more easily translate 
between studies.  
Given that neural activity and CBF underlie the BOLD signal, assessing these 
measures in this study provided some insight into how neurovascular coupling 
may be affected under this anaesthetic protocol. However, the limitation with 
this study was that due to the lack of facilities to monitor the hemodynamic 
response and neural response simultaneously in the same animal, our findings 
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are only speculative. The ability to assess neural and hemodynamic changes 
simultaneously can indicate whether a change in the hemodynamic response 
arises due to a change in neural response or a change in the vascular response. 
Indeed, such a technique would have been informative in our SHRSP fMRI study 
(Chapter 5) to indicate the origin of the observed increased BOLD and CBF 
responses in the SHRSP compared with the WKY. While it is assumed that such 
observations are attributable to the vasculature, measuring the neural 
response could have confirmed that the neural component remained 
consistent, i.e. a larger BOLD / CBF response was not observed due to increase 
excitability of the neurons.  
 
6.3 The hemodynamic response and SHRSPs 
The increased hemodynamic response observed in the SHRSPs compared to 
WKYs was surprising given that this model has shown many similarities with 
human cerebral SVD pathology and assessments of the hemodynamic response 
in patients with cerebral SVD have generally shown blunted hemodynamic 
responses to stimulation (Pineiro et al. 2002; Dumas et al. 2012; Peca et al. 
2013; van Opstal et al. 2017). As previously described, this observation may be 
due to increased vessel distensibility following a significant and sustained 
reduction in blood pressure. Additionally, baseline CBF is known to affect the 
resultant size of the stimulus-evoked response and therefore, if baseline CBF 
was lower in these animals due to hypertension induced vascular remodelling 
and increased arterial stiffness, it is possible that an increased BOLD response 
could be observed. During the scanning session in this study, diffusion weighted 
imaging were acquired, in addition to RARE and FLASH scans prior to and 
following intravenous administration of ferumoxytol, an ultra small 
superparamagnetic iron oxide agent. The analysis of these scans could have 
informed on baseline CBV and on vessel size index as previously described 
(Boehm-Sturm et al. 2013; Kim et al. 2013), which may provide some insight 
into the results we have observed. However, due to time constraints, this 
analysis could not be performed. Yet, it is worth noting that our observations 
are consistent with other studies that have also observed an increased 
stimulus-evoked BOLD response in the parent SHR strain, compared with WKYs 
(Kim et al. 2014; Li et al. 2021). Thus, evidence is accumulating to suggest that 
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increased BOLD responses are observed in these animals, which could 
subsequently lead us to question whether the SHRSP is an appropriate model 
for assessing cerebrovascular reactivity giving that its response appears the 
opposite of that observed in the human condition. Future studies should aim to 
clarify the mechanisms underlying this observation and confirm whether such 
may arise artificially due to the use of anaesthesia in these preclinical models. 
Such studies could assess the hemodynamic response in this model under other 
anaesthetics that do not drastically affect blood pressure, or even in awake 
animals to confirm whether these may underlie our observations. Until such 
clarification is achieved, it will likely be difficult to use the stimulus-evoked 
BOLD response as a marker of therapeutic response in this preclinical model 
owing to the current difficulty in reconciling endothelial dysfunction with an 
increased hemodynamic response. 
 
6.4 The use of the hemodynamic response as a biomarker of 
cerebrovascular health and therapeutic response 
Endothelial cells comprise the luminal surface of blood vessels and in addition 
to maintaining the integrity of the BBB, they play an active, functional role in 
propagating vasodilatory signals along the vasculature to dilate upstream 
vessels and amplify the hemodynamic response. Endothelial dysfunction, as 
well as dampened stimulus-evoked BOLD responses in the visual and 
somatosensory cortices have been observed in SHRSPs and patients with 
cerebral SVD (Pineiro et al. 2002; Dumas et al. 2012; Peca et al. 2013; van 
Opstal et al. 2017; Rajani et al. 2018). Furthermore, disruption of the 
endothelium results in the failure of neural activation induced vasodilation to 
propagate beyond the local area of activity and attenuates the amplitude and 
temporal dynamics of the hemodynamic response (Chen et al. 2014). 
Collectively, these observations indicate a key role for endothelial cells in 
mediating the hemodynamic response and thereby support the potential for 
the hemodynamic response to provide a biomarker of endothelial function.  
 
Few studies have investigated CVR in patients with cerebral SVD. However, in 
the few reported studies, not only was a reduction in CVR observed, but most 
studies also reported an association between reduced CVR and pathological 
changes, in particular WMHs. One study observed that decreased CVR in an ROI 
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around the carotid and basilar arteries was significantly associated with an 
increased number of WMHs in patients from the Dutch cross-sectional CADASIL 
study (Liem et al. 2009). Impaired CVR has also been associated with subtle 
changes in the tissue integrity of normal-appearing white matter (NAWM), as 
evidenced by a reduction in fractional anisotropy, CBF, CBV and increased 
diffusivity (Sam et al. 2016a). Furthermore, lower CVR values were observed in 
NAWM that later progressed to a WMH, thus indicating an association between 
cerebrovascular regulation and development of WMHs (Sam et al. 2016b). An 
association between a reduced stimulus-evoked BOLD response in the visual 
cortex, higher white matter lesion volume and an increased number of 
microbleeds was also observed in patients with CAA (Peca et al. 2013). 
Collectively, these observations suggest there is value in assessing the 
hemodynamic response in the study of SVD as such studies provide support for 
the key role of endothelial dysfunction in disease pathology and thus identify a 
potential therapeutic target. Indeed, SHRSPs treated with simvastatin or 
perindopril demonstrated reduced endothelial cell proliferation (an indication 
of endothelial dysfunction), significantly increased mature tight junctions and 
reduced myelin rarefaction (Rajani et al. 2018). Given that these drugs have 
differing mechanisms of action and that these changes were observed 
independent of changes in blood pressure, the role of endothelial dysfunction 
as a key mechanism underlying white matter lesions in cerebral SVD is further 
supported and thus a promising therapeutic target. 
 
The use of MRI in cerebral SVD is already established given its role in aiding the 
diagnosis of the disease through the evaluation of structural brain images such 
as T2-weighted and FLAIR images. While other neuroimaging modalities can 
detect some pathological changes to support a diagnosis of SVD, such as 
computed tomography, MRI is the key and preferred neuroimaging modality 
given its higher sensitivity and specificity (Heiss 2018). Therefore, it is not 
unreasonable to assume that in addition to the current MRI protocols already 
being used, others such as those assessing cerebrovascular reactivity could also 
make their way into clinical practice. These could potentially form a standard 
battery of MRI assessments that provide a more comprehensive overview of the 
patient’s condition than that provided by analysis of structural images alone. 
The association between reduced CVR and microstructural changes in NAWM 
(e.g. FA, MD), and the observation that such changes precede the formation of 
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WMHs suggests that the assessment of CVR may identify tissue at risk in 
patients with cerebral SVD. Furthermore, monitoring the hemodynamic 
response of specific areas of known decreased CVR, such as the visual or 
somatosensory cortices, could be used to assess the effect of therapeutic 
intervention on endothelial function, given the critical role of the endothelial 
in mediating the hemodynamic response.  
 
While current evidence is promising it is also limited given the infrequency of 
such assessments in the SVD patient population. Therefore, more studies are 
required to confirm such findings. Furthermore, there is a need to standardise 
the approach for assessing CVR in the patient population. Of the currently 
available studies assessing CVR in patients with cerebral SVD, several different 
stimuli have been used such as breath-holding, hyperventilation, inspired CO2 
challenges, pharmacological stimuli (e.g. acetazolamide) and task-based 
stimulation. Of all these methods, inspired CO2 is likely the easiest to 
implement and requires no task on the part of the patient. It could be argued 
that task-based assessments (i.e. somatosensory or visual) may be limited by 
their reliance on neural activity in response to a stimulus to evoke the 
cerebrovascular response. If over the course of the disease, the relevant neural 
pathways were injured, a reduced hemodynamic response to stimulation may 
result from the reduced neural response owing to injury and therefore the 
hemodynamic response would not be representative of endothelial function. 
However, a CO2 challenge exerts it effect directly on the vasculature, dilating 
the vessels in the absence of any task-based stimuli. Therefore, it is not 
subject to any potential confound owing to reduced neural activity. Previous 
studies in patients with possible CCA-related disease have observed that neural 
responses in the visual cortex remain unaffected despite blunted stimulus-
evoked BOLD responses to visual stimuli (Peca et al. 2013). However, it is not 
known whether neural responses remain intact in different patient populations 
of cerebral SVD or whether they may be affected with increasing disease 
burden and progression. Future studies should clarify whether such a confound 
exists, but it is likely that both task-based and hypercapnic approaches will 
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